CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: f-block element atom
Accession: CHEBI:33562
browse the term
Synonyms: related_synonym: f-block element; f-block elements
G
Akt1
AKT serine/threonine kinase 1
decreases expression
ISO
ceric oxide analog results in decreased expression of AKT1 mRNA
CTD
PMID:24821434
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Alb
albumin
decreases expression increases secretion affects expression
EXP ISO
ceric oxide results in decreased expression of ALB protein ceric oxide results in increased secretion of ALB protein ceric oxide affects the expression of ALB mRNA
CTD
PMID:22072870 PMID:23726862 PMID:29463257
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Ap3d1
adaptor related protein complex 3 subunit delta 1
decreases expression
ISO
ceric oxide analog results in decreased expression of AP3D1 mRNA
CTD
PMID:24821434
NCBI chr 7:9,620,909...9,656,350
Ensembl chr 7:8,970,291...9,005,643
G
Apaf1
apoptotic peptidase activating factor 1
increases expression
ISO
ceric oxide results in increased expression of APAF1 protein
CTD
PMID:24987704
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:25,494,609...25,579,540
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
ceric oxide results in increased expression of BAX protein
CTD
PMID:24987704
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression multiple interactions
ISO
ceric oxide results in decreased expression of BCL2 protein [Air Pollutants results in increased abundance of ceric oxide] which results in decreased expression of BCL2 protein
CTD
PMID:24987704 PMID:36982514
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Birc5
baculoviral IAP repeat-containing 5
increases expression
EXP
ceric oxide results in increased expression of BIRC5 mRNA
CTD
PMID:29463257
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
G
Brca1
BRCA1, DNA repair associated
decreases expression
EXP
ceric oxide results in decreased expression of BRCA1 mRNA
CTD
PMID:29463257
NCBI chr10:86,917,693...86,978,012
Ensembl chr10:86,418,000...86,477,304
G
Car9
carbonic anhydrase 9
multiple interactions
ISO
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of CA9 protein; [Air Pollutants results in increased abundance of ceric oxide] which results in decreased expression of CA9 protein
CTD
PMID:36982514
NCBI chr 5:62,559,024...62,565,626
Ensembl chr 5:57,763,206...57,769,838
G
Casp3
caspase 3
increases cleavage increases expression
ISO
ceric oxide results in increased cleavage of CASP3 protein ceric oxide results in increased expression of CASP3 protein
CTD
PMID:24987704 PMID:26028148
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
affects expression
ISO
ceric oxide analog affects the expression of CASP7 mRNA
CTD
PMID:22960666
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
G
Casp9
caspase 9
increases expression
ISO
ceric oxide results in increased expression of CASP9 protein
CTD
PMID:24987704
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
decreases activity multiple interactions affects expression
ISO EXP
ceric oxide results in decreased activity of CAT protein Acetylcysteine inhibits the reaction [ceric oxide results in decreased activity of CAT protein] ceric oxide affects the expression of CAT protein
CTD
PMID:20457660 PMID:23416263
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Ccl11
C-C motif chemokine ligand 11
multiple interactions increases expression
ISO EXP
[Antigens, Dermatophagoides co-treated with ceric oxide] results in decreased expression of CCL11 mRNA; [Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CCL11 protein; ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of CCL11 mRNA] ceric oxide results in increased expression of CCL11 mRNA
CTD
PMID:29463257 PMID:29792201
NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,028,328...67,032,926
G
Ccl17
C-C motif chemokine ligand 17
multiple interactions increases expression
ISO EXP
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CCL17 mRNA ceric oxide results in increased expression of CCL17 mRNA
CTD
PMID:29463257 PMID:29792201
NCBI chr19:10,208,120...10,218,340
Ensembl chr19:10,202,128...10,203,819
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions increases secretion increases expression
ISO EXP
[Antigens, Dermatophagoides co-treated with ceric oxide] results in decreased expression of CCL2 mRNA ceric oxide results in increased secretion of CCL2 protein ceric oxide results in increased expression of CCL2 mRNA
CTD
PMID:29463257 PMID:29792201
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
multiple interactions affects expression
ISO EXP
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CCL20 mRNA ceric oxide affects the expression of CCL20 mRNA
CTD
PMID:29463257 PMID:29792201
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:84,388,904...84,391,629
G
Ccl22
C-C motif chemokine ligand 22
increases expression
EXP
ceric oxide results in increased expression of CCL22 mRNA
CTD
PMID:29463257
NCBI chr19:10,263,589...10,270,359
Ensembl chr19:10,257,601...10,264,400
G
Ccl24
C-C motif chemokine ligand 24
increases expression
EXP
ceric oxide results in increased expression of CCL24 mRNA
CTD
PMID:29463257
NCBI chr12:21,100,835...21,104,832
Ensembl chr12:21,100,835...21,104,893
G
Ccl26
C-C motif chemokine ligand 26
multiple interactions
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CCL26 mRNA
CTD
PMID:29792201
NCBI chr12:21,109,384...21,114,336
Ensembl chr12:21,109,421...21,114,335
G
Ccl3
C-C motif chemokine ligand 3
increases expression
EXP
ceric oxide results in increased expression of CCL3 mRNA
CTD
PMID:29463257
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
increases expression
EXP
ceric oxide results in increased expression of CCL4 mRNA
CTD
PMID:29463257
NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,452,052...68,468,231
G
Ccl7
C-C motif chemokine ligand 7
increases expression
EXP
ceric oxide results in increased expression of CCL7 mRNA
CTD
PMID:29463257
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Ccr2
C-C motif chemokine receptor 2
increases expression
EXP
ceric oxide results in increased expression of CCR2 mRNA
CTD
PMID:29463257
NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:123,734,430...123,742,100
G
Cd177
CD177 molecule
multiple interactions
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CD177 mRNA
CTD
PMID:29792201
NCBI chr 1:80,340,034...80,360,599
Ensembl chr 1:80,340,034...80,360,621
G
Cd40lg
CD40 ligand
decreases expression
EXP
ceric oxide results in decreased expression of CD40LG mRNA
CTD
PMID:29463257
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:135,126,969...135,138,306
G
Cd63
Cd63 molecule
increases expression
ISO
ceric oxide results in increased expression of CD63 protein
CTD
PMID:23726862
NCBI chr 7:1,909,538...1,924,937
Ensembl chr 7:1,325,103...1,399,178
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions
ISO
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in increased expression of CDKN1A mRNA; [Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in increased expression of CDKN1A protein; [Air Pollutants results in increased abundance of ceric oxide] which results in decreased expression of CDKN1A protein; [Air Pollutants results in increased abundance of ceric oxide] which results in increased expression of CDKN1A protein
CTD
PMID:36982514
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
multiple interactions
ISO
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of CDKN1B protein
CTD
PMID:36982514
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:167,760,181...167,764,982
G
Clca1
chloride channel accessory 1
multiple interactions
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CLCA1 mRNA [Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CLCA1 mRNA; ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of CLCA1 protein]
CTD
PMID:29792201
NCBI chr 2:233,938,677...233,964,369
Ensembl chr 2:233,938,677...233,964,369
G
Clec10a
C-type lectin domain containing 10A
multiple interactions
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CLEC10A mRNA
CTD
PMID:29792201
NCBI chr10:54,876,244...54,880,439
Ensembl chr10:54,876,260...54,880,435
G
Cx3cl1
C-X3-C motif chemokine ligand 1
increases expression
EXP
ceric oxide results in increased expression of CX3CL1 mRNA
CTD
PMID:29463257
NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,227,340...10,236,833
G
Cx3cr1
C-X3-C motif chemokine receptor 1
affects expression
EXP
ceric oxide affects the expression of CX3CR1 mRNA
CTD
PMID:29463257
NCBI chr 8:128,661,294...128,679,048
Ensembl chr 8:119,782,595...119,800,014
G
Cxcl10
C-X-C motif chemokine ligand 10
multiple interactions
ISO
ceric oxide inhibits the reaction [Antigens, Dermatophagoides results in increased expression of CXCL10 mRNA]
CTD
PMID:29792201
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,704,758...15,706,975
G
Cxcl12
C-X-C motif chemokine ligand 12
decreases expression
EXP
ceric oxide results in decreased expression of CXCL12 mRNA
CTD
PMID:29463257
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:150,388,325...150,401,168
G
Cxcl9
C-X-C motif chemokine ligand 9
affects expression
EXP
ceric oxide affects the expression of CXCL9 mRNA
CTD
PMID:29463257
NCBI chr14:16,007,166...16,012,077
Ensembl chr14:15,722,908...15,728,435
G
Cxcr2
C-X-C motif chemokine receptor 2
increases expression
EXP
ceric oxide results in increased expression of CXCR2 mRNA
CTD
PMID:29463257
NCBI chr 9:83,178,645...83,185,017
Ensembl chr 9:75,729,115...75,739,425
G
Cxcr3
C-X-C motif chemokine receptor 3
increases expression
EXP
ceric oxide results in increased expression of CXCR3 mRNA
CTD
PMID:29463257
NCBI chr X:70,884,293...70,886,944
Ensembl chr X:66,844,318...66,846,969
G
Cxcr5
C-X-C motif chemokine receptor 5
decreases expression
EXP
ceric oxide results in decreased expression of CXCR5 mRNA
CTD
PMID:29463257
NCBI chr 8:44,842,098...44,858,425
Ensembl chr 8:44,843,413...44,857,893
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
ISO
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in increased expression of CYP1A1 mRNA; [Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in increased expression of CYP1A1 protein; [Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CYP1A1 mRNA
CTD
PMID:29792201 PMID:36982514
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
affects expression
EXP
ceric oxide affects the expression of CYP1B1 mRNA
CTD
PMID:29463257
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:15,342,344...15,350,917
G
Dbnl
drebrin-like
decreases expression
ISO
ceric oxide analog results in decreased expression of DBNL mRNA
CTD
PMID:24821434
NCBI chr14:80,666,115...80,681,155
Ensembl chr14:80,666,124...80,681,155
G
Dkk4
dickkopf WNT signaling pathway inhibitor 4
multiple interactions
ISO
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of DKK4 protein
CTD
PMID:36982514
NCBI chr16:69,403,215...69,406,580
Ensembl chr16:69,402,989...69,406,580
G
Epas1
endothelial PAS domain protein 1
multiple interactions
ISO
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of EPAS1 protein; [Air Pollutants results in increased abundance of ceric oxide] which results in decreased expression of EPAS1 protein
CTD
PMID:36982514
NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:7,790,647...7,871,228
G
Epx
eosinophil peroxidase
decreases expression
EXP
ceric oxide results in decreased expression of EPX mRNA
CTD
PMID:29463257
NCBI chr10:73,164,096...73,175,180
Ensembl chr10:72,666,865...72,677,952
G
Exo1
exonuclease 1
affects expression
EXP
ceric oxide affects the expression of EXO1 mRNA
CTD
PMID:29463257
NCBI chr13:90,341,947...90,366,861
Ensembl chr13:87,809,810...87,834,654
G
Fabp4
fatty acid binding protein 4
increases expression
EXP
ceric oxide results in increased expression of FABP4 mRNA
CTD
PMID:29463257
NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:91,580,885...91,585,578
G
Gclc
glutamate-cysteine ligase, catalytic subunit
decreases expression
EXP
ceric oxide results in decreased expression of GCLC mRNA
CTD
PMID:29463257
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
decreases expression
EXP
ceric oxide results in decreased expression of GCLM mRNA
CTD
PMID:29463257
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
G
Gpx2
glutathione peroxidase 2
decreases expression
EXP
ceric oxide results in decreased expression of GPX2 mRNA
CTD
PMID:29463257
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Hba-a2
hemoglobin alpha, adult chain 2
decreases expression
EXP
ceric oxide results in decreased expression of HBA1 mRNA
CTD
PMID:29463257
NCBI chr10:15,828,291...15,829,138
Ensembl chr10:15,307,815...15,338,392 Ensembl chr10:15,307,815...15,338,392
G
Hfe
homeostatic iron regulator
decreases expression
ISO
ceric oxide analog results in decreased expression of HFE mRNA
CTD
PMID:24821434
NCBI chr17:41,841,302...41,849,359
Ensembl chr17:41,413,451...41,421,502
G
Hif1a
hypoxia inducible factor 1 subunit alpha
multiple interactions
ISO
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of HIF1A protein; [Air Pollutants results in increased abundance of ceric oxide] which results in decreased expression of HIF1A protein
CTD
PMID:36982514
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
affects expression increases expression decreases expression multiple interactions
ISO
ceric oxide analog affects the expression of HMOX1 mRNA ceric oxide results in increased expression of HMOX1 protein ceric oxide results in decreased expression of HMOX1 mRNA ceric oxide inhibits the reaction [potassium bromate results in increased expression of HMOX1 mRNA]
CTD
PMID:19429248 PMID:22960666 PMID:25618551
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Id2
inhibitor of DNA binding 2
decreases expression
ISO
ceric oxide analog results in decreased expression of ID2 mRNA
CTD
PMID:24821434
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Il13
interleukin 13
multiple interactions
ISO
ceric oxide inhibits the reaction [Antigens, Dermatophagoides results in increased expression of IL13 mRNA]
CTD
PMID:29792201
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:37,790,130...37,792,737
G
Il1a
interleukin 1 alpha
increases expression
EXP
ceric oxide results in increased expression of IL1A mRNA
CTD
PMID:29463257
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
increases expression
EXP
ceric oxide results in increased expression of IL1B mRNA; ceric oxide results in increased expression of IL1B protein
CTD
PMID:21624445 PMID:29463257
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
increases expression
EXP
ceric oxide results in increased expression of IL1RN mRNA
CTD
PMID:29463257
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:7,111,550...7,127,445
G
Il2rb
interleukin 2 receptor subunit beta
decreases expression
EXP
ceric oxide results in decreased expression of IL2RB mRNA
CTD
PMID:29463257
NCBI chr 7:111,913,828...111,928,537
Ensembl chr 7:110,033,341...110,048,054
G
Il2rg
interleukin 2 receptor subunit gamma
increases expression
EXP
ceric oxide results in increased expression of IL2RG mRNA
CTD
PMID:29463257
NCBI chr X:70,435,340...70,439,052
Ensembl chr X:66,392,542...66,399,823
G
Il4
interleukin 4
multiple interactions
ISO
ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of IL4 mRNA]
CTD
PMID:29792201
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:37,771,203...37,776,750
G
Il6
interleukin 6
increases expression multiple interactions
EXP ISO
ceric oxide results in increased expression of IL6 protein [Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of IL6 mRNA
CTD
PMID:21624445 PMID:29792201
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Irf7
interferon regulatory factor 7
multiple interactions
ISO
ceric oxide inhibits the reaction [Antigens, Dermatophagoides results in increased expression of IRF7 mRNA]
CTD
PMID:29792201
NCBI chr 1:205,796,956...205,800,543
Ensembl chr 1:196,367,361...196,370,832
G
Kif13b
kinesin family member 13B
increases expression
ISO
ceric oxide analog results in increased expression of KIF13B mRNA
CTD
PMID:24821434
NCBI chr15:38,908,257...39,066,021
Ensembl chr15:38,924,624...39,084,879
G
Kitlg
KIT ligand
increases expression
ISO
ceric oxide analog results in increased expression of KITLG mRNA
CTD
PMID:24821434
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
G
Lig4
DNA ligase 4
affects expression
EXP
ceric oxide affects the expression of LIG4 mRNA
CTD
PMID:29463257
NCBI chr16:79,518,393...79,526,956
Ensembl chr16:79,518,312...79,527,040
G
Lpo
lactoperoxidase
increases expression
EXP
ceric oxide results in increased expression of LPO mRNA; ceric oxide results in increased expression of LPO protein
CTD
PMID:29463257
NCBI chr10:73,104,170...73,124,683
Ensembl chr10:72,606,944...72,626,535
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation multiple interactions
ISO
ceric oxide results in increased phosphorylation of MAPK1 protein Acetylcysteine inhibits the reaction [ceric oxide results in increased phosphorylation of MAPK1 protein]
CTD
PMID:23416263
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions increases phosphorylation
ISO
Acetylcysteine inhibits the reaction [ceric oxide results in increased phosphorylation of MAPK3 protein]
CTD
PMID:23416263
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mmp12
matrix metallopeptidase 12
multiple interactions increases expression
ISO EXP
ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of MMP12 mRNA] ceric oxide results in increased expression of MMP12 mRNA; ceric oxide results in increased expression of MMP12 protein
CTD
PMID:29463257 PMID:29792201
NCBI chr 8:12,866,652...12,876,554
Ensembl chr 8:4,581,785...4,599,611
G
Mmp9
matrix metallopeptidase 9
increases activity increases secretion
ISO
ceric oxide results in increased activity of MMP9 protein ceric oxide results in increased secretion of MMP9 protein
CTD
PMID:23726862
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
increases secretion increases expression
ISO EXP
ceric oxide results in increased secretion of MPO protein ceric oxide results in increased expression of MPO mRNA
CTD
PMID:23726862 PMID:29463257
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
G
Msh5
mutS homolog 5
increases expression
EXP
ceric oxide results in increased expression of MSH5 mRNA
CTD
PMID:29463257
NCBI chr20:3,779,180...3,797,996
Ensembl chr20:3,776,942...3,793,336
G
Muc1
mucin 1, cell surface associated
multiple interactions
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of MUC1 mRNA
CTD
PMID:29792201
NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:174,635,995...174,640,733
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
multiple interactions
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of MUC5AC mRNA
CTD
PMID:29792201
NCBI chr 1:206,293,717...206,326,006
Ensembl chr 1:196,864,336...196,896,475
G
Mutyh
mutY DNA glycosylase
decreases expression
EXP
ceric oxide results in decreased expression of MUTYH mRNA
CTD
PMID:29463257
NCBI chr 5:135,510,666...135,522,777
Ensembl chr 5:130,274,122...130,286,146
G
Ncf2
neutrophil cytosolic factor 2
increases expression decreases expression
EXP
ceric oxide results in increased expression of NCF2 mRNA ceric oxide results in decreased expression of NCF2 mRNA
CTD
PMID:29463257
NCBI chr13:67,505,492...67,536,015
Ensembl chr13:64,955,503...64,986,277
G
Nfe2l2
NFE2 like bZIP transcription factor 2
affects localization
ISO
ceric oxide affects the localization of NFE2L2 protein
CTD
PMID:19429248
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of NFKB1 protein
CTD
PMID:36982514
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Ngb
neuroglobin
decreases expression
EXP
ceric oxide results in decreased expression of NGB mRNA
CTD
PMID:29463257
NCBI chr 6:106,744,378...106,749,830
Ensembl chr 6:106,744,378...106,749,830
G
Noxo1
NADPH oxidase organizer 1
increases expression
EXP
ceric oxide results in increased expression of NOXO1 mRNA
CTD
PMID:29463257
NCBI chr10:13,723,253...13,726,008
Ensembl chr10:13,721,473...13,726,061
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of NQO1 mRNA
CTD
PMID:29792201
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Opcml
opioid binding protein/cell adhesion molecule-like
increases expression
EXP
ceric oxide results in increased expression of OPCML mRNA
CTD
PMID:29463257
NCBI chr 8:34,451,629...35,562,897
Ensembl chr 8:26,192,841...27,300,620
G
Osm
oncostatin M
affects expression
EXP
ceric oxide affects the expression of OSM mRNA
CTD
PMID:29463257
NCBI chr14:83,327,202...83,332,073
Ensembl chr14:79,104,344...79,108,313
G
Pf4
platelet factor 4
increases expression
EXP
ceric oxide results in increased expression of PF4 mRNA
CTD
PMID:29463257
NCBI chr14:17,582,477...17,583,392
Ensembl chr14:17,298,308...17,299,365
G
Pon3
paraoxonase 3
multiple interactions
ISO
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of PON3 protein
CTD
PMID:36982514
NCBI chr 4:33,356,983...33,383,681
Ensembl chr 4:33,349,168...33,383,855
G
Prdx1
peroxiredoxin 1
multiple interactions
ISO
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased oxidation of PRDX1 protein modified form; [Air Pollutants results in increased abundance of ceric oxide] which results in decreased oxidation of PRDX1 protein modified form
CTD
PMID:36982514
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
G
RT1-CE16
RT1 class I, locus CE16
decreases expression
ISO
ceric oxide analog results in decreased expression of HLA-A mRNA
CTD
PMID:24821434
NCBI chr20:3,261,656...3,265,548
Ensembl chr20:3,257,123...3,279,563
G
Scd
stearoyl-CoA desaturase
affects expression
EXP
ceric oxide affects the expression of SCD1 mRNA
CTD
PMID:29463257
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:243,269,747...243,282,562
G
Sectm1b
secreted and transmembrane 1B
decreases expression
ISO
ceric oxide analog results in decreased expression of SECTM1 mRNA
CTD
PMID:24821434
NCBI chr10:106,324,070...106,333,779
Ensembl chr10:106,325,203...106,333,769
G
Sirt2
sirtuin 2
multiple interactions
ISO
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of SIRT2 protein
CTD
PMID:36982514
NCBI chr 1:93,181,472...93,204,499
Ensembl chr 1:84,052,903...84,076,975
G
Slc26a4
solute carrier family 26 member 4
multiple interactions
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of SLC26A4 mRNA [Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of SLC26A4 mRNA; ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of SLC26A4 mRNA]
CTD
PMID:29792201
NCBI chr 6:53,835,102...53,873,968
Ensembl chr 6:48,107,588...48,145,703
G
Smug1
single-strand-selective monofunctional uracil-DNA glycosylase 1
increases expression
EXP
ceric oxide results in increased expression of SMUG1 mRNA
CTD
PMID:29463257
NCBI chr 7:134,288,565...134,302,179
Ensembl chr 7:134,287,675...134,297,226
G
Sod2
superoxide dismutase 2
multiple interactions increases expression
ISO
[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of SOD2 protein; ceric oxide inhibits the reaction [potassium bromate results in increased expression of SOD2 mRNA] ceric oxide results in increased expression of SOD2 mRNA
CTD
PMID:25618551 PMID:36982514
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Spp1
secreted phosphoprotein 1
decreases expression
EXP
ceric oxide results in decreased expression of SPP1 mRNA
CTD
PMID:29463257
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
G
Tafazzin
tafazzin, phospholipid-lysophospholipid transacylase
decreases expression
ISO
ceric oxide analog results in decreased expression of TAFAZZIN mRNA
CTD
PMID:24821434
NCBI chr X:157,216,826...157,230,524
Ensembl chr X:152,065,609...152,074,001
G
Tirap
TIR domain containing adaptor protein
decreases expression
ISO
ceric oxide analog results in decreased expression of TIRAP mRNA
CTD
PMID:24821434
NCBI chr 8:41,789,557...41,805,903
Ensembl chr 8:33,531,725...33,547,432
G
Tlr6
toll-like receptor 6
decreases expression
ISO
ceric oxide analog results in decreased expression of TLR6 mRNA
CTD
PMID:24821434
NCBI chr14:43,715,809...43,727,019
Ensembl chr14:43,362,164...43,375,685
G
Tnf
tumor necrosis factor
increases expression
EXP ISO
ceric oxide results in increased expression of TNF protein
CTD
PMID:21624445 PMID:27693598
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf4
TNF superfamily member 4
affects expression
EXP
ceric oxide affects the expression of TNFSF4 mRNA
CTD
PMID:29463257
NCBI chr13:76,256,654...76,280,133
Ensembl chr13:73,723,329...73,746,788
G
Tollip
toll interacting protein
decreases expression
ISO
ceric oxide analog results in decreased expression of TOLLIP mRNA
CTD
PMID:24821434
NCBI chr 1:196,961,585...196,984,252
Ensembl chr 1:196,950,771...196,983,625
G
Tp53
tumor protein p53
increases phosphorylation multiple interactions
ISO
ceric oxide results in increased phosphorylation of TP53 protein [Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in increased expression of TP53 protein; [Air Pollutants results in increased abundance of ceric oxide] which results in increased expression of TP53 protein
CTD
PMID:24987704 PMID:36982514
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Tslp
thymic stromal lymphopoietin
multiple interactions
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of TSLP mRNA
CTD
PMID:29792201
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
G
Txnip
thioredoxin interacting protein
decreases expression
EXP
ceric oxide results in decreased expression of TXNIP mRNA
CTD
PMID:29463257
NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:184,092,991...184,096,886
G
Ahr
aryl hydrocarbon receptor
affects expression
ISO
Cerium affects the expression of AHR mRNA
CTD
PMID:35641671
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Atf4
activating transcription factor 4
affects expression
ISO
Cerium affects the expression of ATF4 mRNA
CTD
PMID:35641671
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:111,804,183...111,806,446
G
Cacna1g
calcium voltage-gated channel subunit alpha1 G
multiple interactions
ISO
Cerium inhibits the reaction [CACNA1G protein results in increased transport of Barium]
CTD
PMID:12163980
NCBI chr10:79,851,886...79,919,926
Ensembl chr10:79,355,008...79,422,752
G
Hif1a
hypoxia inducible factor 1 subunit alpha
decreases expression
ISO
Cerium results in decreased expression of HIF1A mRNA
CTD
PMID:35641671
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Mtf1
metal-regulatory transcription factor 1
decreases expression
ISO
Cerium results in decreased expression of MTF1 mRNA
CTD
PMID:35641671
NCBI chr 5:137,062,319...137,107,136
Ensembl chr 5:137,062,376...137,107,136
G
Nfe2l2
NFE2 like bZIP transcription factor 2
decreases expression
ISO
Cerium results in decreased expression of NFE2L2 mRNA
CTD
PMID:35641671
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
decreases expression
ISO
Cerium results in decreased expression of NFKB1 mRNA
CTD
PMID:35641671
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Pparg
peroxisome proliferator-activated receptor gamma
decreases expression
ISO
Cerium results in decreased expression of PPARG mRNA
CTD
PMID:35641671
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Stat1
signal transducer and activator of transcription 1
affects expression
ISO
Cerium affects the expression of STAT1 mRNA
CTD
PMID:35641671
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:49,419,340...49,588,540
G
Stat2
signal transducer and activator of transcription 2
affects expression
ISO
Cerium affects the expression of STAT2 mRNA
CTD
PMID:35641671
NCBI chr 7:1,287,025...1,302,858
Ensembl chr 7:702,495...718,967
G
Tp53
tumor protein p53
decreases expression
ISO
Cerium results in decreased expression of TP53 mRNA
CTD
PMID:35641671
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Xbp1
X-box binding protein 1
decreases expression
ISO
Cerium results in decreased expression of XBP1 mRNA
CTD
PMID:35641671
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Alb
albumin
affects expression
ISO
cerous chloride affects the expression of ALB mRNA
CTD
PMID:23139204
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Alox12
arachidonate 12-lipoxygenase, 12S type
decreases expression multiple interactions
ISO
cerous chloride results in decreased expression of ALOX12 mRNA [cerous chloride co-treated with lanthanum chloride] results in decreased expression of ALOX12 mRNA
CTD
PMID:28954213
NCBI chr10:55,456,923...55,469,239
Ensembl chr10:54,958,271...54,970,542
G
Aox1
aldehyde oxidase 1
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of AOX1 mRNA
CTD
PMID:28954213
NCBI chr 9:67,073,831...67,152,980
Ensembl chr 9:59,579,649...59,658,770
G
Apoa4
apolipoprotein A4
affects expression
ISO
cerous chloride affects the expression of APOA4 mRNA
CTD
PMID:23139204
NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:46,539,082...46,541,469
G
Apoe
apolipoprotein E
affects expression multiple interactions
ISO
cerous chloride affects the expression of APOE mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of APOE mRNA
CTD
PMID:28954213
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
G
B2m
beta-2 microglobulin
increases expression
ISO
cerous chloride results in increased expression of B2M mRNA
CTD
PMID:28954213
NCBI chr 3:129,549,236...129,555,354
Ensembl chr 3:109,095,729...109,101,766
G
Cat
catalase
multiple interactions decreases expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of CAT mRNA cerous chloride results in decreased expression of CAT mRNA
CTD
PMID:28954213
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Ccl5
C-C motif chemokine ligand 5
increases expression multiple interactions
ISO
cerous chloride results in increased expression of CCL5 mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of CCL5 mRNA
CTD
PMID:28954213
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,322,829...68,327,377
G
Ccs
copper chaperone for superoxide dismutase
multiple interactions decreases expression
ISO
[cerous chloride co-treated with lanthanum chloride] affects the expression of CCS mRNA cerous chloride results in decreased expression of CCS mRNA
CTD
PMID:28954213
NCBI chr 1:211,543,192...211,564,354
Ensembl chr 1:202,113,804...202,134,915
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
decreases expression
ISO
cerous chloride results in decreased expression of CDKN1A mRNA
CTD
PMID:23139204
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cel
carboxyl ester lipase
increases expression
ISO
cerous chloride results in increased expression of CEL mRNA
CTD
PMID:23139204
NCBI chr 3:32,281,518...32,289,019
Ensembl chr 3:11,883,532...11,891,035
G
Cfd
complement factor D
affects expression
ISO
cerous chloride affects the expression of CFD mRNA
CTD
PMID:23139204
NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:9,813,150...9,815,053
G
Chuk
component of inhibitor of nuclear factor kappa B kinase complex
increases expression
ISO
cerous chloride results in increased expression of CHUK mRNA; cerous chloride results in increased expression of CHUK protein
CTD
PMID:21656643
NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:242,959,760...242,995,065
G
Cygb
cytoglobin
affects expression multiple interactions
ISO
cerous chloride affects the expression of CYGB mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of CYGB mRNA
CTD
PMID:28954213
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
cerous chloride results in increased expression of CYP1A1
CTD
PMID:23712967
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Cyp51
cytochrome P450, family 51
affects expression
ISO
cerous chloride affects the expression of CYP51 mRNA
CTD
PMID:23139204
NCBI chr 4:30,991,693...31,010,147
Ensembl chr 4:30,036,865...30,055,410 Ensembl chr 6:30,036,865...30,055,410
G
Cyp7b1
cytochrome P450 family 7 subfamily B member 1
increases expression
ISO
cerous chloride results in increased expression of CYP7B1 mRNA
CTD
PMID:23139204
NCBI chr 2:102,419,011...102,586,047
Ensembl chr 2:100,502,791...100,669,698
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
affects expression
ISO
cerous chloride affects the expression of CYP8B1 mRNA
CTD
PMID:23139204
NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:121,557,062...121,580,166
G
Dhcr24
24-dehydrocholesterol reductase
decreases expression
ISO
cerous chloride results in decreased expression of DHCR24 mRNA
CTD
PMID:28954213
NCBI chr 5:126,573,366...126,599,940
Ensembl chr 5:121,344,575...121,371,137
G
Dhcr7
7-dehydrocholesterol reductase
affects expression
ISO
cerous chloride affects the expression of DHCR7 mRNA
CTD
PMID:23139204
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
G
Duox1
dual oxidase 1
decreases expression multiple interactions
ISO
cerous chloride results in decreased expression of DUOX1 mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of DUOX1 mRNA
CTD
PMID:28954213
NCBI chr 3:109,260,526...109,295,588
Ensembl chr 3:109,262,397...109,295,563
G
Duox2
dual oxidase 2
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of DUOX2 mRNA
CTD
PMID:28954213
NCBI chr 3:109,223,809...109,247,023
Ensembl chr 3:109,226,924...109,245,902
G
Dusp1
dual specificity phosphatase 1
multiple interactions affects expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of DUSP1 mRNA cerous chloride affects the expression of DUSP1 mRNA
CTD
PMID:28954213
NCBI chr10:17,184,853...17,187,646
G
Ebp
EBP, cholestenol delta-isomerase
affects expression
ISO
cerous chloride affects the expression of EBP mRNA
CTD
PMID:23139204
NCBI chr X:16,971,372...16,977,782
Ensembl chr X:14,299,448...14,305,826
G
Ehhadh
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase
affects expression
ISO
cerous chloride affects the expression of EHHADH mRNA
CTD
PMID:23139204
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
G
Ephx2
epoxide hydrolase 2
affects expression multiple interactions
ISO
cerous chloride affects the expression of EPHX2 mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of EPHX2 mRNA
CTD
PMID:28954213
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:40,289,902...40,327,615
G
Epx
eosinophil peroxidase
decreases expression
ISO
cerous chloride results in decreased expression of EPX mRNA
CTD
PMID:28954213
NCBI chr10:73,164,096...73,175,180
Ensembl chr10:72,666,865...72,677,952
G
Foxm1
forkhead box M1
multiple interactions decreases expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of FOXM1 mRNA cerous chloride results in decreased expression of FOXM1 mRNA
CTD
PMID:28954213
NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:161,638,816...161,650,684
G
Fth1
ferritin heavy chain 1
increases expression
ISO
cerous chloride results in increased expression of FTH1 mRNA
CTD
PMID:28954213
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
decreases expression multiple interactions
ISO
cerous chloride results in decreased expression of GAPDH mRNA [cerous chloride co-treated with lanthanum chloride] results in decreased expression of GAPDH mRNA
CTD
PMID:28954213
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:157,962,343...157,966,235
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression multiple interactions
ISO
cerous chloride results in increased expression of GCLC mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of GCLC mRNA
CTD
PMID:28954213
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
decreases expression
ISO
cerous chloride results in decreased expression of GCLM mRNA
CTD
PMID:28954213
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
G
Gpd2
glycerol-3-phosphate dehydrogenase 2
affects expression
ISO
cerous chloride affects the expression of GPD2 mRNA
CTD
PMID:23139204
NCBI chr 3:62,209,432...62,346,590
Ensembl chr 3:41,801,930...41,936,901
G
Gpx2
glutathione peroxidase 2
decreases expression
ISO
cerous chloride results in decreased expression of GPX2 mRNA
CTD
PMID:28954213
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Gpx3
glutathione peroxidase 3
multiple interactions affects expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of GPX3 mRNA cerous chloride affects the expression of GPX3 mRNA
CTD
PMID:28954213
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
G
Gpx4
glutathione peroxidase 4
affects expression
ISO
cerous chloride affects the expression of GPX4 mRNA
CTD
PMID:28954213
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
G
Gpx7
glutathione peroxidase 7
decreases expression multiple interactions
ISO
cerous chloride results in decreased expression of GPX7 mRNA [cerous chloride co-treated with lanthanum chloride] results in decreased expression of GPX7 mRNA
CTD
PMID:28954213
NCBI chr 5:123,145,151...123,153,141
Ensembl chr 5:123,144,331...123,153,004
G
Grb2
growth factor receptor bound protein 2
affects expression
ISO
cerous chloride affects the expression of GRB2 mRNA
CTD
PMID:23139204
NCBI chr10:101,380,354...101,448,138
Ensembl chr10:100,869,718...100,949,309
G
Gstp1
glutathione S-transferase pi 1
decreases expression
ISO
cerous chloride results in decreased expression of GSTP1 mRNA
CTD
PMID:28954213
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Gstz1
glutathione S-transferase zeta 1
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of GSTZ1 mRNA
CTD
PMID:28954213
NCBI chr 6:112,525,576...112,536,228
Ensembl chr 6:106,794,074...106,805,284
G
Gtf2i
general transcription factor II I
decreases expression
ISO
cerous chloride results in decreased expression of GTF2I mRNA
CTD
PMID:28954213
NCBI chr12:28,037,344...28,112,677
Ensembl chr12:22,401,431...22,476,243
G
Hmox1
heme oxygenase 1
multiple interactions affects expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of HMOX1 mRNA cerous chloride affects the expression of HMOX1 mRNA
CTD
PMID:28954213
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
decreases expression
ISO
cerous chloride results in decreased expression of HSPA1A mRNA
CTD
PMID:28954213
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,856,006...3,873,227
G
Ifng
interferon gamma
increases expression
ISO
cerous chloride results in increased expression of IFNG
CTD
PMID:23712967
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
increases expression
ISO
cerous chloride results in increased expression of IKBKB mRNA; cerous chloride results in increased expression of IKBKB protein
CTD
PMID:21656643
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
G
Il10
interleukin 10
increases expression
ISO
cerous chloride results in increased expression of IL10
CTD
PMID:23712967
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il18
interleukin 18
increases expression
ISO
cerous chloride results in increased expression of IL18
CTD
PMID:23712967
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
increases expression
ISO
cerous chloride results in increased expression of IL1B
CTD
PMID:23712967
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
decreases expression increases expression
ISO
cerous chloride results in decreased expression of IL2 mRNA; cerous chloride results in decreased expression of IL2 protein cerous chloride results in increased expression of IL2
CTD
PMID:21656643 PMID:23712967
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
G
Il4
interleukin 4
increases expression
ISO
cerous chloride results in increased expression of IL4
CTD
PMID:23712967
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:37,771,203...37,776,750
G
Il6
interleukin 6
multiple interactions increases expression
ISO
IL6 mutant form inhibits the reaction [cerous chloride results in increased expression of SAA protein] cerous chloride results in increased expression of IL6; cerous chloride results in increased expression of IL6 protein
CTD
PMID:16204935 PMID:23712967
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
affects expression
ISO
cerous chloride affects the expression of JUN mRNA
CTD
PMID:23139204
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Lpo
lactoperoxidase
multiple interactions increases expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of LPO mRNA cerous chloride results in increased expression of LPO mRNA
CTD
PMID:28954213
NCBI chr10:73,104,170...73,124,683
Ensembl chr10:72,606,944...72,626,535
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
increases expression
ISO
cerous chloride results in increased expression of MAP1LC3B protein
CTD
PMID:38253231
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
G
Map4k4
mitogen-activated protein kinase kinase kinase kinase 4
increases expression
ISO
cerous chloride results in increased expression of MAP4K4 mRNA; cerous chloride results in increased expression of MAP4K4 protein
CTD
PMID:21656643
NCBI chr 9:42,200,708...42,326,708
Ensembl chr 9:42,200,278...42,326,698
G
Mb
myoglobin
increases expression multiple interactions
ISO
cerous chloride results in increased expression of MB mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of MB mRNA
CTD
PMID:28954213
NCBI chr 7:108,759,903...108,767,134
Ensembl chr 7:108,759,904...108,767,383
G
Mbl2
mannose binding lectin 2
decreases expression multiple interactions
ISO
cerous chloride results in decreased expression of MBL2 mRNA [cerous chloride co-treated with lanthanum chloride] results in decreased expression of MBL2 mRNA
CTD
PMID:28954213
NCBI chr 1:237,429,873...237,465,567
G
Mif
macrophage migration inhibitory factor
increases expression
ISO
cerous chloride results in increased expression of MIF
CTD
PMID:23712967
NCBI chr20:12,767,138...12,791,222
Ensembl chr20:12,790,902...12,799,504 Ensembl chr 4:12,790,902...12,799,504
G
Mpo
myeloperoxidase
affects expression
ISO
cerous chloride affects the expression of MPO mRNA
CTD
PMID:28954213
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
G
Mpv17
mitochondrial inner membrane protein MPV17
multiple interactions decreases expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of MPV17 mRNA cerous chloride results in decreased expression of MPV17 mRNA
CTD
PMID:28954213
NCBI chr 6:25,221,668...25,236,241
Ensembl chr 6:25,222,896...25,236,244
G
Msra
methionine sulfoxide reductase A
decreases expression
ISO
cerous chloride results in decreased expression of MSRA mRNA
CTD
PMID:28954213
NCBI chr15:38,363,459...38,677,406
Ensembl chr15:38,351,445...38,676,585
G
Mt1
metallothionein 1
increases expression multiple interactions
ISO
cerous chloride results in increased expression of MT1 protein cerous chloride promotes the reaction [Zinc binds to MT1 protein]
CTD
PMID:15964310 PMID:16204935
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
G
Mt2
metallothionein 2
multiple interactions increases expression
ISO
cerous chloride promotes the reaction [Zinc binds to MT2 protein] cerous chloride results in increased expression of MT2 protein
CTD
PMID:15964310 PMID:16204935
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,832,002...10,832,784
G
Ncf1
neutrophil cytosolic factor 1
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of NCF1 mRNA
CTD
PMID:28954213
NCBI chr12:28,121,816...28,131,080
Ensembl chr12:22,485,451...22,494,646
G
Ncf2
neutrophil cytosolic factor 2
affects expression multiple interactions
ISO
cerous chloride affects the expression of NCF2 mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of NCF2 mRNA
CTD
PMID:28954213
NCBI chr13:67,505,492...67,536,015
Ensembl chr13:64,955,503...64,986,277
G
Nfkb1
nuclear factor kappa B subunit 1
increases expression
ISO
cerous chloride results in increased expression of NFKB1 mRNA; cerous chloride results in increased expression of NFKB1 protein
CTD
PMID:21656643
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Nfkb2
nuclear factor kappa B subunit 2
increases expression
ISO
cerous chloride results in increased expression of NFKB2 mRNA; cerous chloride results in increased expression of NFKB2 protein
CTD
PMID:21656643
NCBI chr 1:255,106,010...255,114,649
Ensembl chr 1:245,165,950...245,173,213
G
Nfkbib
NFKB inhibitor beta
decreases expression
ISO
cerous chloride results in decreased expression of NFKBIB mRNA; cerous chloride results in decreased expression of NFKBIB protein
CTD
PMID:21656643
NCBI chr 1:93,173,817...93,181,387
Ensembl chr 1:84,046,295...84,053,862
G
Nnmt
nicotinamide N-methyltransferase
affects expression
ISO
cerous chloride affects the expression of NNMT mRNA
CTD
PMID:23139204
NCBI chr 8:48,928,663...48,947,734
Ensembl chr 8:48,933,598...48,946,655
G
Nos2
nitric oxide synthase 2
decreases expression multiple interactions
ISO
cerous chloride results in decreased expression of NOS2 mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of NOS2 mRNA
CTD
PMID:28954213
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Npm1
nucleophosmin 1
multiple interactions
ISO
cerous chloride results in decreased expression of and affects the localization of NPM1 protein
CTD
PMID:38253231
NCBI chr10:17,741,512...17,751,626
Ensembl chr10:17,739,941...17,751,645 Ensembl chr X:17,739,941...17,751,645
G
Nt5e
5' nucleotidase, ecto
decreases expression
ISO
cerous chloride results in decreased expression of NT5E mRNA
CTD
PMID:23139204
NCBI chr 8:98,150,925...98,195,646
Ensembl chr 8:89,270,696...89,314,881
G
Nudt1
nudix hydrolase 1
multiple interactions decreases expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of NUDT1 mRNA cerous chloride results in decreased expression of NUDT1 mRNA
CTD
PMID:28954213
NCBI chr12:14,302,514...14,309,559
Ensembl chr12:14,302,694...14,305,826
G
Pcna
proliferating cell nuclear antigen
affects expression multiple interactions
ISO
cerous chloride affects the expression of PCNA protein [cerous chloride co-treated with lanthanum chloride] affects the expression of PCNA protein
CTD
PMID:28954213
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pnkp
polynucleotide kinase 3'-phosphatase
decreases expression
ISO
cerous chloride results in decreased expression of PNKP mRNA
CTD
PMID:28954213
NCBI chr 1:95,341,465...95,346,921
Ensembl chr 1:95,341,620...95,346,920
G
Prdx1
peroxiredoxin 1
multiple interactions decreases expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of PRDX1 mRNA cerous chloride results in decreased expression of PRDX1 mRNA
CTD
PMID:28954213
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
G
Prdx2
peroxiredoxin 2
decreases expression
ISO
cerous chloride results in decreased expression of PRDX2 mRNA
CTD
PMID:28954213
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
G
Prdx5
peroxiredoxin 5
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of PRDX5 mRNA
CTD
PMID:28954213
NCBI chr 1:204,099,826...204,103,589
Ensembl chr 1:204,099,826...204,114,268
G
Prex1
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of PREX1 mRNA
CTD
PMID:28954213
NCBI chr 3:155,306,950...155,456,688
Ensembl chr 3:155,306,950...155,456,688
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression
ISO
cerous chloride results in decreased expression of PTGS2 mRNA
CTD
PMID:28954213
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Pxdn
peroxidasin
multiple interactions decreases expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of PXDN mRNA cerous chloride results in decreased expression of PXDN mRNA
CTD
PMID:28954213
NCBI chr 6:46,580,749...46,658,345
Ensembl chr 6:46,580,761...46,658,345
G
Rad51
RAD51 recombinase
multiple interactions
ISO
[cerous chloride co-treated with Cisplatin] results in increased expression of RAD51 protein
CTD
PMID:38253231
NCBI chr 3:126,554,210...126,578,888
Ensembl chr 3:106,100,381...106,125,035
G
Rela
RELA proto-oncogene, NF-kB subunit
increases expression
ISO
cerous chloride results in increased expression of RELA mRNA; cerous chloride results in increased expression of RELA protein
CTD
PMID:21656643
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Scara3
scavenger receptor class A, member 3
decreases expression
ISO
cerous chloride results in decreased expression of SCARA3 mRNA
CTD
PMID:28954213
NCBI chr15:40,139,873...40,172,866
Ensembl chr15:40,140,161...40,172,894
G
Selenop
selenoprotein P
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of SELENOP mRNA
CTD
PMID:28954213
NCBI chr 2:54,225,736...54,236,022
Ensembl chr 2:52,498,339...52,508,852
G
Sirt2
sirtuin 2
multiple interactions decreases expression increases expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of SIRT2 mRNA cerous chloride results in decreased expression of SIRT2 mRNA cerous chloride results in increased expression of SIRT2 mRNA
CTD
PMID:28954213
NCBI chr 1:93,181,472...93,204,499
Ensembl chr 1:84,052,903...84,076,975
G
Sod1
superoxide dismutase 1
decreases activity
ISO
cerous chloride results in decreased activity of SOD1 protein
CTD
PMID:15964310
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
decreases activity multiple interactions
ISO
cerous chloride results in decreased activity of SOD2 protein [cerous chloride co-treated with lanthanum chloride] results in increased expression of SOD2 mRNA
CTD
PMID:15964310 PMID:28954213
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Sqstm1
sequestosome 1
multiple interactions affects expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of SQSTM1 mRNA cerous chloride affects the expression of SQSTM1 mRNA
CTD
PMID:28954213
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673
G
Srxn1
sulfiredoxin 1
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of SRXN1 mRNA
CTD
PMID:28954213
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Stk25
serine/threonine kinase 25
decreases expression multiple interactions
ISO
cerous chloride results in decreased expression of STK25 mRNA [cerous chloride co-treated with lanthanum chloride] results in decreased expression of STK25 mRNA
CTD
PMID:28954213
NCBI chr 9:94,161,834...94,174,095
Ensembl chr 9:94,161,836...94,174,244
G
Tgfb1
transforming growth factor, beta 1
increases expression
ISO
cerous chloride results in increased expression of TGFB1
CTD
PMID:23712967
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Tlr2
toll-like receptor 2
increases expression
ISO
cerous chloride results in increased expression of TLR2 mRNA; cerous chloride results in increased expression of TLR2 protein
CTD
PMID:21656643
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
increases expression
ISO
cerous chloride results in increased expression of TLR4 mRNA; cerous chloride results in increased expression of TLR4 protein
CTD
PMID:21656643
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
increases expression
ISO
cerous chloride results in increased expression of TNF; cerous chloride results in increased expression of TNF mRNA; cerous chloride results in increased expression of TNF protein
CTD
PMID:21656643 PMID:23712967
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Txn1
thioredoxin 1
increases expression
ISO
cerous chloride results in increased expression of TXN mRNA
CTD
PMID:28954213
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:72,711,933...72,724,629
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
cerous chloride results in increased expression of TXNRD1 mRNA
CTD
PMID:28954213
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:20,830,045...20,907,863
G
Txnrd2
thioredoxin reductase 2
decreases expression
ISO
cerous chloride results in decreased expression of TXNRD2 mRNA
CTD
PMID:28954213
NCBI chr11:96,024,321...96,072,475
Ensembl chr11:82,519,999...82,568,156
G
Ucp2
uncoupling protein 2
multiple interactions decreases expression
ISO
[cerous chloride co-treated with lanthanum chloride] affects the expression of UCP2 mRNA cerous chloride results in decreased expression of UCP2 mRNA
CTD
PMID:28954213
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:154,839,209...154,845,611
G
Zap70
zeta chain of T cell receptor associated protein kinase 70
affects expression
ISO
cerous chloride affects the expression of ZAP70 mRNA
CTD
PMID:23139204
NCBI chr 9:46,485,605...46,507,552
Ensembl chr 9:38,989,750...39,011,700
G
Cacna1g
calcium voltage-gated channel subunit alpha1 G
multiple interactions
ISO
Erbium inhibits the reaction [CACNA1G protein results in increased transport of Barium]
CTD
PMID:12163980
NCBI chr10:79,851,886...79,919,926
Ensembl chr10:79,355,008...79,422,752
G
Adipoq
adiponectin, C1Q and collagen domain containing
decreases expression
ISO
gadobutrol results in decreased expression of ADIPOQ mRNA
CTD
PMID:37437671
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Fabp4
fatty acid binding protein 4
decreases expression
ISO
gadobutrol results in decreased expression of FABP4 mRNA
CTD
PMID:37437671
NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:91,580,885...91,585,578
G
Pparg
peroxisome proliferator-activated receptor gamma
decreases expression
ISO
gadobutrol results in decreased expression of PPARG mRNA
CTD
PMID:37437671
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Adipoq
adiponectin, C1Q and collagen domain containing
decreases expression
ISO
gadodiamide results in decreased expression of ADIPOQ mRNA; gadodiamide results in decreased expression of ADIPOQ protein
CTD
PMID:37437671
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Akt1
AKT serine/threonine kinase 1
increases phosphorylation multiple interactions
ISO
gadodiamide results in increased phosphorylation of AKT1 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [gadodiamide results in increased phosphorylation of AKT1 protein]
CTD
PMID:19561517
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
increases expression
ISO
gadodiamide results in increased expression of ALDH1A1 mRNA
CTD
PMID:20959327
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:218,042,127...218,152,961
G
Ankrd22
ankyrin repeat domain 22
increases expression
ISO
gadodiamide results in increased expression of ANKRD22 mRNA
CTD
PMID:20959327
NCBI chr 1:231,639,035...231,670,537
Ensembl chr 1:231,639,314...231,670,381
G
Atm
ATM serine/threonine kinase
increases expression
ISO
gadodiamide results in increased expression of ATM mRNA
CTD
PMID:20959327
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:53,831,093...53,932,437
G
Atp8b1
ATPase phospholipid transporting 8B1
increases expression
ISO
gadodiamide results in increased expression of ATP8B1 mRNA
CTD
PMID:20959327
NCBI chr18:58,016,382...58,157,213
Ensembl chr18:58,018,268...58,157,396
G
Ccl2
C-C motif chemokine ligand 2
increases expression increases secretion
ISO EXP
gadodiamide results in increased expression of CCL2 mRNA gadodiamide results in increased expression of CCL2 mRNA; gadodiamide results in increased expression of CCL2 protein gadodiamide results in increased secretion of CCL2 protein
CTD
PMID:20938346 PMID:20959327
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl4
C-C motif chemokine ligand 4
increases expression
EXP
gadodiamide results in increased expression of CCL4 protein
CTD
PMID:20938346
NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,452,052...68,468,231
G
Ccl7
C-C motif chemokine ligand 7
increases expression
EXP
gadodiamide results in increased expression of CCL7 protein
CTD
PMID:20938346
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Cep15
centrosomal protein 15
increases expression
ISO
gadodiamide results in increased expression of CEP15 mRNA
CTD
PMID:20959327
NCBI chr15:12,815,159...12,835,115
Ensembl chr15:12,818,385...12,833,838
G
Cxcl10
C-X-C motif chemokine ligand 10
increases expression increases secretion
ISO EXP
gadodiamide results in increased expression of CXCL10 mRNA gadodiamide results in increased expression of CXCL10 protein gadodiamide results in increased secretion of CXCL10 protein
CTD
PMID:20938346 PMID:20959327
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,704,758...15,706,975
G
Cxcl11
C-X-C motif chemokine ligand 11
increases secretion increases expression
ISO
gadodiamide results in increased secretion of CXCL11 protein gadodiamide results in increased expression of CXCL11 mRNA
CTD
PMID:20959327
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
G
Cxcl12
C-X-C motif chemokine ligand 12
increases expression
ISO
gadodiamide results in increased expression of CXCL12 mRNA
CTD
PMID:20959327
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:150,388,325...150,401,168
G
Cxcl9
C-X-C motif chemokine ligand 9
increases expression
ISO
gadodiamide results in increased expression of CXCL9 mRNA
CTD
PMID:20959327
NCBI chr14:16,007,166...16,012,077
Ensembl chr14:15,722,908...15,728,435
G
Fabp4
fatty acid binding protein 4
decreases expression
ISO
gadodiamide results in decreased expression of FABP4 mRNA; gadodiamide results in decreased expression of FABP4 protein
CTD
PMID:37437671
NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:91,580,885...91,585,578
G
Ido1
indoleamine 2,3-dioxygenase 1
increases expression
ISO
gadodiamide results in increased expression of IDO1 mRNA
CTD
PMID:20959327
NCBI chr16:74,133,259...74,145,328
Ensembl chr16:67,430,578...67,442,730
G
Ifi44l
interferon-induced protein 44-like
increases expression
ISO
gadodiamide results in increased expression of IFI44L mRNA
CTD
PMID:20959327
NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
increases expression
ISO
gadodiamide results in increased expression of IFIT3 mRNA
CTD
PMID:20959327
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
G
Ifng
interferon gamma
increases expression
ISO
gadodiamide results in increased expression of IFNG mRNA; gadodiamide results in increased expression of IFNG protein
CTD
PMID:19404939
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Il13
interleukin 13
increases expression
ISO
gadodiamide results in increased expression of IL13 mRNA; gadodiamide results in increased expression of IL13 protein
CTD
PMID:19404939
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:37,790,130...37,792,737
G
Il1a
interleukin 1 alpha
increases expression
EXP
gadodiamide results in increased expression of IL1A protein
CTD
PMID:20938346
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
G
Il4
interleukin 4
increases expression affects expression
ISO
gadodiamide results in increased expression of IL4 protein gadodiamide affects the expression of IL4 mRNA
CTD
PMID:19404939
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:37,771,203...37,776,750
G
Il4i1
interleukin 4 induced 1
increases expression
ISO
gadodiamide results in increased expression of IL4I1 mRNA
CTD
PMID:20959327
NCBI chr 1:104,435,540...104,461,049
Ensembl chr 1:95,295,601...95,324,562
G
Il6
interleukin 6
affects expression increases expression
ISO
gadodiamide affects the expression of IL6 protein gadodiamide results in increased expression of IL6 mRNA
CTD
PMID:19404939
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Kitlg
KIT ligand
increases expression
EXP
gadodiamide results in increased expression of KITLG protein
CTD
PMID:20938346
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
G
Mapk1
mitogen activated protein kinase 1
multiple interactions increases phosphorylation
ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [gadodiamide results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [gadodiamide results in increased phosphorylation of MAPK1 protein]
CTD
PMID:19561517
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions increases phosphorylation
ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [gadodiamide results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [gadodiamide results in increased phosphorylation of MAPK3 protein]
CTD
PMID:19561517
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mmp1
matrix metallopeptidase 1
multiple interactions increases expression
ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [gadodiamide results in increased expression of MMP1 protein]; U 0126 inhibits the reaction [gadodiamide results in increased expression of MMP1 protein] gadodiamide results in increased expression of MMP1 mRNA; gadodiamide results in increased expression of MMP1 protein
CTD
PMID:19561517
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:4,658,588...4,679,097
G
Nos2
nitric oxide synthase 2
increases expression
ISO
gadodiamide results in increased expression of NOS2 protein
CTD
PMID:20959327
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nxpe3
neurexophilin and PC-esterase domain family, member 3
increases expression
ISO
gadodiamide results in increased expression of NXPE3 mRNA
CTD
PMID:20959327
NCBI chr11:44,726,905...44,777,694
Ensembl chr11:44,727,069...44,777,694
G
Pparg
peroxisome proliferator-activated receptor gamma
decreases expression
ISO
gadodiamide results in decreased expression of PPARG mRNA; gadodiamide results in decreased expression of PPARG protein
CTD
PMID:37437671
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Rela
RELA proto-oncogene, NF-kB subunit
increases localization
ISO
gadodiamide results in increased localization of RELA protein
CTD
PMID:20959327
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Rhoq
ras homolog family member Q
increases expression
ISO
gadodiamide results in increased expression of RHOQ mRNA
CTD
PMID:20959327
NCBI chr 6:7,613,632...7,652,047
Ensembl chr 1:106,622,141...106,623,699
G
Rit1
Ras-like without CAAX 1
increases expression
ISO
gadodiamide results in increased expression of RIT1 mRNA
CTD
PMID:20959327
NCBI chr 2:174,180,742...174,195,455
Ensembl chr 2:174,180,848...174,195,455
G
Rnf125
ring finger protein 125
increases expression
ISO
gadodiamide results in increased expression of RNF125 mRNA
CTD
PMID:20959327
NCBI chr18:12,254,066...12,275,719
Ensembl chr18:12,253,852...12,275,983
G
Rsad2
radical S-adenosyl methionine domain containing 2
increases expression
ISO
gadodiamide results in increased expression of RSAD2 mRNA
CTD
PMID:20959327
NCBI chr 6:48,774,985...48,788,245
Ensembl chr 6:43,047,658...43,059,699
G
Slc39a10
solute carrier family 39 member 10
increases expression
ISO
gadodiamide results in increased expression of SLC39A10 mRNA
CTD
PMID:20959327
NCBI chr 9:54,836,841...54,960,325
Ensembl chr 9:54,876,141...54,960,325
G
Spn
sialophorin
increases expression
ISO
gadodiamide results in increased expression of SPN mRNA
CTD
PMID:20959327
NCBI chr 1:181,746,937...181,759,564
Ensembl chr 1:181,746,429...181,759,628
G
Spp1
secreted phosphoprotein 1
increases expression
EXP
gadodiamide results in increased expression of SPP1 protein
CTD
PMID:20938346
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
G
Tgfb1
transforming growth factor, beta 1
increases expression
ISO EXP
gadodiamide results in increased expression of TGFB1 mRNA; gadodiamide results in increased expression of TGFB1 protein
CTD
PMID:19404939 PMID:20938346
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression multiple interactions
ISO EXP
gadodiamide results in increased expression of TIMP1 mRNA; gadodiamide results in increased expression of TIMP1 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [gadodiamide results in increased expression of TIMP1 protein]; U 0126 inhibits the reaction [gadodiamide results in increased expression of TIMP1 protein]
CTD
PMID:19561517 PMID:20938346
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:1,212,972...1,217,664
G
Ubd
ubiquitin D
increases expression
ISO
gadodiamide results in increased expression of UBD mRNA
CTD
PMID:20959327
NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639 Ensembl chr20:1,385,864...1,408,639
G
Vegfa
vascular endothelial growth factor A
increases expression
ISO EXP
gadodiamide results in increased expression of VEGFA mRNA; gadodiamide results in increased expression of VEGFA protein
CTD
PMID:19404939 PMID:20938346
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Wdr5
WD repeat domain 5
increases expression
ISO
gadodiamide results in increased expression of WDR5 mRNA
CTD
PMID:20959327
NCBI chr 3:10,836,964...10,856,682
Ensembl chr 3:10,837,025...10,856,671
G
Xiap
X-linked inhibitor of apoptosis
increases expression
ISO
gadodiamide results in increased expression of XIAP mRNA
CTD
PMID:20959327
NCBI chr X:125,756,107...125,803,979
Ensembl chr X:120,897,907...120,934,700
G
Zfp652
zinc finger protein 652
increases expression
ISO
gadodiamide results in increased expression of ZNF652 mRNA
CTD
PMID:20959327
NCBI chr10:81,123,326...81,203,153
Ensembl chr10:80,649,400...80,698,674
G
Acaca
acetyl-CoA carboxylase alpha
multiple interactions
ISO
[gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of ACACA mRNA
CTD
PMID:34878122
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,014,170...69,276,457
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
ISO
[gadolinium chloride results in increased abundance of Gadolinium] which results in decreased expression of BCL2 protein
CTD
PMID:34878122
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bmal1
basic helix-loop-helix ARNT like 1
multiple interactions
ISO
[gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of BMAL1 protein
CTD
PMID:34878122
NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:167,331,633...167,430,231
G
Cacna1g
calcium voltage-gated channel subunit alpha1 G
multiple interactions
ISO
Gadolinium inhibits the reaction [CACNA1G protein results in increased transport of Barium]
CTD
PMID:12163980
NCBI chr10:79,851,886...79,919,926
Ensembl chr10:79,355,008...79,422,752
G
Casp3
caspase 3
increases activity multiple interactions
EXP ISO
Gadolinium results in increased activity of CASP3 protein [gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of CASP3 mRNA
CTD
PMID:20398695 PMID:34878122
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casr
calcium-sensing receptor
multiple interactions
EXP
[Gadolinium binds to and results in increased activity of CASR protein] which results in increased abundance of Calcium; [Gadolinium binds to and results in increased activity of CASR protein] which results in increased abundance of Inositol Phosphates; Gadolinium binds to and results in increased activity of CASR protein; Gadolinium inhibits the reaction [Calcium binds to and results in increased activity of CASR protein]
CTD
PMID:10231437 PMID:11071898
NCBI chr11:77,738,398...77,813,639
Ensembl chr11:64,235,251...64,304,811
G
Cat
catalase
multiple interactions
ISO
CAT protein inhibits the reaction [Gadolinium promotes the reaction [TRPC5 protein results in increased transport of Calcium]]
CTD
PMID:21127073
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Chrm1
cholinergic receptor, muscarinic 1
multiple interactions
ISO
Gadolinium inhibits the reaction [[Carbachol results in increased activity of CHRM1 protein] which results in increased abundance of Calcium]
CTD
PMID:18316702
NCBI chr 1:214,996,180...215,012,136
Ensembl chr 1:205,567,220...205,582,356
G
Cpt1a
carnitine palmitoyltransferase 1A
multiple interactions
ISO
[gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of CPT1A mRNA
CTD
PMID:34878122
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:200,565,613...200,627,055
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions
ISO
Gadolinium inhibits the reaction [Glucose results in increased expression of DDIT3 protein]
CTD
PMID:30076216
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
G
Drd1
dopamine receptor D1
multiple interactions
EXP
Gadolinium inhibits the reaction [SCH 23390 binds to DRD1 protein]
CTD
PMID:9109525
NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
multiple interactions
EXP
Gadolinium inhibits the reaction [3-N-methylspiperone binds to DRD2 protein]
CTD
PMID:9109525
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Gnaq
G protein subunit alpha q
increases response to substance
ISO
GNAQ protein results in increased susceptibility to Gadolinium
CTD
PMID:15068510
NCBI chr 1:222,852,453...223,098,754
Ensembl chr 1:213,424,465...213,667,672
G
Hif1a
hypoxia inducible factor 1 subunit alpha
multiple interactions
ISO
[gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of HIF1A mRNA
CTD
PMID:34878122
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions
ISO
Gadolinium inhibits the reaction [Glucose results in increased expression of HSPA5 protein]
CTD
PMID:30076216
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
G
Ift88
intraflagellar transport 88
multiple interactions
ISO
Gadolinium inhibits the reaction [IFT88 protein mutant form results in increased uptake of Calcium]
CTD
PMID:16396941
NCBI chr15:35,685,678...35,786,875
Ensembl chr15:31,573,376...31,672,147
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of IL1B mRNA
CTD
PMID:34878122
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
[gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of IL6 mRNA
CTD
PMID:34878122
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
EXP
Gadolinium inhibits the reaction [[Norepinephrine co-treated with Timolol] results in increased activity of MAPK1 protein]; Gadolinium inhibits the reaction [Calcimycin results in increased phosphorylation of MAPK1 protein]
CTD
PMID:11914123
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
EXP
Gadolinium inhibits the reaction [[Norepinephrine co-treated with Timolol] results in increased activity of MAPK3 protein]; Gadolinium inhibits the reaction [Calcimycin results in increased phosphorylation of MAPK3 protein]
CTD
PMID:11914123
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
ISO
[gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of NFE2L2 mRNA
CTD
PMID:34878122
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO
[gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of NFKB1 mRNA
CTD
PMID:34878122
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
[gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of RELA protein
CTD
PMID:34878122
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
S100a6
S100 calcium binding protein A6
affects response to substance
ISO
S100A6 protein affects the susceptibility to Gadolinium
CTD
PMID:15068510
NCBI chr 2:178,398,189...178,399,763
Ensembl chr 2:176,100,899...176,102,180
G
Spp1
secreted phosphoprotein 1
multiple interactions
ISO
[gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of SPP1 mRNA
CTD
PMID:34878122
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
G
Sqstm1
sequestosome 1
multiple interactions
ISO
[gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of SQSTM1 mRNA
CTD
PMID:34878122
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
[gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of TGFB1 mRNA
CTD
PMID:34878122
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Trpa1
transient receptor potential cation channel, subfamily A, member 1
multiple interactions
ISO
Gadolinium inhibits the reaction [allyl isothiocyanate results in increased activity of TRPA1 protein]
CTD
PMID:15843607
NCBI chr 5:9,163,060...9,217,325
Ensembl chr 5:4,379,999...4,433,570
G
Trpc3
transient receptor potential cation channel, subfamily C, member 3
multiple interactions
ISO
Gadolinium affects the localization of and results in decreased activity of TRPC3 protein
CTD
PMID:16522635
NCBI chr 2:121,409,436...121,487,095
Ensembl chr 2:119,481,400...119,558,855
G
Trpc5
transient receptor potential cation channel, subfamily C, member 5
multiple interactions
ISO
2-aminoethoxydiphenyl borate promotes the reaction [resveratrol inhibits the reaction [Gadolinium promotes the reaction [TRPC5 protein results in increased transport of Calcium]]]; Ascorbic Acid inhibits the reaction [Gadolinium promotes the reaction [TRPC5 protein results in increased transport of Calcium]]; Calcium promotes the reaction [resveratrol inhibits the reaction [Gadolinium promotes the reaction [TRPC5 protein results in increased transport of Calcium]]]; CAT protein inhibits the reaction [Gadolinium promotes the reaction [TRPC5 protein results in increased transport of Calcium]]; Gadolinium promotes the reaction [TRPC5 protein results in increased transport of Calcium]; Gallic Acid inhibits the reaction [Gadolinium promotes the reaction [TRPC5 protein results in increased transport of Calcium]]; resveratrol inhibits the reaction [Gadolinium promotes the reaction [TRPC5 protein results in increased transport of Calcium]]; resveratrol promotes the reaction [Ascorbic Acid inhibits the reaction [Gadolinium promotes the reaction [TRPC5 protein results in increased transport of Calcium]]]
CTD
PMID:21127073
NCBI chr X:112,742,828...113,027,638
Ensembl chr X:107,939,131...108,230,991
G
Trpc6
transient receptor potential cation channel, subfamily C, member 6
decreases activity
ISO
Gadolinium results in decreased activity of TRPC6 protein
CTD
PMID:11179201
NCBI chr 8:14,044,216...14,148,808
Ensembl chr 8:5,758,935...5,828,092
G
Trpm6
transient receptor potential cation channel, subfamily M, member 6
multiple interactions
ISO
Gadolinium inhibits the reaction [TRPM6 protein affects the reaction [1-oleoyl-2-acetylglycerol results in increased transport of Calcium]]
CTD
PMID:11988098
NCBI chr 1:216,136,407...216,320,523
Ensembl chr 1:216,170,038...216,320,520
G
Trpv4
transient receptor potential cation channel, subfamily V, member 4
multiple interactions decreases activity
EXP
[Gadolinium results in decreased activity of TRPV4 protein] which results in decreased susceptibility to Buthionine Sulfoximine
CTD
PMID:20064552
NCBI chr12:47,599,161...47,638,143
Ensembl chr12:41,938,560...41,977,517
G
Trpv6
transient receptor potential cation channel, subfamily V, member 6
multiple interactions increases uptake
ISO
Gadolinium inhibits the reaction [TRPV6 protein results in increased uptake of Calcium] TRPV6 protein results in increased uptake of Gadolinium
CTD
PMID:21146870
NCBI chr 4:71,474,006...71,489,667
Ensembl chr 4:70,507,348...70,523,017
G
Abcc4
ATP binding cassette subfamily C member 4
multiple interactions
ISO
gadolinium chloride inhibits the reaction [perfluorodecanoic acid results in increased expression of ABCC4 mRNA]
CTD
PMID:18757529
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:95,542,315...95,774,283
G
Acaca
acetyl-CoA carboxylase alpha
multiple interactions
ISO
gadolinium chloride promotes the reaction [Ethanol results in decreased expression of ACACA protein] [gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of ACACA mRNA
CTD
PMID:28882574 PMID:34878122
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,014,170...69,276,457
G
Acot1
acyl-CoA thioesterase 1
multiple interactions
EXP
gadolinium chloride promotes the reaction [perfluoro-n-nonanoic acid results in increased expression of ACOT1 mRNA]
CTD
PMID:22648072
NCBI chr 6:109,367,274...109,375,268
Ensembl chr 6:103,636,041...103,644,163
G
Acta2
actin alpha 2, smooth muscle
multiple interactions
EXP
gadolinium chloride inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein]
CTD
PMID:11408273
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:231,746,548...231,759,554
G
Adgre1
adhesion G protein-coupled receptor E1
multiple interactions
EXP ISO
[gadolinium chloride co-treated with Fructose co-treated with Copper deficiency] results in decreased expression of ADGRE1 mRNA gadolinium chloride inhibits the reaction [Ethanol results in increased expression of ADGRE1 protein]
CTD
PMID:25813056 PMID:28882574
NCBI chr 9:2,242,476...2,398,000
Ensembl chr 9:2,242,474...2,398,000
G
Adipoq
adiponectin, C1Q and collagen domain containing
decreases expression
ISO
gadolinium chloride results in decreased expression of ADIPOQ mRNA
CTD
PMID:37437671
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Apob
apolipoprotein B
multiple interactions
EXP
gadolinium chloride promotes the reaction [[Fructose co-treated with Copper deficiency] results in decreased expression of APOB mRNA]
CTD
PMID:25813056
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:30,844,368...30,892,497
G
Atf4
activating transcription factor 4
affects expression
EXP
gadolinium chloride affects the expression of ATF4 mRNA
CTD
PMID:21198628
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:111,804,183...111,806,446
G
Atf6
activating transcription factor 6
multiple interactions increases expression affects expression
EXP
Acetylcysteine inhibits the reaction [gadolinium chloride results in increased expression of ATF6 protein] gadolinium chloride affects the expression of ATF6 mRNA
CTD
PMID:21198628
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:82,930,034...83,107,177
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
ISO
[gadolinium chloride results in increased abundance of Gadolinium] which results in decreased expression of BCL2 protein
CTD
PMID:34878122
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bmal1
basic helix-loop-helix ARNT like 1
multiple interactions
ISO
[gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of BMAL1 protein
CTD
PMID:34878122
NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:167,331,633...167,430,231
G
Bmp2
bone morphogenetic protein 2
multiple interactions
EXP
gadolinium chloride promotes the reaction [Carbon Tetrachloride results in increased expression of BMP2 mRNA]
CTD
PMID:17158861
NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:120,812,882...120,821,397
G
Casp3
caspase 3
multiple interactions
ISO
[gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of CASP3 mRNA
CTD
PMID:34878122
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
multiple interactions
EXP
gadolinium chloride inhibits the reaction [[Triiodothyronine co-treated with Hexachlorocyclohexane] results in decreased activity of CAT protein]
CTD
PMID:12516873
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
EXP
gadolinium chloride inhibits the reaction [[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased expression of CCL2 mRNA]; gadolinium chloride inhibits the reaction [[Fructose co-treated with Copper deficiency] results in increased expression of CCL2 protein]
CTD
PMID:25813056 PMID:26177832
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccne1
cyclin E1
increases expression
ISO
gadolinium chloride results in increased expression of CCNE1
CTD
PMID:19184457
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:90,781,949...90,791,101
G
Cd163
CD163 molecule
multiple interactions
EXP
[gadolinium chloride co-treated with Fructose co-treated with Copper deficiency] results in decreased expression of CD163 mRNA; gadolinium chloride inhibits the reaction [[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased expression of CD163 mRNA]
CTD
PMID:25813056 PMID:26177832
NCBI chr 4:158,770,751...158,804,146
Ensembl chr 4:157,085,093...157,117,878
G
Cd68
Cd68 molecule
multiple interactions
ISO EXP
gadolinium chloride inhibits the reaction [[Dietary Fats co-treated with bromodichloromethane] results in increased expression of CD68 mRNA] [gadolinium chloride co-treated with Fructose co-treated with Copper deficiency] results in decreased expression of CD68 mRNA; [gadolinium chloride co-treated with Fructose co-treated with Copper deficiency] results in decreased expression of CD68 protein; gadolinium chloride inhibits the reaction [[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased expression of CD68 mRNA]
CTD
PMID:23438451 PMID:25813056 PMID:26177832
NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,381,815...54,383,697
G
Cpt1a
carnitine palmitoyltransferase 1A
multiple interactions
EXP ISO
gadolinium chloride promotes the reaction [perfluoro-n-nonanoic acid results in increased expression of CPT1A mRNA] [gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of CPT1A mRNA
CTD
PMID:22648072 PMID:34878122
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:200,565,613...200,627,055
G
Cxcl1
C-X-C motif chemokine ligand 1
multiple interactions
EXP
gadolinium chloride inhibits the reaction [[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased expression of CXCL1 mRNA]
CTD
PMID:26177832
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,193,365...17,195,215
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions
ISO EXP
gadolinium chloride inhibits the reaction [[Progesterone co-treated with Halothane] results in increased expression of CXCL2 mRNA] gadolinium chloride inhibits the reaction [[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased expression of CXCL2 mRNA]
CTD
PMID:22157104 PMID:26177832
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions
ISO
gadolinium chloride inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of CXCL1 mRNA]]; gadolinium chloride inhibits the reaction [Progesterone results in increased expression of CXCL1 mRNA]
CTD
PMID:22157104
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,270,146...17,289,511
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
EXP
gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP1A2 protein]
CTD
PMID:18202523
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
multiple interactions
EXP
gadolinium chloride inhibits the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA]; gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP2B1 mRNA]; gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP2B1 protein]
CTD
PMID:10918498 PMID:18202523
NCBI chr 1:90,646,098...90,669,762
Ensembl chr 1:81,518,408...81,542,052
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
multiple interactions
EXP
gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP2B2 mRNA]; gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP2B2 protein]
CTD
PMID:18202523
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
multiple interactions
EXP
gadolinium chloride inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased activity of and results in decreased expression of CYP2C11 protein]
CTD
PMID:18079364
NCBI chr 1:246,175,216...246,211,445
Ensembl chr 1:236,762,842...236,799,066
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
EXP
gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP2E1 mRNA]; gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP2E1 protein]
CTD
PMID:18202523
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
EXP
gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP3A2 mRNA]; gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP3A2 protein]; gadolinium chloride inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased activity of and results in decreased expression of CYP3A2 protein]
CTD
PMID:18079364 PMID:18202523
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
G
Cyp4a1
cytochrome P450, family 4, subfamily a, polypeptide 1
multiple interactions
EXP
gadolinium chloride promotes the reaction [[Fructose co-treated with Copper deficiency] results in decreased expression of CYP4A1 mRNA]
CTD
PMID:25813056
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions increases expression affects expression
EXP
Acetylcysteine inhibits the reaction [gadolinium chloride results in increased expression of DDIT3 protein] gadolinium chloride affects the expression of DDIT3 mRNA
CTD
PMID:21198628
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
increases expression
EXP
gadolinium chloride results in increased expression of EIF2AK3 protein
CTD
PMID:21198628
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:102,805,510...102,866,911
G
Ern1
endoplasmic reticulum to nucleus signaling 1
multiple interactions increases expression
EXP
Acetylcysteine inhibits the reaction [gadolinium chloride results in increased expression of ERN1 protein]
CTD
PMID:21198628
NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,330,654...91,421,029
G
Fabp4
fatty acid binding protein 4
decreases expression
ISO
gadolinium chloride results in decreased expression of FABP4 mRNA
CTD
PMID:37437671
NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:91,580,885...91,585,578
G
Fasn
fatty acid synthase
multiple interactions
EXP ISO
[gadolinium chloride co-treated with Fructose co-treated with Copper deficiency] results in decreased expression of FASN mRNA gadolinium chloride promotes the reaction [Ethanol results in decreased expression of FASN protein]
CTD
PMID:25813056 PMID:28882574
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
EXP ISO
gadolinium chloride inhibits the reaction [[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased expression of GPT protein]; gadolinium chloride inhibits the reaction [Vitamin A results in increased activity of GPT protein] gadolinium chloride inhibits the reaction [Amiodarone promotes the reaction [Dexamethasone results in increased expression of GPT protein]]
CTD
PMID:8627517 PMID:25900201 PMID:26177832
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
G
Hamp
hepcidin antimicrobial peptide
increases expression
EXP
gadolinium chloride results in increased expression of HAMP
CTD
PMID:19721414
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:86,170,901...86,172,891
G
Hif1a
hypoxia inducible factor 1 subunit alpha
multiple interactions
ISO
[gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of HIF1A mRNA
CTD
PMID:34878122
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hjv
hemojuvelin BMP co-receptor
decreases expression
EXP
gadolinium chloride results in decreased expression of HJV
CTD
PMID:19721414
NCBI chr 2:184,065,944...184,069,851
Ensembl chr 2:184,065,970...184,069,850
G
Hmgb1
high mobility group box 1
multiple interactions
EXP
gadolinium chloride inhibits the reaction [[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased secretion of HMGB1 protein]
CTD
PMID:26177832
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
multiple interactions
EXP
gadolinium chloride promotes the reaction [[Fructose co-treated with Copper deficiency] results in decreased expression of HMGCS2 mRNA]
CTD
PMID:25813056
NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:185,875,616...185,902,130
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
multiple interactions
EXP
gadolinium chloride inhibits the reaction [Thioacetamide results in increased expression of HSPA1A mRNA]; gadolinium chloride inhibits the reaction [Thioacetamide results in increased expression of HSPA1A protein]
CTD
PMID:12963478
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,856,006...3,873,227
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression multiple interactions affects expression
EXP
gadolinium chloride results in increased expression of HSPA5 protein Acetylcysteine inhibits the reaction [gadolinium chloride results in increased expression of HSPA5 protein] gadolinium chloride affects the expression of HSPA5 mRNA
CTD
PMID:21198628
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
G
Icam1
intercellular adhesion molecule 1
multiple interactions
ISO
gadolinium chloride inhibits the reaction [[Progesterone co-treated with Halothane] results in increased expression of ICAM1 mRNA]
CTD
PMID:22157104
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Ifng
interferon gamma
affects expression increases expression
ISO
gadolinium chloride affects the expression of IFNG protein gadolinium chloride results in increased expression of IFNG mRNA
CTD
PMID:15590129 PMID:19404939
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Igf1
insulin-like growth factor 1
multiple interactions
EXP
gadolinium chloride inhibits the reaction [Lipopolysaccharides results in decreased expression of IGF1 protein]
CTD
PMID:16522730
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Igfbp3
insulin-like growth factor binding protein 3
multiple interactions
EXP
gadolinium chloride inhibits the reaction [Lipopolysaccharides results in decreased expression of IGFBP3 protein]
CTD
PMID:16522730
NCBI chr14:86,270,208...86,277,944
Ensembl chr14:82,056,347...82,064,083
G
Il10
interleukin 10
multiple interactions
EXP
gadolinium chloride inhibits the reaction [[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased expression of IL10 mRNA]; gadolinium chloride inhibits the reaction [perfluoro-n-nonanoic acid results in decreased expression of IL10 protein]
CTD
PMID:22648072 PMID:26177832
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il13
interleukin 13
increases expression
ISO
gadolinium chloride results in increased expression of IL13 mRNA
CTD
PMID:19404939
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:37,790,130...37,792,737
G
Il1a
interleukin 1 alpha
multiple interactions
EXP
gadolinium chloride inhibits the reaction [Hexachlorocyclohexane results in increased expression of IL1A mRNA]; gadolinium chloride inhibits the reaction [Hexachlorocyclohexane results in increased expression of IL1A protein]
CTD
PMID:15025948
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
increases expression multiple interactions
EXP ISO
gadolinium chloride results in increased expression of IL1B [gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of IL1B mRNA [gadolinium chloride co-treated with Fructose co-treated with Copper deficiency] results in decreased expression of IL1B mRNA; gadolinium chloride inhibits the reaction [perfluoro-n-nonanoic acid results in increased expression of IL1B protein]
CTD
PMID:19721414 PMID:22648072 PMID:25813056 PMID:34878122
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il4
interleukin 4
affects expression
ISO
gadolinium chloride affects the expression of IL4 mRNA; gadolinium chloride affects the expression of IL4 protein
CTD
PMID:19404939
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:37,771,203...37,776,750
G
Il6
interleukin 6
multiple interactions increases expression
EXP ISO
[gadolinium chloride co-treated with Fructose co-treated with Copper deficiency] results in decreased expression of IL6 mRNA; gadolinium chloride inhibits the reaction [[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased expression of IL6 mRNA]; gadolinium chloride inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; gadolinium chloride inhibits the reaction [Thioacetamide results in increased expression of IL6 protein] [gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of IL6 mRNA gadolinium chloride inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] gadolinium chloride results in increased expression of IL6 gadolinium chloride results in increased expression of IL6 mRNA
CTD
PMID:12127824 PMID:12963478 PMID:19404939 PMID:19721414 PMID:24849676 PMID:25813056 PMID:26177832 PMID:34878122 More...
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Lipe
lipase E, hormone sensitive type
multiple interactions
ISO
gadolinium chloride inhibits the reaction [Ethanol results in increased phosphorylation of LIPE protein]
CTD
PMID:28882574
NCBI chr 1:90,093,433...90,112,117
Ensembl chr 1:80,965,627...80,984,310
G
Ltb
lymphotoxin beta
increases expression
ISO
gadolinium chloride results in increased expression of LTB mRNA
CTD
PMID:15590129
NCBI chr20:3,632,209...3,634,054
Ensembl chr20:3,627,537...3,629,381
G
Mapk1
mitogen activated protein kinase 1
decreases phosphorylation multiple interactions increases activity
ISO EXP
gadolinium chloride results in decreased phosphorylation of MAPK1 protein gadolinium chloride inhibits the reaction [[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased phosphorylation of MAPK1 protein] gadolinium chloride results in increased activity of MAPK1 protein Pertussis Toxin inhibits the reaction [gadolinium chloride results in decreased phosphorylation of MAPK1 protein]
CTD
PMID:12493575 PMID:21605080 PMID:26177832
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
decreases phosphorylation multiple interactions increases activity
ISO EXP
gadolinium chloride results in decreased phosphorylation of MAPK3 protein gadolinium chloride inhibits the reaction [[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased phosphorylation of MAPK3 protein] Pertussis Toxin inhibits the reaction [gadolinium chloride results in decreased phosphorylation of MAPK3 protein] gadolinium chloride results in increased activity of MAPK3 protein
CTD
PMID:12493575 PMID:21605080 PMID:26177832
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mmp13
matrix metallopeptidase 13
multiple interactions increases expression
EXP
[Dimethylnitrosamine co-treated with gadolinium chloride] results in increased expression of MMP13 mRNA; SB 203580 inhibits the reaction [gadolinium chloride results in increased expression of MMP13 mRNA]
CTD
PMID:12493575
NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:4,497,960...4,508,239
G
Mmp14
matrix metallopeptidase 14
multiple interactions increases expression
EXP
[Dimethylnitrosamine co-treated with gadolinium chloride] results in increased expression of MMP14 mRNA gadolinium chloride results in increased expression of MMP14 mRNA; gadolinium chloride results in increased expression of MMP14 protein
CTD
PMID:12493575
NCBI chr15:31,857,824...31,867,049
Ensembl chr15:27,887,727...27,899,864
G
Mmp9
matrix metallopeptidase 9
increases expression multiple interactions
EXP
gadolinium chloride results in increased expression of MMP9 mRNA SB 203580 inhibits the reaction [gadolinium chloride results in increased expression of MMP9 mRNA]
CTD
PMID:12493575
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
multiple interactions
EXP
gadolinium chloride inhibits the reaction [Thioacetamide results in increased activity of MPO protein]
CTD
PMID:12963478
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
ISO
[gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of NFE2L2 mRNA
CTD
PMID:34878122
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
EXP ISO
gadolinium chloride inhibits the reaction [Hexachlorocyclohexane results in increased activity of NFKB1 protein] [gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of NFKB1 mRNA
CTD
PMID:15025948 PMID:34878122
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Nos2
nitric oxide synthase 2
increases expression
EXP
gadolinium chloride results in increased expression of NOS2 mRNA
CTD
PMID:15135310
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Pdgfa
platelet derived growth factor subunit A
decreases expression
EXP
gadolinium chloride results in decreased expression of PDGFA mRNA
CTD
PMID:14578756
NCBI chr12:20,759,366...20,780,337
Ensembl chr12:15,645,541...15,666,497
G
Pdgfb
platelet derived growth factor subunit B
decreases expression
EXP
gadolinium chloride results in decreased expression of PDGFB mRNA
CTD
PMID:14578756
NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:111,540,345...111,557,984
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions
EXP
gadolinium chloride promotes the reaction [perfluoro-n-nonanoic acid results in increased expression of PPARA mRNA]
CTD
PMID:22648072
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
G
Pparg
peroxisome proliferator-activated receptor gamma
decreases expression
ISO
gadolinium chloride results in decreased expression of PPARG mRNA
CTD
PMID:37437671
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Ptk2
protein tyrosine kinase 2
increases activity
ISO
gadolinium chloride results in increased activity of PTK2
CTD
PMID:19184457
NCBI chr 7:107,015,730...107,220,865
Ensembl chr 7:105,126,728...105,331,783
G
Rb1
RB transcriptional corepressor 1
increases phosphorylation
ISO
gadolinium chloride results in increased phosphorylation of RB1 protein
CTD
PMID:19184457
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP ISO
gadolinium chloride inhibits the reaction [Hexachlorocyclohexane results in increased activity of RELA protein] [gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of RELA protein
CTD
PMID:15025948 PMID:34878122
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
S100a8
S100 calcium binding protein A8
multiple interactions
EXP
gadolinium chloride inhibits the reaction [[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased expression of S100A8 mRNA]
CTD
PMID:26177832
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
S100a9
S100 calcium binding protein A9
multiple interactions
EXP
gadolinium chloride inhibits the reaction [[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased expression of S100A9 mRNA]
CTD
PMID:26177832
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Scd
stearoyl-CoA desaturase
multiple interactions
EXP ISO
gadolinium chloride promotes the reaction [[Fructose co-treated with Copper deficiency] results in decreased expression of SCD1 mRNA] gadolinium chloride promotes the reaction [Ethanol results in decreased expression of SCD1 protein]
CTD
PMID:25813056 PMID:28882574
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:243,269,747...243,282,562
G
Slc40a1
solute carrier family 40 member 1
decreases expression
EXP
gadolinium chloride results in decreased expression of SLC40A1
CTD
PMID:19721414
NCBI chr 9:48,033,526...48,053,876
Ensembl chr 9:48,033,526...48,051,481
G
Spp1
secreted phosphoprotein 1
multiple interactions
ISO
[gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of SPP1 mRNA
CTD
PMID:34878122
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
G
Sqstm1
sequestosome 1
multiple interactions
ISO
[gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of SQSTM1 mRNA
CTD
PMID:34878122
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions
EXP
gadolinium chloride inhibits the reaction [[Fructose co-treated with Copper deficiency] results in increased expression of SREBF1 protein]
CTD
PMID:25813056
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,007,637...45,029,650
G
Tgfb1
transforming growth factor, beta 1
multiple interactions increases expression affects expression
EXP ISO
gadolinium chloride inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA]; gadolinium chloride inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 protein]; gadolinium chloride inhibits the reaction [Thioacetamide results in increased expression of TGFB1 mRNA] [gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of TGFB1 mRNA gadolinium chloride results in increased expression of TGFB1 protein gadolinium chloride results in increased expression of TGFB1 mRNA gadolinium chloride affects the expression of TGFB1 mRNA
CTD
PMID:11408273 PMID:15590129 PMID:15964588 PMID:19404939 PMID:34878122
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Tlr4
toll-like receptor 4
multiple interactions
EXP
[gadolinium chloride co-treated with Fructose co-treated with Copper deficiency] results in decreased expression of TLR4 mRNA; gadolinium chloride inhibits the reaction [[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased expression of TLR4 protein]
CTD
PMID:25813056 PMID:26177832
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
multiple interactions decreases expression increases expression
EXP ISO
[gadolinium chloride co-treated with Fructose co-treated with Copper deficiency] results in decreased expression of TNF mRNA; gadolinium chloride inhibits the reaction [Hexachlorocyclohexane results in increased expression of TNF mRNA]; gadolinium chloride inhibits the reaction [Hexachlorocyclohexane results in increased expression of TNF protein]; gadolinium chloride inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; gadolinium chloride inhibits the reaction [perfluoro-n-nonanoic acid results in increased expression of TNF protein]; gadolinium chloride inhibits the reaction [Thioacetamide results in increased expression of TNF protein] gadolinium trichloride inhibits the reaction [estriol enhances the reaction [lipopolysaccharide increases expression of Tnf mRNA in liver]] gadolinium chloride inhibits the reaction [lead acetate promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]]; gadolinium chloride inhibits the reaction [perfluorodecanoic acid results in increased expression of TNF protein] gadolinium chloride results in increased expression of TNF gadolinium chloride results in increased expression of TNF mRNA
CTD RGD
PMID:12127824 PMID:12963478 PMID:14687926 PMID:15025948 PMID:15590129 PMID:16581537 PMID:18757529 PMID:19721414 PMID:22648072 PMID:25813056 PMID:9575848 More...
RGD:15017096
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf11b
TNF receptor superfamily member 11B
increases expression
ISO
gadolinium chloride results in increased expression of TNFRSF11B mRNA
CTD
PMID:21605080
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:85,566,520...85,594,538
G
Tnfrsf1a
TNF receptor superfamily member 1A
increases expression
ISO
gadolinium chloride results in increased expression of TNFRSF1A mRNA
CTD
PMID:15590129
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:158,150,820...158,163,591
G
Tnfsf10
TNF superfamily member 10
increases expression
ISO
gadolinium chloride results in increased expression of TNFSF10 mRNA
CTD
PMID:15590129
NCBI chr 2:112,136,550...112,155,903
Ensembl chr 2:110,207,916...110,225,135
G
Tnfsf11
TNF superfamily member 11
decreases expression
ISO
gadolinium chloride results in decreased expression of TNFSF11 mRNA
CTD
PMID:21605080
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:53,673,877...53,705,445
G
Ucp2
uncoupling protein 2
multiple interactions
EXP
gadolinium chloride inhibits the reaction [Carbon Tetrachloride results in increased expression of UCP2 mRNA]
CTD
PMID:18314881
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:154,839,209...154,845,611
G
Vegfa
vascular endothelial growth factor A
increases expression
ISO
gadolinium chloride results in increased expression of VEGFA mRNA; gadolinium chloride results in increased expression of VEGFA protein
CTD
PMID:19404939
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Xbp1
X-box binding protein 1
increases splicing
EXP
gadolinium chloride results in increased splicing of XBP1 mRNA
CTD
PMID:21198628
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Cacna1g
calcium voltage-gated channel subunit alpha1 G
multiple interactions
ISO
Holmium inhibits the reaction [CACNA1G protein results in increased transport of Barium]
CTD
PMID:12163980
NCBI chr10:79,851,886...79,919,926
Ensembl chr10:79,355,008...79,422,752
G
Cacna1g
calcium voltage-gated channel subunit alpha1 G
multiple interactions
ISO
Lanthanum inhibits the reaction [CACNA1G protein results in increased transport of Barium]
CTD
PMID:12163980
NCBI chr10:79,851,886...79,919,926
Ensembl chr10:79,355,008...79,422,752
G
Camk4
calcium/calmodulin-dependent protein kinase IV
decreases phosphorylation
EXP
Lanthanum results in decreased phosphorylation of CAMK4 protein
CTD
PMID:21695898
NCBI chr18:24,582,988...24,811,918
Ensembl chr18:24,585,269...24,802,487
G
Casr
calcium-sensing receptor
multiple interactions
ISO
Lanthanum inhibits the reaction [Calcium binds to and results in increased activity of CASR protein]; Lanthanum inhibits the reaction [CASR protein results in increased uptake of Calcium]; Lanthanum inhibits the reaction [Spermine binds to and results in increased activity of CASR protein]
CTD
PMID:17041782 PMID:21562303
NCBI chr11:77,738,398...77,813,639
Ensembl chr11:64,235,251...64,304,811
G
Chrm1
cholinergic receptor, muscarinic 1
multiple interactions
ISO
Lanthanum inhibits the reaction [[Carbachol results in increased activity of CHRM1 protein] which results in increased abundance of Calcium]
CTD
PMID:18316702
NCBI chr 1:214,996,180...215,012,136
Ensembl chr 1:205,567,220...205,582,356
G
Creb1
cAMP responsive element binding protein 1
decreases phosphorylation
EXP
Lanthanum results in decreased phosphorylation of CREB1 protein
CTD
PMID:21695898
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Drd1
dopamine receptor D1
multiple interactions
EXP
Lanthanum inhibits the reaction [SCH 23390 binds to DRD1 protein]
CTD
PMID:9109525
NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
multiple interactions
EXP
Lanthanum inhibits the reaction [3-N-methylspiperone binds to DRD2 protein]
CTD
PMID:9109525
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Egr1
early growth response 1
decreases expression
EXP
Lanthanum results in decreased expression of EGR1 mRNA
CTD
PMID:21695898
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
decreases expression
EXP
Lanthanum results in decreased expression of FOS mRNA
CTD
PMID:21695898
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Gabra1
gamma-aminobutyric acid type A receptor subunit alpha 1
multiple interactions
ISO
[delta-hexachlorocyclohexane co-treated with Lanthanum] promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Lanthanum promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]
CTD
PMID:9316872
NCBI chr10:26,595,151...26,650,611
Ensembl chr10:26,595,160...26,650,864
G
Gabrb3
gamma-aminobutyric acid type A receptor subunit beta 3
multiple interactions
ISO
[delta-hexachlorocyclohexane co-treated with Lanthanum] promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Lanthanum promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]
CTD
PMID:9316872
NCBI chr 1:108,467,047...108,702,522
Ensembl chr 1:108,296,124...108,698,961
G
Gabrg2
gamma-aminobutyric acid type A receptor subunit gamma 2
multiple interactions
ISO
[delta-hexachlorocyclohexane co-treated with Lanthanum] promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Lanthanum promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]
CTD
PMID:9316872
NCBI chr10:26,374,693...26,463,937
Ensembl chr10:26,374,694...26,464,346
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions
ISO
Lanthanum binds to and results in increased expression of HSPA5 protein
CTD
PMID:18773883
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
G
Igf2
insulin-like growth factor 2
multiple interactions
ISO
Lanthanum inhibits the reaction [IGF2 protein results in increased import of Calcium]
CTD
PMID:2442157
NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:197,814,410...197,823,018
G
Ins2
insulin 2
decreases response to substance
ISO
Lanthanum results in decreased susceptibility to INS protein
CTD
PMID:22031853
NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:197,843,281...197,864,775
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
decreases expression
EXP
Lanthanum results in decreased expression of JUN mRNA
CTD
PMID:21695898
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Lep
leptin
multiple interactions
ISO
Lanthanum promotes the reaction [LEP protein results in increased transport of Calcium]
CTD
PMID:20107083
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262
G
Trpc6
transient receptor potential cation channel, subfamily C, member 6
decreases activity
ISO
Lanthanum results in decreased activity of TRPC6 protein
CTD
PMID:11179201
NCBI chr 8:14,044,216...14,148,808
Ensembl chr 8:5,758,935...5,828,092
G
Trpm6
transient receptor potential cation channel, subfamily M, member 6
multiple interactions
ISO
Lanthanum inhibits the reaction [TRPM6 protein affects the reaction [1-oleoyl-2-acetylglycerol results in increased transport of Calcium]]
CTD
PMID:11988098
NCBI chr 1:216,136,407...216,320,523
Ensembl chr 1:216,170,038...216,320,520
G
Trpv6
transient receptor potential cation channel, subfamily V, member 6
multiple interactions increases uptake
ISO
Lanthanum inhibits the reaction [TRPV6 protein results in increased uptake of Calcium] TRPV6 protein results in increased uptake of Lanthanum
CTD
PMID:21146870
NCBI chr 4:71,474,006...71,489,667
Ensembl chr 4:70,507,348...70,523,017
G
Xbp1
X-box binding protein 1
increases expression
ISO
Lanthanum results in increased expression of XBP1 mRNA alternative form
CTD
PMID:18773883
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Alb
albumin
increases expression
ISO
lanthanum chloride results in increased expression of ALB mRNA
CTD
PMID:28954213
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Alox12
arachidonate 12-lipoxygenase, 12S type
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of ALOX12 mRNA
CTD
PMID:28954213
NCBI chr10:55,456,923...55,469,239
Ensembl chr10:54,958,271...54,970,542
G
Aox1
aldehyde oxidase 1
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of AOX1 mRNA
CTD
PMID:28954213
NCBI chr 9:67,073,831...67,152,980
Ensembl chr 9:59,579,649...59,658,770
G
Apoe
apolipoprotein E
increases expression multiple interactions
ISO
lanthanum chloride results in increased expression of APOE mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of APOE mRNA
CTD
PMID:28954213
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
G
Atg12
autophagy related 12
increases expression
EXP
lanthanum chloride results in increased expression of ATG12 protein
CTD
PMID:35090998
NCBI chr18:41,638,841...41,649,311
Ensembl chr18:39,452,191...39,462,418
G
Atg7
autophagy related 7
increases expression
EXP
lanthanum chloride results in increased expression of ATG7 protein
CTD
PMID:35090998
NCBI chr 4:149,390,000...149,597,534
Ensembl chr 4:147,718,752...147,925,593
G
B2m
beta-2 microglobulin
increases expression
ISO
lanthanum chloride results in increased expression of B2M mRNA
CTD
PMID:28954213
NCBI chr 3:129,549,236...129,555,354
Ensembl chr 3:109,095,729...109,101,766
G
Bcap31
B-cell receptor-associated protein 31
decreases expression
EXP
lanthanum chloride results in decreased expression of BCAP31 protein
CTD
PMID:35090998
NCBI chr X:151,397,567...151,429,666
Ensembl chr X:151,397,576...151,428,506
G
Becn1
beclin 1
increases expression
EXP
lanthanum chloride results in increased expression of BECN1 protein
CTD
PMID:35090998
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Camk4
calcium/calmodulin-dependent protein kinase IV
decreases phosphorylation
EXP
lanthanum chloride results in decreased phosphorylation of CAMK4 protein
CTD
PMID:19643171
NCBI chr18:24,582,988...24,811,918
Ensembl chr18:24,585,269...24,802,487
G
Casp3
caspase 3
increases expression
EXP
lanthanum chloride results in increased expression of CASP3 protein
CTD
PMID:21793157
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
increases expression
EXP
lanthanum chloride results in increased expression of CASP9 protein
CTD
PMID:21793157
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of CAT mRNA
CTD
PMID:28954213
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions increases expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of CCL5 mRNA lanthanum chloride results in increased expression of CCL5 mRNA
CTD
PMID:28954213
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,322,829...68,327,377
G
Ccs
copper chaperone for superoxide dismutase
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] affects the expression of CCS mRNA
CTD
PMID:28954213
NCBI chr 1:211,543,192...211,564,354
Ensembl chr 1:202,113,804...202,134,915
G
Cygb
cytoglobin
multiple interactions affects expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of CYGB mRNA lanthanum chloride affects the expression of CYGB mRNA
CTD
PMID:28954213
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
G
Duox1
dual oxidase 1
multiple interactions increases expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of DUOX1 mRNA lanthanum chloride results in increased expression of DUOX1 mRNA
CTD
PMID:28954213
NCBI chr 3:109,260,526...109,295,588
Ensembl chr 3:109,262,397...109,295,563
G
Duox2
dual oxidase 2
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of DUOX2 mRNA
CTD
PMID:28954213
NCBI chr 3:109,223,809...109,247,023
Ensembl chr 3:109,226,924...109,245,902
G
Dusp1
dual specificity phosphatase 1
increases expression multiple interactions
ISO
lanthanum chloride results in increased expression of DUSP1 mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of DUSP1 mRNA
CTD
PMID:28954213
NCBI chr10:17,184,853...17,187,646
G
Egr1
early growth response 1
decreases expression
EXP
lanthanum chloride results in decreased expression of EGR1 mRNA; lanthanum chloride results in decreased expression of EGR1 protein
CTD
PMID:19643171 PMID:21624330
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Ephx2
epoxide hydrolase 2
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of EPHX2 mRNA
CTD
PMID:28954213
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:40,289,902...40,327,615
G
Epx
eosinophil peroxidase
increases expression
ISO
lanthanum chloride results in increased expression of EPX mRNA
CTD
PMID:28954213
NCBI chr10:73,164,096...73,175,180
Ensembl chr10:72,666,865...72,677,952
G
Fis1
fission, mitochondrial 1
decreases expression
EXP
lanthanum chloride results in decreased expression of FIS1 protein
CTD
PMID:35090998
NCBI chr12:19,708,560...19,723,392
Ensembl chr12:19,708,558...19,723,377
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
decreases expression
EXP
lanthanum chloride results in decreased expression of FOS protein
CTD
PMID:19643171
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Foxm1
forkhead box M1
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of FOXM1 mRNA
CTD
PMID:28954213
NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:161,638,816...161,650,684
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of GAPDH mRNA
CTD
PMID:28954213
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:157,962,343...157,966,235
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression multiple interactions decreases expression
ISO
lanthanum chloride results in increased expression of GCLC mRNA; lanthanum chloride results in increased expression of GCLC protein [cerous chloride co-treated with lanthanum chloride] results in increased expression of GCLC mRNA lanthanum chloride results in decreased expression of GCLC protein
CTD
PMID:24142884 PMID:28954213 PMID:33098623
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
G
Gls
glutaminase
decreases expression
EXP
lanthanum chloride results in decreased expression of GLS
CTD
PMID:29353069
NCBI chr 9:56,836,584...56,908,861
Ensembl chr 9:49,344,781...49,416,900
G
Glul
glutamate-ammonia ligase
decreases expression
EXP
lanthanum chloride results in decreased expression of GLUL
CTD
PMID:29353069
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:66,025,630...66,035,108
G
Gpx3
glutathione peroxidase 3
increases expression multiple interactions
ISO
lanthanum chloride results in increased expression of GPX3 mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of GPX3 mRNA
CTD
PMID:28954213
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
G
Gpx7
glutathione peroxidase 7
multiple interactions decreases expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of GPX7 mRNA lanthanum chloride results in decreased expression of GPX7 mRNA
CTD
PMID:28954213
NCBI chr 5:123,145,151...123,153,141
Ensembl chr 5:123,144,331...123,153,004
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
increases expression
EXP
lanthanum chloride results in increased expression of GRIN1
CTD
PMID:29353069
NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:8,103,680...8,130,603
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
increases expression
EXP
lanthanum chloride results in increased expression of GRIN2A
CTD
PMID:29353069
NCBI chr10:6,136,458...6,560,003
Ensembl chr10:5,631,369...6,044,637
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
increases expression
EXP
lanthanum chloride results in increased expression of GRIN2B
CTD
PMID:29353069
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:168,599,546...169,042,279
G
Gstz1
glutathione S-transferase zeta 1
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of GSTZ1 mRNA
CTD
PMID:28954213
NCBI chr 6:112,525,576...112,536,228
Ensembl chr 6:106,794,074...106,805,284
G
Hmox1
heme oxygenase 1
multiple interactions decreases expression increases expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of HMOX1 mRNA lanthanum chloride results in decreased expression of HMOX1 protein lanthanum chloride results in increased expression of HMOX1 mRNA; lanthanum chloride results in increased expression of HMOX1 protein lanthanum chloride results in decreased expression of HMOX1 mRNA
CTD
PMID:24142884 PMID:28954213 PMID:33098623
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
decreases expression
EXP
lanthanum chloride results in decreased expression of JUN mRNA; lanthanum chloride results in decreased expression of JUN protein
CTD
PMID:21624330
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Kcnip1
potassium voltage-gated channel interacting protein 1
decreases expression
EXP
lanthanum chloride results in decreased expression of KCNIP1 protein
CTD
PMID:35090998
NCBI chr10:18,219,519...18,588,833
Ensembl chr10:18,219,519...18,589,045
G
Keap1
Kelch-like ECH-associated protein 1
increases expression
ISO
lanthanum chloride results in increased expression of KEAP1 protein
CTD
PMID:33098623
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862
G
Lamp2
lysosomal-associated membrane protein 2
increases expression
EXP
lanthanum chloride results in increased expression of LAMP2 protein
CTD
PMID:35090998
NCBI chr X:122,038,734...122,087,745
Ensembl chr X:117,057,606...117,260,522
G
Ldha
lactate dehydrogenase A
decreases expression
EXP
lanthanum chloride results in decreased expression of LDHA mRNA; lanthanum chloride results in decreased expression of LDHA protein
CTD
PMID:29264619
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
G
Ldhb
lactate dehydrogenase B
increases expression
EXP
lanthanum chloride results in increased expression of LDHB mRNA; lanthanum chloride results in increased expression of LDHB protein
CTD
PMID:29264619
NCBI chr 4:175,428,382...175,446,403
Ensembl chr 4:175,428,385...175,446,403
G
Lpo
lactoperoxidase
multiple interactions increases expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of LPO mRNA lanthanum chloride results in increased expression of LPO mRNA
CTD
PMID:28954213
NCBI chr10:73,104,170...73,124,683
Ensembl chr10:72,606,944...72,626,535
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
increases expression
EXP ISO
lanthanum chloride results in increased expression of MAP1LC3B protein modified form
CTD
PMID:35090998 PMID:38253231
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
G
Mb
myoglobin
multiple interactions increases expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of MB mRNA lanthanum chloride results in increased expression of MB mRNA
CTD
PMID:28954213
NCBI chr 7:108,759,903...108,767,134
Ensembl chr 7:108,759,904...108,767,383
G
Mbl2
mannose binding lectin 2
multiple interactions decreases expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of MBL2 mRNA lanthanum chloride results in decreased expression of MBL2 mRNA
CTD
PMID:28954213
NCBI chr 1:237,429,873...237,465,567
G
Mfn1
mitofusin 1
decreases expression
EXP
lanthanum chloride results in decreased expression of MFN1 protein
CTD
PMID:35090998
NCBI chr 2:115,313,380...115,359,651
Ensembl chr 2:115,313,401...115,359,640
G
Mfn2
mitofusin 2
decreases expression
EXP
lanthanum chloride results in decreased expression of MFN2 protein
CTD
PMID:35090998
NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:158,304,287...158,335,342
G
Mpo
myeloperoxidase
affects expression
ISO
lanthanum chloride affects the expression of MPO mRNA
CTD
PMID:28954213
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
G
Mpv17
mitochondrial inner membrane protein MPV17
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of MPV17 mRNA
CTD
PMID:28954213
NCBI chr 6:25,221,668...25,236,241
Ensembl chr 6:25,222,896...25,236,244
G
Mtor
mechanistic target of rapamycin kinase
decreases expression
EXP
lanthanum chloride results in decreased expression of MTOR protein modified form
CTD
PMID:35090998
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
G
Ncf1
neutrophil cytosolic factor 1
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of NCF1 mRNA
CTD
PMID:28954213
NCBI chr12:28,121,816...28,131,080
Ensembl chr12:22,485,451...22,494,646
G
Ncf2
neutrophil cytosolic factor 2
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of NCF2 mRNA
CTD
PMID:28954213
NCBI chr13:67,505,492...67,536,015
Ensembl chr13:64,955,503...64,986,277
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases expression
ISO
lanthanum chloride results in increased expression of NFE2L2 mRNA; lanthanum chloride results in increased expression of NFE2L2 protein
CTD
PMID:24142884 PMID:33098623
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nos2
nitric oxide synthase 2
increases expression multiple interactions
ISO
lanthanum chloride results in increased expression of NOS2 mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of NOS2 mRNA
CTD
PMID:28954213
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nox4
NADPH oxidase 4
increases expression
EXP
lanthanum chloride results in increased expression of NOX4 protein
CTD
PMID:35090998
NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:140,901,097...141,077,406
G
Npm1
nucleophosmin 1
multiple interactions
ISO
lanthanum chloride results in decreased expression of and affects the localization of NPM1 protein
CTD
PMID:38253231
NCBI chr10:17,741,512...17,751,626
Ensembl chr10:17,739,941...17,751,645 Ensembl chr X:17,739,941...17,751,645
G
Nqo1
NAD(P)H quinone dehydrogenase 1
decreases expression
ISO
lanthanum chloride results in decreased expression of NQO1 protein
CTD
PMID:33098623
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nudt1
nudix hydrolase 1
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of NUDT1 mRNA
CTD
PMID:28954213
NCBI chr12:14,302,514...14,309,559
Ensembl chr12:14,302,694...14,305,826
G
Pcna
proliferating cell nuclear antigen
affects expression multiple interactions
ISO
lanthanum chloride affects the expression of PCNA protein [cerous chloride co-treated with lanthanum chloride] affects the expression of PCNA protein
CTD
PMID:28954213
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Prdx1
peroxiredoxin 1
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of PRDX1 mRNA
CTD
PMID:28954213
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
G
Prdx5
peroxiredoxin 5
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of PRDX5 mRNA
CTD
PMID:28954213
NCBI chr 1:204,099,826...204,103,589
Ensembl chr 1:204,099,826...204,114,268
G
Prex1
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1
multiple interactions decreases expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of PREX1 mRNA lanthanum chloride results in decreased expression of PREX1 mRNA
CTD
PMID:28954213
NCBI chr 3:155,306,950...155,456,688
Ensembl chr 3:155,306,950...155,456,688
G
Pxdn
peroxidasin
multiple interactions decreases expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of PXDN mRNA lanthanum chloride results in decreased expression of PXDN mRNA
CTD
PMID:28954213
NCBI chr 6:46,580,749...46,658,345
Ensembl chr 6:46,580,761...46,658,345
G
Pygb
glycogen phosphorylase B
decreases expression
EXP
lanthanum chloride results in decreased expression of PYGB mRNA; lanthanum chloride results in decreased expression of PYGB protein
CTD
PMID:29264619
NCBI chr 3:139,611,724...139,658,521
Ensembl chr 3:139,611,749...139,663,553
G
Rab7a
RAB7A, member RAS oncogene family
increases expression
EXP
lanthanum chloride results in increased expression of RAB7A protein
CTD
PMID:35090998
NCBI chr 4:122,019,281...122,068,067
Ensembl chr 4:120,461,963...120,506,889
G
Rad51
RAD51 recombinase
multiple interactions
ISO
[lanthanum chloride co-treated with Cisplatin] results in increased expression of RAD51 protein
CTD
PMID:38253231
NCBI chr 3:126,554,210...126,578,888
Ensembl chr 3:106,100,381...106,125,035
G
Rmdn3
regulator of microtubule dynamics 3
decreases expression
EXP
lanthanum chloride results in decreased expression of RMDN3 protein
CTD
PMID:35090998
NCBI chr 3:106,125,961...106,146,568
Ensembl chr 3:106,125,951...106,146,586
G
Scara3
scavenger receptor class A, member 3
increases expression
ISO
lanthanum chloride results in increased expression of SCARA3 mRNA
CTD
PMID:28954213
NCBI chr15:40,139,873...40,172,866
Ensembl chr15:40,140,161...40,172,894
G
Selenop
selenoprotein P
multiple interactions increases expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of SELENOP mRNA lanthanum chloride results in increased expression of SELENOP mRNA
CTD
PMID:28954213
NCBI chr 2:54,225,736...54,236,022
Ensembl chr 2:52,498,339...52,508,852
G
Sirt2
sirtuin 2
multiple interactions increases expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of SIRT2 mRNA lanthanum chloride results in increased expression of SIRT2 mRNA
CTD
PMID:28954213
NCBI chr 1:93,181,472...93,204,499
Ensembl chr 1:84,052,903...84,076,975
G
Slc16a1
solute carrier family 16 member 1
decreases expression
EXP
lanthanum chloride results in decreased expression of SLC16A1 mRNA; lanthanum chloride results in decreased expression of SLC16A1 protein
CTD
PMID:29264619
NCBI chr 2:194,805,556...194,832,966
Ensembl chr 2:192,124,289...192,144,611
G
Slc16a3
solute carrier family 16 member 3
decreases expression
EXP
lanthanum chloride results in decreased expression of SLC16A3 mRNA; lanthanum chloride results in decreased expression of SLC16A3 protein
CTD
PMID:29264619
NCBI chr10:106,712,328...106,756,168
Ensembl chr10:106,212,778...106,222,562
G
Slc16a7
solute carrier family 16 member 7
decreases expression
EXP
lanthanum chloride results in decreased expression of SLC16A7 mRNA; lanthanum chloride results in decreased expression of SLC16A7 protein
CTD
PMID:29264619
NCBI chr 7:62,929,067...63,096,995
Ensembl chr 7:61,051,167...61,154,994
G
Slc1a2
solute carrier family 1 member 2
decreases expression
EXP
lanthanum chloride results in decreased expression of SLC1A2
CTD
PMID:29353069
NCBI chr 3:109,460,109...109,590,445
Ensembl chr 3:89,005,129...89,126,498
G
Slc1a3
solute carrier family 1 member 3
decreases expression
EXP
lanthanum chloride results in decreased expression of SLC1A3
CTD
PMID:29353069
NCBI chr 2:59,482,707...59,557,808
Ensembl chr 2:57,755,497...57,830,605
G
Slc2a1
solute carrier family 2 member 1
decreases expression
EXP
lanthanum chloride results in decreased expression of SLC2A1 mRNA; lanthanum chloride results in decreased expression of SLC2A1 protein
CTD
PMID:29264619
NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:132,717,196...132,745,416
G
Sod2
superoxide dismutase 2
multiple interactions increases expression
ISO
[cerous chloride co-treated with lanthanum chloride] results in increased expression of SOD2 mRNA lanthanum chloride results in increased expression of SOD2 mRNA
CTD
PMID:28954213
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Sqstm1
sequestosome 1
multiple interactions decreases expression
ISO EXP
[cerous chloride co-treated with lanthanum chloride] results in increased expression of SQSTM1 mRNA lanthanum chloride results in decreased expression of SQSTM1 protein
CTD
PMID:28954213 PMID:35090998
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673
G
Srxn1
sulfiredoxin 1
increases expression multiple interactions
ISO
lanthanum chloride results in increased expression of SRXN1 mRNA [cerous chloride co-treated with lanthanum chloride] results in increased expression of SRXN1 mRNA
CTD
PMID:28954213
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Stk25
serine/threonine kinase 25
multiple interactions
ISO
[cerous chloride co-treated with lanthanum chloride] results in decreased expression of STK25 mRNA
CTD
PMID:28954213
NCBI chr 9:94,161,834...94,174,095
Ensembl chr 9:94,161,836...94,174,244
G
Stx17
syntaxin 17
increases expression
EXP
lanthanum chloride results in increased expression of STX17 protein
CTD
PMID:35090998
NCBI chr 5:67,241,673...67,302,228
Ensembl chr 5:62,446,187...62,504,451
G
Ucp2
uncoupling protein 2
decreases expression multiple interactions
ISO
lanthanum chloride results in decreased expression of UCP2 mRNA [cerous chloride co-treated with lanthanum chloride] affects the expression of UCP2 mRNA
CTD
PMID:28954213
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:154,839,209...154,845,611
G
Ulk1
unc-51 like autophagy activating kinase 1
increases expression decreases expression
EXP
lanthanum chloride results in increased expression of ULK1 protein lanthanum chloride results in decreased expression of ULK1 protein modified form
CTD
PMID:35090998
NCBI chr12:51,511,492...51,537,746
Ensembl chr12:45,851,710...45,877,966
G
Vapb
VAMP associated protein B and C
decreases expression
EXP
lanthanum chloride results in decreased expression of VAPB protein
CTD
PMID:35090998
NCBI chr 3:162,535,974...162,578,747
Ensembl chr 3:162,535,905...162,573,763
G
Agl
amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase
multiple interactions decreases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of AGL mRNA motexafin gadolinium results in decreased expression of AGL mRNA
CTD
PMID:16357179
NCBI chr 2:207,389,949...207,445,959
Ensembl chr 2:204,705,053...204,760,828
G
Aldh5a1
aldehyde dehydrogenase 5 family, member A1
multiple interactions increases expression
ISO
motexafin gadolinium inhibits the reaction [Zinc Acetate results in increased expression of ALDH5A1 mRNA] motexafin gadolinium results in increased expression of ALDH5A1 mRNA
CTD
PMID:16357179
NCBI chr17:40,560,373...40,586,711
Ensembl chr17:40,130,883...40,158,677
G
Aldh6a1
aldehyde dehydrogenase 6 family, member A1
decreases expression multiple interactions
ISO
motexafin gadolinium results in decreased expression of ALDH6A1 mRNA Zinc Acetate inhibits the reaction [motexafin gadolinium results in decreased expression of ALDH6A1 mRNA]
CTD
PMID:16357179
NCBI chr 6:109,809,092...109,829,725
Ensembl chr 6:104,077,979...104,098,656
G
Arhgap17
Rho GTPase activating protein 17
decreases expression multiple interactions
ISO
motexafin gadolinium results in decreased expression of ARHGAP17 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of ARHGAP17 mRNA
CTD
PMID:16357179
NCBI chr 1:177,807,579...177,897,027
Ensembl chr 1:177,807,583...177,896,854
G
Atf3
activating transcription factor 3
multiple interactions increases expression
ISO
motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of ATF3 mRNA] motexafin gadolinium results in increased expression of ATF3 mRNA
CTD
PMID:16357179
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:102,751,321...102,764,631
G
Atm
ATM serine/threonine kinase
multiple interactions increases expression
ISO
motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of ATM mRNA] motexafin gadolinium results in increased expression of ATM mRNA
CTD
PMID:16357179
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:53,831,093...53,932,437
G
Atr
ATR serine/threonine kinase
decreases expression multiple interactions
ISO
motexafin gadolinium results in decreased expression of ATR mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of ATR mRNA
CTD
PMID:16357179
NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
G
Bach1
BTB domain and CNC homolog 1
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of BACH1 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of BACH1 mRNA
CTD
PMID:16357179
NCBI chr11:26,939,429...26,974,876
Ensembl chr11:26,939,480...26,972,447
G
Bag3
BAG cochaperone 3
multiple interactions increases expression
ISO
motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of BAG3 mRNA] motexafin gadolinium results in increased expression of BAG3 mRNA
CTD
PMID:16357179
NCBI chr 1:192,533,460...192,557,281
Ensembl chr 1:183,102,871...183,126,858
G
Bbc3
Bcl-2 binding component 3
multiple interactions
ISO
[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of BBC3 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of BBC3 protein]
CTD
PMID:20530418
NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:77,014,543...77,022,509
G
Birc5
baculoviral IAP repeat-containing 5
multiple interactions increases expression
ISO
motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of BIRC5 mRNA] motexafin gadolinium results in increased expression of BIRC5 mRNA
CTD
PMID:16357179
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
G
Bnip3
BCL2 interacting protein 3
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of BNIP3 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of BNIP3 mRNA
CTD
PMID:16357179
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:193,708,167...193,725,359
G
Bnip3l
BCL2 interacting protein 3 like
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of BNIP3L mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of BNIP3L mRNA
CTD
PMID:16357179
NCBI chr15:45,350,081...45,373,213
Ensembl chr15:41,174,594...41,197,803
G
Canx
calnexin
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of CANX mRNA [Zinc Acetate co-treated with motexafin gadolinium] affects the expression of CANX mRNA
CTD
PMID:16357179
NCBI chr10:35,124,941...35,157,954
Ensembl chr10:34,625,191...34,656,821
G
Casp3
caspase 3
decreases expression multiple interactions
ISO
motexafin gadolinium results in decreased expression of CASP3 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CASP3 mRNA
CTD
PMID:16357179
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Cbfb
core-binding factor subunit beta
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of CBFB mRNA [Zinc Acetate co-treated with motexafin gadolinium] affects the expression of CBFB mRNA
CTD
PMID:16357179
NCBI chr19:33,049,162...33,092,752
Ensembl chr19:33,049,172...33,092,751
G
Ccnj
cyclin J
multiple interactions decreases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CCNJ mRNA motexafin gadolinium results in decreased expression of CCNJ mRNA
CTD
PMID:16357179
NCBI chr 1:239,659,588...239,677,367
G
Cdc16
cell division cycle 16
decreases expression multiple interactions
ISO
motexafin gadolinium results in decreased expression of CDC16 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CDC16 mRNA
CTD
PMID:16357179
NCBI chr16:75,773,026...75,796,586
Ensembl chr16:75,773,028...75,796,550
G
Cdc25c
cell division cycle 25C
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of CDC25C mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of CDC25C mRNA
CTD
PMID:16357179
NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,335,834...26,356,185
G
Cdc27
cell division cycle 27
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of CDC27 mRNA [Zinc Acetate co-treated with motexafin gadolinium] affects the expression of CDC27 mRNA
CTD
PMID:16357179
NCBI chr10:89,900,676...89,949,770
Ensembl chr10:89,400,940...89,449,736
G
Cdc5l
cell division cycle 5-like
decreases expression multiple interactions
ISO
motexafin gadolinium results in decreased expression of CDC5L mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CDC5L mRNA
CTD
PMID:16357179
NCBI chr 9:15,564,949...15,603,453
Ensembl chr 9:15,564,767...15,603,450
G
Cdca2
cell division cycle associated 2
decreases expression multiple interactions
ISO
motexafin gadolinium results in decreased expression of CDCA2 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CDCA2 mRNA
CTD
PMID:16357179
NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611
G
Cdk19
cyclin-dependent kinase 19
increases expression
ISO
motexafin gadolinium results in increased expression of CDK19 mRNA
CTD
PMID:16357179
NCBI chr20:43,770,409...43,910,629
Ensembl chr20:43,770,409...43,910,628
G
Cdk2
cyclin dependent kinase 2
multiple interactions increases expression
ISO
motexafin gadolinium inhibits the reaction [Zinc Acetate results in increased expression of CDK2 mRNA] motexafin gadolinium results in increased expression of CDK2 mRNA
CTD
PMID:16357179
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,129,811...1,137,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions
ISO
[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CDKN1A mRNA; nutlin 3 inhibits the reaction [[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CDKN1A mRNA]
CTD
PMID:20530418
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of CDKN1B mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of CDKN1B mRNA
CTD
PMID:16357179
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:167,760,181...167,764,982
G
Cth
cystathionine gamma-lyase
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of CTH mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of CTH mRNA
CTD
PMID:16357179
NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:246,975,894...247,002,234
G
Cul3
cullin 3
decreases expression multiple interactions
ISO
motexafin gadolinium results in decreased expression of CUL3 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CUL3 mRNA
CTD
PMID:16357179
NCBI chr 9:81,592,641...81,670,428
Ensembl chr 9:81,592,641...81,670,462
G
Cyb5r1
cytochrome b5 reductase 1
multiple interactions increases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of CYB5R1 mRNA motexafin gadolinium results in increased expression of CYB5R1 mRNA
CTD
PMID:16357179
NCBI chr13:45,849,017...45,855,458
Ensembl chr13:45,849,091...45,855,458
G
Dapk3
death-associated protein kinase 3
multiple interactions decreases expression
ISO
motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of DAPK3 mRNA] motexafin gadolinium results in decreased expression of DAPK3 mRNA
CTD
PMID:16357179
NCBI chr 7:9,174,903...9,183,272
Ensembl chr 7:8,524,183...8,532,558
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions increases expression
ISO
motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of DDIT3 mRNA] motexafin gadolinium results in increased expression of DDIT3 mRNA
CTD
PMID:16357179
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
G
Ddit4
DNA-damage-inducible transcript 4
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of DDIT4 mRNA motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of DDIT4 mRNA]; Zinc Acetate promotes the reaction [motexafin gadolinium results in increased expression of DDIT4 mRNA]
CTD
PMID:16357179
NCBI chr20:28,434,938...28,437,037
Ensembl chr20:27,891,998...27,894,105
G
Dedd2
death effector domain containing 2
multiple interactions increases expression
ISO
motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of DEDD2 mRNA] motexafin gadolinium results in increased expression of DEDD2 mRNA
CTD
PMID:16357179
NCBI chr 1:80,789,084...80,807,789
Ensembl chr 1:80,792,000...80,807,714
G
Dffb
DNA fragmentation factor subunit beta
decreases expression multiple interactions
ISO
motexafin gadolinium results in decreased expression of DFFB mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of DFFB mRNA
CTD
PMID:16357179
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
G
Dhcr7
7-dehydrocholesterol reductase
decreases expression
ISO
motexafin gadolinium results in decreased expression of DHCR7 mRNA
CTD
PMID:16357179
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
G
Dnajb1
DnaJ heat shock protein family (Hsp40) member B1
multiple interactions increases expression
ISO
motexafin gadolinium inhibits the reaction [Zinc Acetate results in decreased expression of DNAJB1 mRNA] motexafin gadolinium results in increased expression of DNAJB1 mRNA
CTD
PMID:16357179
NCBI chr19:41,427,453...41,431,141
Ensembl chr19:24,522,717...24,526,458
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of DNAJB4 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of DNAJB4 mRNA
CTD
PMID:16357179
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
G
Dnajb6
DnaJ heat shock protein family (Hsp40) member B6
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of DNAJB6 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of DNAJB6 mRNA
CTD
PMID:16357179
NCBI chr 4:5,452,683...5,556,679
Ensembl chr 4:5,452,683...5,556,659
G
Dnajc3
DnaJ heat shock protein family (Hsp40) member C3
multiple interactions increases expression
ISO
motexafin gadolinium inhibits the reaction [Zinc Acetate results in increased expression of DNAJC3 mRNA] motexafin gadolinium results in increased expression of DNAJC3 mRNA
CTD
PMID:16357179
NCBI chr15:102,432,667...102,475,643
Ensembl chr15:96,025,624...96,065,181
G
E2f1
E2F transcription factor 1
multiple interactions increases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of E2F1 mRNA motexafin gadolinium results in increased expression of E2F1 mRNA
CTD
PMID:16357179
NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:143,049,478...143,075,361
G
E2f3
E2F transcription factor 3
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of E2F3 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of E2F3 mRNA
CTD
PMID:16357179
NCBI chr17:34,810,355...34,887,725
Ensembl chr17:34,601,830...34,676,253
G
Egln1
egl-9 family hypoxia-inducible factor 1
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of EGLN1 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of EGLN1 mRNA
CTD
PMID:16357179
NCBI chr19:69,765,276...69,804,681
Ensembl chr19:52,869,486...52,907,777
G
Elp1
elongator acetyltransferase complex subunit 1
decreases expression multiple interactions
ISO
motexafin gadolinium results in decreased expression of ELP1 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of ELP1 mRNA
CTD
PMID:16357179
NCBI chr 5:71,453,338...71,505,833
Ensembl chr 5:71,456,310...71,505,762
G
Eno1
enolase 1
increases expression
ISO
motexafin gadolinium results in increased expression of ENO1 mRNA
CTD
PMID:16357179
NCBI chr 5:166,002,867...166,014,252
Ensembl chr 5:160,719,951...160,731,336 Ensembl chr 3:160,719,951...160,731,336
G
Fadd
Fas associated via death domain
decreases expression multiple interactions
ISO
motexafin gadolinium results in decreased expression of FADD mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of FADD mRNA
CTD
PMID:16357179
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:199,739,994...199,745,653
G
Faim
Fas apoptotic inhibitory molecule
decreases expression multiple interactions
ISO
motexafin gadolinium results in decreased expression of FAIM mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of FAIM mRNA
CTD
PMID:16357179
NCBI chr 8:99,543,877...99,569,499
Ensembl chr 8:99,542,405...99,560,562
G
Fam162a
family with sequence similarity 162, member A
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of FAM162A mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of FAM162A mRNA
CTD
PMID:16357179
NCBI chr11:64,680,978...64,709,865
Ensembl chr11:64,680,323...64,711,239
G
Fasn
fatty acid synthase
decreases expression
ISO
motexafin gadolinium results in decreased expression of FASN mRNA
CTD
PMID:16357179
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261
G
Foxo3
forkhead box O3
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of FOXO3 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of FOXO3 mRNA
CTD
PMID:16357179
NCBI chr20:47,251,968...47,348,254
Ensembl chr20:45,672,995...45,764,561
G
Gclm
glutamate cysteine ligase, modifier subunit
multiple interactions increases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of GCLM mRNA motexafin gadolinium results in increased expression of GCLM mRNA
CTD
PMID:16357179
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
G
Gls
glutaminase
decreases expression multiple interactions
ISO
motexafin gadolinium results in decreased expression of GLS mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of GLS mRNA
CTD
PMID:16357179
NCBI chr 9:56,836,584...56,908,861
Ensembl chr 9:49,344,781...49,416,900
G
Gpr146
G protein-coupled receptor 146
increases expression
ISO
motexafin gadolinium results in increased expression of GPR146 mRNA
CTD
PMID:16357179
NCBI chr12:15,251,936...15,267,217
Ensembl chr12:15,251,813...15,267,206
G
Gpt2
glutamic--pyruvic transaminase 2
increases expression
ISO
motexafin gadolinium results in increased expression of GPT2 mRNA
CTD
PMID:16357179
NCBI chr19:37,700,023...37,734,551
Ensembl chr19:21,517,621...21,560,610
G
Gpx1
glutathione peroxidase 1
multiple interactions
ISO
[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of GPX1 mRNA; nutlin 3 inhibits the reaction [[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of GPX1 mRNA]
CTD
PMID:20530418
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024
G
Gsr
glutathione-disulfide reductase
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of GSR mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of GSR mRNA
CTD
PMID:16357179
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
Gtf3c2
general transcription factor IIIC subunit 2
increases expression
ISO
motexafin gadolinium results in increased expression of GTF3C2 mRNA
CTD
PMID:16357179
NCBI chr 6:25,196,439...25,221,338
Ensembl chr 6:25,197,268...25,220,490
G
Hbp1
HMG-box transcription factor 1
multiple interactions increases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of HBP1 mRNA motexafin gadolinium results in increased expression of HBP1 mRNA
CTD
PMID:16357179
NCBI chr 6:54,257,118...54,283,373
Ensembl chr 6:48,529,372...48,555,787
G
Hif1a
hypoxia inducible factor 1 subunit alpha
multiple interactions increases expression
ISO
[motexafin gadolinium co-treated with Zinc Acetate] results in increased expression of HIF1A protein motexafin gadolinium results in increased expression of HIF1A protein
CTD
PMID:16357179
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hilpda
hypoxia inducible lipid droplet-associated
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of HILPDA mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of HILPDA mRNA
CTD
PMID:16357179
NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557
G
Hipk1
homeodomain interacting protein kinase 1
multiple interactions increases expression
ISO
motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of HIPK1 mRNA] motexafin gadolinium results in increased expression of HIPK1 mRNA
CTD
PMID:16357179
NCBI chr 2:191,248,817...191,299,787
Ensembl chr 2:191,248,817...191,298,902
G
Hltf
helicase-like transcription factor
multiple interactions decreases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of HLTF mRNA motexafin gadolinium results in decreased expression of HLTF mRNA
CTD
PMID:16357179
NCBI chr 2:102,549,724...102,609,492
Ensembl chr 2:102,549,724...102,609,327
G
Hmox1
heme oxygenase 1
multiple interactions increases expression
ISO
[motexafin gadolinium co-treated with Zinc Acetate] results in increased expression of HMOX1 protein; motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of HMOX1 mRNA] motexafin gadolinium results in increased expression of HMOX1 mRNA
CTD
PMID:16357179
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hrk
harakiri, BCL2 interacting protein
multiple interactions increases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of HRK mRNA motexafin gadolinium results in increased expression of HRK mRNA
CTD
PMID:16357179
NCBI chr12:38,387,484...38,409,652
G
Hsp90ab1
heat shock protein 90 alpha family class B member 1
multiple interactions increases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of HSP90AB1 mRNA motexafin gadolinium results in increased expression of HSP90AB1 mRNA
CTD
PMID:16357179
NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:15,433,691...15,438,488
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
multiple interactions increases expression
ISO
motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of HSPA1A mRNA]; Zinc Acetate promotes the reaction [motexafin gadolinium results in increased expression of HSPA1A mRNA]
CTD
PMID:16357179
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
multiple interactions increases expression
ISO
motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of HSPA1B mRNA]; Zinc Acetate promotes the reaction [motexafin gadolinium results in increased expression of HSPA1B mRNA]
CTD
PMID:16357179
NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa4
heat shock protein family A (Hsp70) member 4
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of HSPA4 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of HSPA4 mRNA
CTD
PMID:16357179
NCBI chr10:37,908,866...37,951,994
Ensembl chr10:37,408,025...37,449,001
G
Hspa4l
heat shock protein family A (Hsp70) member 4 like
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of HSPA4L mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of HSPA4L mRNA
CTD
PMID:16357179
NCBI chr 2:123,740,384...123,793,088
Ensembl chr 2:123,740,384...123,793,084
G
Hspb1
heat shock protein family B (small) member 1
multiple interactions increases expression
ISO
motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of HSPB1 mRNA] motexafin gadolinium results in increased expression of HSPB1 mRNA
CTD
PMID:16357179
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:20,794,028...20,795,743
G
Hspd1
heat shock protein family D (Hsp60) member 1
multiple interactions increases expression
ISO
motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of HSPD1 mRNA] motexafin gadolinium results in increased expression of HSPD1 mRNA
CTD
PMID:16357179
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:56,579,201...56,589,662
G
Hsph1
heat shock protein family H (Hsp110) member 1
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of HSPH1 mRNA motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of HSPH1 mRNA]
CTD
PMID:16357179
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
G
Id2
inhibitor of DNA binding 2
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of ID2 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of ID2 mRNA
CTD
PMID:16357179
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Ikbke
inhibitor of nuclear factor kappa B kinase subunit epsilon
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of IKBKE mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of IKBKE mRNA
CTD
PMID:16357179
NCBI chr13:45,264,404...45,290,737
Ensembl chr13:42,712,159...42,737,143
G
Irf2bp2
interferon regulatory factor 2 binding protein 2
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of IRF2BP2 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of IRF2BP2 mRNA
CTD
PMID:16357179
NCBI chr19:54,559,417...54,565,096
Ensembl chr19:54,560,128...54,566,642
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of JUND mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of JUND mRNA
CTD
PMID:16357179
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
G
Kdm3a
lysine demethylase 3A
increases expression
ISO
motexafin gadolinium results in increased expression of KDM3A mRNA
CTD
PMID:16357179
NCBI chr 4:105,189,208...105,233,526
Ensembl chr 4:103,630,908...103,675,073
G
Mdm2
MDM2 proto-oncogene
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of MDM2 mRNA motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of MDM2 mRNA]
CTD
PMID:16357179
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:53,290,664...53,314,915
G
Mob1a
MOB kinase activator 1A
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of MOB1A mRNA motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of MOB1A mRNA]
CTD
PMID:16357179
NCBI chr 4:115,831,581...115,848,561
Ensembl chr 4:115,831,551...115,848,561 Ensembl chr 1:115,831,551...115,848,561
G
Mt1
metallothionein 1
multiple interactions
ISO
[Zinc co-treated with motexafin gadolinium] results in increased expression of MT1A mRNA
CTD
PMID:15867382
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
G
Mt1-ps3
metallothionein 1, pseudogene 3
multiple interactions increases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of MT1E mRNA motexafin gadolinium results in increased expression of MT1E mRNA
CTD
PMID:15867382 PMID:16357179
NCBI chr17:74,786,652...74,787,040
Ensembl chr17:74,786,654...74,787,135
G
Mt2
metallothionein 2
multiple interactions increases expression
ISO
motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of MT2A mRNA] motexafin gadolinium results in increased expression of MT2A mRNA
CTD
PMID:15867382 PMID:16357179
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,832,002...10,832,784
G
Mt2-ps1
metallothionein 2, pseudogene 1
multiple interactions increases expression
ISO
motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of MT1HL1 mRNA] motexafin gadolinium results in increased expression of MT1HL1 mRNA
CTD
PMID:15867382 PMID:16357179
NCBI chr20:3,159,037...3,159,409
Ensembl chr 5:119,728,811...119,730,073
G
Myd88
MYD88, innate immune signal transduction adaptor
multiple interactions decreases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of MYD88 mRNA motexafin gadolinium results in decreased expression of MYD88 mRNA
CTD
PMID:16357179
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:119,074,437...119,079,415
G
Nadk
NAD kinase
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of NADK mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of NADK mRNA
CTD
PMID:16357179
NCBI chr 5:166,145,708...166,176,328
Ensembl chr 5:166,145,481...166,176,322
G
Nf1
neurofibromin 1
multiple interactions increases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of NF1 mRNA motexafin gadolinium results in increased expression of NF1 mRNA
CTD
PMID:16357179
NCBI chr10:64,803,986...65,037,086
Ensembl chr10:64,306,301...64,536,658
G
Nisch
nischarin
decreases expression
ISO
motexafin gadolinium results in decreased expression of NISCH mRNA
CTD
PMID:16357179
NCBI chr16:6,364,370...6,400,675
Ensembl chr16:6,364,374...6,400,668
G
Nr1d2
nuclear receptor subfamily 1, group D, member 2
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of NR1D2 mRNA motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of NR1D2 mRNA]
CTD
PMID:16357179
NCBI chr15:7,524,257...7,550,553
Ensembl chr15:7,524,257...7,550,553
G
P4hb
prolyl 4-hydroxylase subunit beta
multiple interactions increases expression
ISO
motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of P4HB mRNA] motexafin gadolinium results in increased expression of P4HB mRNA
CTD
PMID:16357179
NCBI chr10:105,836,972...105,848,583
Ensembl chr10:105,836,982...105,848,500
G
Pdcd11
programmed cell death 11
decreases expression
ISO
motexafin gadolinium results in decreased expression of PDCD11 mRNA
CTD
PMID:16357179
NCBI chr 1:245,980,840...246,021,999
Ensembl chr 1:245,980,880...246,021,999
G
Pdcd4
programmed cell death 4
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of PDCD4 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of PDCD4 mRNA
CTD
PMID:16357179
NCBI chr 1:252,921,342...252,944,278
Ensembl chr 1:252,921,392...252,944,275
G
Pdcd5
programmed cell death 5
decreases expression multiple interactions
ISO
motexafin gadolinium results in decreased expression of PDCD5 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of PDCD5 mRNA
CTD
PMID:16357179
NCBI chr 1:88,305,869...88,311,200
Ensembl chr 1:88,305,869...88,311,200
G
Pfkfb3
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of PFKFB3 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of PFKFB3 mRNA
CTD
PMID:16357179
NCBI chr17:66,983,629...67,064,702
Ensembl chr17:66,983,686...67,063,125
G
Pfkfb4
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of PFKFB4 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of PFKFB4 mRNA
CTD
PMID:16357179
NCBI chr 8:109,643,558...109,687,006
Ensembl chr 8:109,643,937...109,685,634
G
Pgk1
phosphoglycerate kinase 1
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of PGK1 mRNA motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of PGK1 mRNA]
CTD
PMID:16357179
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
G
Phtf2
putative homeodomain transcription factor 2
multiple interactions increases expression
ISO
motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of PHTF2 mRNA] motexafin gadolinium results in increased expression of PHTF2 mRNA
CTD
PMID:16357179
NCBI chr 4:14,215,190...14,330,549
Ensembl chr 4:14,215,263...14,330,513
G
Pias1
protein inhibitor of activated STAT, 1
multiple interactions increases expression
ISO
motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of PIAS1 mRNA] motexafin gadolinium results in increased expression of PIAS1 mRNA
CTD
PMID:16357179
NCBI chr 8:72,233,566...72,347,085
Ensembl chr 8:63,338,150...63,438,905
G
Pik3ip1
phosphoinositide-3-kinase interacting protein 1
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of PIK3IP1 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of PIK3IP1 mRNA
CTD
PMID:16357179
NCBI chr14:78,204,668...78,216,616
Ensembl chr14:78,204,053...78,216,608
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
multiple interactions increases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of PMAIP1 mRNA motexafin gadolinium results in increased expression of PMAIP1 mRNA
CTD
PMID:16357179
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
G
Prkacb
protein kinase cAMP-activated catalytic subunit beta
multiple interactions increases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of PRKACB mRNA motexafin gadolinium results in increased expression of PRKACB mRNA
CTD
PMID:16357179
NCBI chr 2:238,297,140...238,389,317
Ensembl chr 2:235,636,885...235,726,198
G
Prkcd
protein kinase C, delta
decreases expression
ISO
motexafin gadolinium results in decreased expression of PRKCD mRNA
CTD
PMID:16357179
NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,769,215...5,799,352
G
Prkd2
protein kinase D2
decreases expression
ISO
motexafin gadolinium results in decreased expression of PRKD2 mRNA
CTD
PMID:16357179
NCBI chr 1:77,513,625...77,542,386
Ensembl chr 1:77,513,986...77,542,376
G
Prkdc
protein kinase, DNA-activated, catalytic subunit
increases expression
ISO
motexafin gadolinium results in increased expression of PRKDC mRNA
CTD
PMID:16357179
NCBI chr11:98,544,952...98,762,499
Ensembl chr11:85,040,792...85,257,952
G
Ptrh2
peptidyl-tRNA hydrolase 2
decreases expression multiple interactions
ISO
motexafin gadolinium results in decreased expression of PTRH2 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of PTRH2 mRNA
CTD
PMID:16357179
NCBI chr10:71,505,113...71,515,297
Ensembl chr10:71,504,956...71,515,398
G
Rb1
RB transcriptional corepressor 1
decreases expression multiple interactions
ISO
motexafin gadolinium results in decreased expression of RB1 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of RB1 mRNA
CTD
PMID:16357179
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
G
Rcbtb2
RCC1 and BTB domain containing protein 2
multiple interactions decreases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of RCBTB2 mRNA motexafin gadolinium results in decreased expression of RCBTB2 mRNA
CTD
PMID:16357179
NCBI chr15:48,319,809...48,364,441
Ensembl chr15:48,323,866...48,383,750
G
Relb
RELB proto-oncogene, NF-kB subunit
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of RELB mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of RELB mRNA
CTD
PMID:16357179
NCBI chr 1:88,385,717...88,413,380
Ensembl chr 1:79,257,725...79,285,507
G
Rnf19b
ring finger protein 19B
increases expression
ISO
motexafin gadolinium results in increased expression of RNF19B mRNA
CTD
PMID:15867382
NCBI chr 5:141,406,085...141,431,376
Ensembl chr 5:141,406,118...141,431,380
G
Samtor
S-adenosylmethionine sensor upstream of mTORC1
multiple interactions increases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of SAMTOR mRNA motexafin gadolinium results in increased expression of SAMTOR mRNA
CTD
PMID:16357179
NCBI chr 4:41,881,630...41,945,472
Ensembl chr 4:41,879,993...41,945,539
G
Selenow
selenoprotein W
multiple interactions increases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of SELENOW mRNA motexafin gadolinium results in increased expression of SELENOW mRNA
CTD
PMID:16357179
NCBI chr 1:76,599,441...76,604,514
Ensembl chr 1:76,598,779...76,604,724 Ensembl chr 1:76,598,779...76,604,724
G
Sesn2
sestrin 2
multiple interactions increases expression
ISO
[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of SESN2 mRNA; [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of SESN2 mRNA; nutlin 3 inhibits the reaction [[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of SESN2 mRNA] motexafin gadolinium results in increased expression of SESN2 mRNA
CTD
PMID:16357179 PMID:20530418
NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:144,701,530...144,721,260
G
Slc16a1
solute carrier family 16 member 1
multiple interactions increases expression
ISO
motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of SLC16A1 mRNA] motexafin gadolinium results in increased expression of SLC16A1 mRNA
CTD
PMID:16357179
NCBI chr 2:194,805,556...194,832,966
Ensembl chr 2:192,124,289...192,144,611
G
Slc16a6
solute carrier family 16, member 6
multiple interactions increases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of SLC16A6 mRNA motexafin gadolinium results in increased expression of SLC16A6 mRNA
CTD
PMID:16357179
NCBI chr10:94,923,888...94,946,990
Ensembl chr10:94,426,244...94,448,779
G
Slc1a4
solute carrier family 1 member 4
multiple interactions increases expression
ISO
motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of SLC1A4 mRNA] motexafin gadolinium results in increased expression of SLC1A4 mRNA
CTD
PMID:16357179
NCBI chr14:98,718,646...98,761,672
Ensembl chr14:94,529,084...94,560,418
G
Slc30a1
solute carrier family 30 member 1
multiple interactions increases expression
ISO
[Zinc co-treated with motexafin gadolinium] results in increased expression of SLC30A1 mRNA; motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of SLC30A1 mRNA]; Zinc Acetate affects the reaction [motexafin gadolinium results in increased expression of SLC30A1 mRNA]
CTD
PMID:15867382 PMID:16357179
NCBI chr13:103,491,037...103,494,910
Ensembl chr13:103,491,037...103,494,910
G
Slc38a2
solute carrier family 38, member 2
multiple interactions increases expression
ISO
motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of SLC38A2 mRNA]; Zinc Acetate affects the reaction [motexafin gadolinium results in increased expression of SLC38A2 mRNA]
CTD
PMID:16357179
NCBI chr 7:129,730,450...129,742,619
Ensembl chr 7:127,851,267...127,863,436
G
Slc39a10
solute carrier family 39 member 10
multiple interactions affects expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] affects the expression of SLC39A10 mRNA motexafin gadolinium affects the expression of SLC39A10 mRNA
CTD
PMID:16357179
NCBI chr 9:54,836,841...54,960,325
Ensembl chr 9:54,876,141...54,960,325
G
Slc39a14
solute carrier family 39 member 14
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of SLC39A14 mRNA [Zinc Acetate co-treated with motexafin gadolinium] affects the expression of SLC39A14 mRNA
CTD
PMID:16357179
NCBI chr15:45,376,806...45,423,549
Ensembl chr15:45,376,917...45,423,524
G
Slc39a9
solute carrier family 39, member 9
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of SLC39A9 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of SLC39A9 mRNA
CTD
PMID:16357179
NCBI chr 6:100,291,537...100,330,419
Ensembl chr 6:100,291,573...100,330,408
G
Slc3a2
solute carrier family 3 member 2
multiple interactions increases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] affects the expression of SLC3A2 mRNA motexafin gadolinium results in increased expression of SLC3A2 mRNA
CTD
PMID:16357179
NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:205,604,468...205,618,931
G
Slc43a1
solute carrier family 43 member 1
multiple interactions increases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of SLC43A1 mRNA motexafin gadolinium results in increased expression of SLC43A1 mRNA
CTD
PMID:16357179
NCBI chr 3:90,327,250...90,353,438
Ensembl chr 3:69,920,649...69,946,768
G
Slc7a1
solute carrier family 7 member 1
multiple interactions increases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] affects the expression of SLC7A1 mRNA motexafin gadolinium results in increased expression of SLC7A1 mRNA
CTD
PMID:16357179
NCBI chr12:11,664,488...11,740,030
Ensembl chr12:6,628,007...6,703,849
G
Slc7a11
solute carrier family 7 member 11
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of SLC7A11 mRNA [Zinc Acetate co-treated with motexafin gadolinium] affects the expression of SLC7A11 mRNA
CTD
PMID:16357179
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:133,963,107...134,517,536
G
Smarca4
SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4
decreases expression multiple interactions
ISO
motexafin gadolinium results in decreased expression of SMARCA4 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of SMARCA4 mRNA
CTD
PMID:16357179
NCBI chr 8:28,438,370...28,535,071
Ensembl chr 8:20,167,717...20,258,975
G
Smarca5
SNF2 related chromatin remodeling ATPase 5
decreases expression multiple interactions
ISO
motexafin gadolinium results in decreased expression of SMARCA5 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of SMARCA5 mRNA
CTD
PMID:16357179
NCBI chr19:27,271,918...27,304,594
Ensembl chr19:27,271,148...27,304,594
G
Tagap
T-cell activation RhoGTPase activating protein
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of TAGAP mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of TAGAP mRNA
CTD
PMID:16357179
NCBI chr 1:49,575,750...49,584,747
Ensembl chr 1:47,170,725...47,179,792
G
Tfrc
transferrin receptor
multiple interactions increases expression
ISO
motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of TFRC mRNA] motexafin gadolinium results in increased expression of TFRC mRNA
CTD
PMID:16357179
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:68,163,413...68,185,257
G
Tnfaip8
TNF alpha induced protein 8
decreases expression multiple interactions
ISO
motexafin gadolinium results in decreased expression of TNFAIP8 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TNFAIP8 mRNA
CTD
PMID:16357179
NCBI chr18:45,370,334...45,486,036
Ensembl chr18:43,183,916...43,299,517
G
Tnfrsf17
TNF receptor superfamily member 17
multiple interactions decreases expression
ISO
[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TNFRSF17 mRNA motexafin gadolinium results in decreased expression of TNFRSF17 mRNA
CTD
PMID:16357179
NCBI chr10:4,301,023...4,306,889
Ensembl chr10:4,301,038...4,306,788
G
Tnfrsf1a
TNF receptor superfamily member 1A
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of TNFRSF1A mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of TNFRSF1A mRNA
CTD
PMID:16357179
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:158,150,820...158,163,591
G
Tnfsf8
TNF superfamily member 8
multiple interactions increases expression
ISO
motexafin gadolinium inhibits the reaction [Zinc Acetate results in increased expression of TNFSF8 mRNA] motexafin gadolinium results in increased expression of TNFSF8 mRNA
CTD
PMID:16357179
NCBI chr 5:82,266,436...82,292,858
Ensembl chr 5:77,251,373...77,277,421
G
Tnip2
TNFAIP3 interacting protein 2
decreases expression
ISO
motexafin gadolinium results in decreased expression of TNIP2 mRNA
CTD
PMID:16357179
NCBI chr14:76,228,350...76,245,553
Ensembl chr14:76,228,371...76,275,265
G
Tp53
tumor protein p53
multiple interactions
ISO
[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein; Acetylcysteine inhibits the reaction [[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein]; nutlin 3 inhibits the reaction [[Ascorbic Acid co-treated with Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein]
CTD
PMID:20530418
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Trib3
tribbles pseudokinase 3
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of TRIB3 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of TRIB3 mRNA
CTD
PMID:16357179
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
G
Txnrd1
thioredoxin reductase 1
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of TXNRD1 mRNA [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of TXNRD1 mRNA
CTD
PMID:16357179
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:20,830,045...20,907,863
G
Vegfa
vascular endothelial growth factor A
increases expression multiple interactions
ISO
motexafin gadolinium results in increased expression of VEGFA mRNA [Zinc Acetate co-treated with motexafin gadolinium] affects the expression of VEGFA mRNA
CTD
PMID:16357179
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Vhl
von Hippel-Lindau tumor suppressor
multiple interactions increases expression
ISO
motexafin gadolinium inhibits the reaction [Zinc Acetate results in increased expression of VHL mRNA] motexafin gadolinium results in increased expression of VHL mRNA
CTD
PMID:16357179
NCBI chr 4:148,328,099...148,334,992
Ensembl chr 4:146,772,468...146,779,377
G
Cacna1g
calcium voltage-gated channel subunit alpha1 G
multiple interactions
ISO
Neodymium inhibits the reaction [CACNA1G protein results in increased transport of Barium]
CTD
PMID:12163980
NCBI chr10:79,851,886...79,919,926
Ensembl chr10:79,355,008...79,422,752
G
Hspb1
heat shock protein family B (small) member 1
decreases phosphorylation increases expression
ISO
Neodymium results in decreased phosphorylation of HSPB1 protein Neodymium results in increased expression of HSPB1 mRNA; Neodymium results in increased expression of HSPB1 protein
CTD
PMID:20332019
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:20,794,028...20,795,743
G
Psmb2
proteasome 20S subunit beta 2
decreases expression
ISO
Neodymium results in decreased expression of PSMB2 protein
CTD
PMID:20332019
NCBI chr 5:138,970,564...139,002,715
Ensembl chr 5:138,970,533...139,021,137
G
Hras
HRas proto-oncogene, GTPase
increases mutagenesis
EXP
Plutonium results in increased mutagenesis of HRAS gene
CTD
PMID:9255578
NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:196,296,263...196,300,615
G
Aadat
aminoadipate aminotransferase
affects expression
ISO
Uranium affects the expression of AADAT mRNA
CTD
PMID:15672453
NCBI chr16:34,520,236...34,566,388
Ensembl chr16:29,509,394...29,544,332
G
Aanat
aralkylamine N-acetyltransferase
affects expression
ISO
Uranium affects the expression of AANAT mRNA
CTD
PMID:15672453
NCBI chr10:102,323,647...102,330,639
Ensembl chr10:101,827,301...101,831,801
G
Aasdhppt
aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase
affects expression
ISO
Uranium affects the expression of AASDHPPT mRNA
CTD
PMID:15672453
NCBI chr 8:1,453,226...1,463,990
Ensembl chr 8:1,452,282...1,463,966
G
Abcc2
ATP binding cassette subfamily C member 2
multiple interactions
EXP
[Acetaminophen co-treated with Uranium analog] results in increased expression of ABCC2 mRNA; Uranium analog promotes the reaction [Acetaminophen results in increased expression of ABCC2 mRNA]
CTD
PMID:17126469
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238
G
Abcc8
ATP binding cassette subfamily C member 8
affects expression
ISO
Uranium affects the expression of ABCC8 mRNA
CTD
PMID:15672453
NCBI chr 1:105,734,992...105,816,272
Ensembl chr 1:96,598,647...96,679,510
G
Abcf2
ATP binding cassette subfamily F member 2
affects expression
ISO
Uranium affects the expression of ABCF2 mRNA
CTD
PMID:15672453
NCBI chr 4:10,594,802...10,607,620
Ensembl chr 4:10,594,907...10,607,606
G
Acat2
acetyl-CoA acetyltransferase 2
affects expression
ISO
Uranium affects the expression of ACAT2 mRNA
CTD
PMID:15672453
NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:47,695,788...47,752,821
G
Acp5
acid phosphatase 5, tartrate resistant
increases expression multiple interactions increases secretion
EXP
Uranium results in increased expression of ACP5 protein GHRL protein inhibits the reaction [Uranium results in increased secretion of ACP5 protein]
CTD
PMID:16436523 PMID:29477364
NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:20,663,985...20,667,929
G
Actb
actin, beta
affects expression
ISO
Uranium affects the expression of ACTB mRNA; Uranium affects the expression of ACTB protein
CTD
PMID:15672453
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:11,663,109...11,672,877
G
Actr2
actin related protein 2
affects expression
ISO
Uranium affects the expression of ACTR2 mRNA
CTD
PMID:15672453
NCBI chr14:94,296,443...94,333,735
Ensembl chr14:94,296,443...94,340,524
G
Adar
adenosine deaminase, RNA-specific
affects expression
ISO
Uranium affects the expression of ADAR mRNA
CTD
PMID:15672453
NCBI chr 2:177,436,076...177,475,969
Ensembl chr 2:175,138,403...175,178,282
G
Adnp
activity-dependent neuroprotector homeobox
affects expression
ISO
Uranium affects the expression of ADNP mRNA
CTD
PMID:15672453
NCBI chr 3:156,886,921...156,921,500
Ensembl chr 3:156,891,381...156,917,312
G
Akap1
A-kinase anchoring protein 1
affects expression
ISO
Uranium affects the expression of AKAP1 mRNA
CTD
PMID:15672453
NCBI chr10:74,118,232...74,151,366
Ensembl chr10:73,621,883...73,653,896
G
Akirin1
akirin 1
increases expression
ISO
Uranium results in increased expression of AKIRIN1 mRNA
CTD
PMID:15672453
NCBI chr 5:141,274,174...141,289,617
Ensembl chr 5:135,989,465...136,004,762
G
Akr1c3
aldo-keto reductase family 1, member C3
affects expression
ISO
Uranium affects the expression of AKR1C3 mRNA
CTD
PMID:15672453
NCBI chr17:71,020,884...71,037,779
Ensembl chr17:66,110,963...66,127,873
G
Alpl
alkaline phosphatase, biomineralization associated
multiple interactions decreases secretion
EXP
GHRL protein inhibits the reaction [Uranium results in decreased secretion of ALPL protein]
CTD
PMID:29477364
NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:149,951,409...150,006,446
G
Apbb1
amyloid beta precursor protein binding family B member 1
affects expression
ISO
Uranium affects the expression of APBB1 mRNA
CTD
PMID:15672453
NCBI chr 1:169,308,719...169,332,372
Ensembl chr 1:159,896,880...159,920,627
G
Apc
APC regulator of WNT signaling pathway
affects expression
ISO
Uranium affects the expression of APC mRNA
CTD
PMID:15672453
NCBI chr18:26,138,382...26,196,021
Ensembl chr18:25,864,222...25,922,696
G
Aplnr
apelin receptor
decreases expression
EXP
Uranium results in decreased expression of APLNR mRNA
CTD
PMID:37270086
NCBI chr 3:90,624,055...90,627,700
Ensembl chr 3:70,217,385...70,221,050
G
App
amyloid beta precursor protein
affects expression
ISO
Uranium affects the expression of APP mRNA
CTD
PMID:15672453
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
G
Appl1
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1
affects expression
ISO
Uranium affects the expression of APPL1 mRNA
CTD
PMID:15672453
NCBI chr16:2,125,234...2,173,457
Ensembl chr16:2,121,255...2,166,692
G
Ar
androgen receptor
decreases expression
EXP
Uranium analog results in decreased expression of AR mRNA
CTD
PMID:27544493
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
G
Armc9
armadillo repeat containing 9
increases expression
ISO
Uranium results in increased expression of ARMC9 mRNA
CTD
PMID:15672453
NCBI chr 9:94,250,492...94,376,589
Ensembl chr 9:86,802,868...86,928,860
G
Asap2
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2
affects expression
ISO
Uranium affects the expression of ASAP2 mRNA
CTD
PMID:15672453
NCBI chr 6:40,658,201...40,821,017
Ensembl chr 6:40,657,880...40,820,975
G
Ascl1
achaete-scute family bHLH transcription factor 1
increases expression
EXP
Uranium results in increased expression of ASCL1 mRNA
CTD
PMID:27639536
NCBI chr 7:21,903,136...21,906,003
Ensembl chr 7:21,903,126...21,905,993
G
Atp6v1a
ATPase H+ transporting V1 subunit A
affects expression
ISO
Uranium affects the expression of ATP6V1A mRNA
CTD
PMID:15672453
NCBI chr11:70,066,800...70,120,603
Ensembl chr11:56,560,974...56,614,694
G
Atp9b
ATPase phospholipid transporting 9B (putative)
affects expression
ISO
Uranium affects the expression of ATP9B mRNA
CTD
PMID:15672453
NCBI chr18:74,176,863...74,368,993
Ensembl chr18:74,176,863...74,368,953
G
Atxn10
ataxin 10
affects expression
ISO
Uranium affects the expression of ATXN10 mRNA
CTD
PMID:15672453
NCBI chr 7:116,441,768...116,565,093
Ensembl chr 7:116,441,613...116,565,087
G
B2m
beta-2 microglobulin
affects expression
ISO
Uranium affects the expression of B2M mRNA
CTD
PMID:15672453
NCBI chr 3:129,549,236...129,555,354
Ensembl chr 3:109,095,729...109,101,766
G
Baalc
BAALC binder of MAP3K1 and KLF4
affects expression
ISO
Uranium affects the expression of BAALC mRNA
CTD
PMID:15672453
NCBI chr 7:69,918,998...69,992,289
Ensembl chr 7:69,918,998...69,992,288
G
Bace1
beta-secretase 1
affects expression
ISO
Uranium affects the expression of BACE mRNA
CTD
PMID:15672453
NCBI chr 8:55,038,842...55,061,138
Ensembl chr 8:46,142,116...46,165,876
G
Bglap
bone gamma-carboxyglutamate protein
increases expression decreases secretion multiple interactions
EXP ISO
Uranium results in increased expression of BGLAP protein Uranium results in increased expression of BGLAP mRNA Uranium results in decreased secretion of BGLAP protein GHRL protein inhibits the reaction [Uranium results in decreased secretion of BGLAP protein]
CTD
PMID:16436523 PMID:29477364 PMID:31120128
NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:173,838,518...173,839,495
G
Bgn
biglycan
affects expression
ISO
Uranium affects the expression of BGN mRNA
CTD
PMID:15672453
NCBI chr X:156,348,633...156,360,797
Ensembl chr X:151,197,273...151,209,461
G
Btf3
basic transcription factor 3
affects expression
ISO
Uranium affects the expression of BTF3 mRNA
CTD
PMID:15672453
NCBI chr 2:29,659,764...29,666,898
Ensembl chr 2:29,659,231...29,666,879 Ensembl chr13:29,659,231...29,666,879
G
C12h12orf43
similar to human chromosome 12 open reading frame 43
affects expression
ISO
Uranium affects the expression of C12ORF43 mRNA
CTD
PMID:15672453
NCBI chr12:47,332,740...47,338,461
Ensembl chr12:41,672,114...41,677,714
G
Calb1
calbindin 1
decreases expression
EXP
Uranium results in decreased expression of CALB1 mRNA
CTD
PMID:17118558
NCBI chr 5:34,172,612...34,199,555
Ensembl chr 5:29,375,642...29,402,431
G
Calm2
calmodulin 2
affects expression
ISO
Uranium affects the expression of CALM2 mRNA
CTD
PMID:15672453
NCBI chr 6:12,845,170...12,857,830
Ensembl chr 6:7,091,567...7,104,287 Ensembl chr15:7,091,567...7,104,287
G
Camk2d
calcium/calmodulin-dependent protein kinase II delta
affects expression
ISO
Uranium affects the expression of CAMK2D mRNA
CTD
PMID:15672453
NCBI chr 2:217,698,324...217,961,898
Ensembl chr 2:215,024,004...215,286,178
G
Canx
calnexin
affects expression
ISO
Uranium affects the expression of CANX mRNA
CTD
PMID:15672453
NCBI chr10:35,124,941...35,157,954
Ensembl chr10:34,625,191...34,656,821
G
Casp3
caspase 3
increases activity increases expression multiple interactions
EXP
Uranium results in increased activity of CASP3 protein Uranium results in increased expression of CASP3 protein EIF2AK3 protein promotes the reaction [Uranium results in increased expression of CASP3 protein]; GHRL protein inhibits the reaction [Uranium results in increased activity of CASP3 protein]; THBS1 protein inhibits the reaction [Uranium results in increased expression of CASP3 protein]
CTD
PMID:29477364 PMID:37270086
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Cbfa2t2
CBFA2/RUNX1 partner transcriptional co-repressor 2
affects expression
ISO
Uranium affects the expression of CBFA2T2 mRNA
CTD
PMID:15672453
NCBI chr 3:142,936,945...143,043,205
Ensembl chr 3:142,936,985...143,043,197
G
Ccl2
C-C motif chemokine ligand 2
decreases expression
EXP
Uranium results in decreased expression of CCL2 mRNA; Uranium results in decreased expression of CCL2 protein
CTD
PMID:16854789 PMID:17566059
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Chchd5
coiled-coil-helix-coiled-coil-helix domain containing 5
increases expression
ISO
Uranium results in increased expression of CHCHD5 mRNA
CTD
PMID:15672453
NCBI chr 3:116,361,845...116,372,238
Ensembl chr 3:116,361,885...116,367,169
G
Chrdl1
chordin-like 1
increases expression
ISO
Uranium results in increased expression of CHRDL1 mRNA
CTD
PMID:15672453
NCBI chr X:106,889,125...106,992,937
Ensembl chr X:106,889,125...106,992,921
G
Churc1
churchill domain containing 1
increases expression
ISO
Uranium results in increased expression of CHURC1 mRNA
CTD
PMID:15672453
NCBI chr 6:95,464,488...95,485,208
Ensembl chr 6:95,470,683...95,619,586
G
Clint1
clathrin interactor 1
affects expression
ISO
Uranium affects the expression of CLINT1 mRNA
CTD
PMID:15672453
NCBI chr10:30,298,618...30,353,185
Ensembl chr10:30,298,704...30,353,063
G
Clstn3
calsyntenin 3
affects expression
ISO
Uranium affects the expression of CLSTN3 mRNA
CTD
PMID:15672453
NCBI chr 4:157,331,494...157,364,769
Ensembl chr 4:157,331,494...157,364,769
G
Cog7
component of oligomeric golgi complex 7
affects expression
ISO
Uranium affects the expression of COG7 mRNA
CTD
PMID:15672453
NCBI chr 1:176,489,795...176,549,455
Ensembl chr 1:176,489,791...176,549,455
G
Col1a1
collagen type I alpha 1 chain
increases expression
ISO
Uranium results in increased expression of COL1A1 mRNA
CTD
PMID:31120128
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:79,883,622...79,900,624
G
Cops3
COP9 signalosome subunit 3
affects expression
ISO
Uranium affects the expression of COPS3 mRNA
CTD
PMID:15672453
NCBI chr10:44,618,115...44,652,807
Ensembl chr10:44,618,115...44,641,597
G
Cp
ceruloplasmin
increases expression
EXP
Uranium results in increased expression of CP mRNA
CTD
PMID:18375546
NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:102,439,624...102,498,075
G
Crls1
cardiolipin synthase 1
affects expression
ISO
Uranium affects the expression of CRLS1 mRNA
CTD
PMID:15672453
NCBI chr 3:120,119,822...120,138,674
Ensembl chr 3:120,119,852...120,138,655
G
Crybb2
crystallin, beta B2
affects expression
ISO
Uranium affects the expression of CRYBB2 mRNA
CTD
PMID:15672453
NCBI chr12:43,569,747...43,579,671
Ensembl chr12:43,569,747...43,579,671
G
Csde1
cold shock domain containing E1
affects expression
ISO
Uranium affects the expression of CSDE1 mRNA
CTD
PMID:15672453
NCBI chr 2:190,546,015...190,582,787
Ensembl chr 2:190,554,980...190,582,784
G
Cstpp1
centriolar satellite-associated tubulin polyglutamylase complex regulator 1
affects expression
ISO
Uranium affects the expression of CSTPP1 mRNA
CTD
PMID:15672453
NCBI chr 3:77,247,393...77,416,307
Ensembl chr 3:77,248,375...77,416,274
G
Ctcf
CCCTC-binding factor
affects expression
ISO
Uranium affects the expression of CTCF mRNA
CTD
PMID:15672453
NCBI chr19:33,521,726...33,571,124
Ensembl chr19:33,529,319...33,571,123
G
Ctnnb1
catenin beta 1
decreases expression
EXP
Uranium analog results in decreased expression of CTNNB1 mRNA
CTD
PMID:27544493
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Ctrl
chymotrypsin-like
affects expression
ISO
Uranium affects the expression of CTRL mRNA
CTD
PMID:15672453
NCBI chr19:33,827,279...33,829,129
Ensembl chr19:33,827,229...33,833,626
G
Cul2
cullin 2
affects expression
ISO
Uranium affects the expression of CUL2 mRNA
CTD
PMID:15672453
NCBI chr17:58,864,274...58,905,447
Ensembl chr17:54,169,086...54,209,968
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
decreases expression
EXP
Uranium analog results in decreased expression of CYP11A1 mRNA
CTD
PMID:27544493
NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:58,404,669...58,434,338
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
decreases expression
EXP
Uranium analog results in decreased expression of CYP17A1 mRNA
CTD
PMID:27544493
NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:245,535,462...245,541,573
G
Cyp24a1
cytochrome P450, family 24, subfamily a, polypeptide 1
decreases expression
EXP
Uranium results in decreased expression of CYP24A1 mRNA
CTD
PMID:17118558
NCBI chr 3:179,694,647...179,709,083
Ensembl chr 3:159,275,947...159,290,383
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
decreases activity increases activity decreases expression
EXP
Uranium results in decreased activity of CYP27A1 protein Uranium results in increased activity of CYP27A1 protein Uranium results in decreased expression of CYP27A1 mRNA
CTD
PMID:16231126 PMID:16502312 PMID:17118558
NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:76,264,860...76,294,551
G
Cyp27b1
cytochrome P450, family 27, subfamily b, polypeptide 1
increases expression
EXP
Uranium results in increased expression of CYP27B1 mRNA
CTD
PMID:16502312
NCBI chr 7:64,756,626...64,761,570
Ensembl chr 7:62,871,297...62,876,241
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
increases expression
EXP
Uranium results in increased expression of CYP2B1 mRNA
CTD
PMID:16039771
NCBI chr 1:90,646,098...90,669,762
Ensembl chr 1:81,518,408...81,542,052
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
multiple interactions
EXP
[Acetaminophen co-treated with Uranium analog] results in decreased expression of CYP2C11 mRNA
CTD
PMID:17126469
NCBI chr 1:246,175,216...246,211,445
Ensembl chr 1:236,762,842...236,799,066
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
EXP
[Acetaminophen co-treated with Uranium analog] results in decreased expression of CYP2E1 mRNA; Uranium analog promotes the reaction [Acetaminophen results in increased expression of CYP2E1 mRNA]
CTD
PMID:17126469
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
G
Cyp2r1
cytochrome P450, family 2, subfamily r, polypeptide 1
increases expression
EXP
Uranium results in increased expression of CYP2R1 mRNA
CTD
PMID:16502312
NCBI chr 1:178,166,984...178,232,191
Ensembl chr 1:168,751,038...168,797,759
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions increases expression
EXP
[Acetaminophen co-treated with Uranium analog] results in decreased expression of CYP3A2 mRNA Uranium results in increased expression of CYP3A2 mRNA
CTD
PMID:16039771 PMID:17126469
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
increases expression
EXP
Uranium results in increased expression of CYP3A23-3A1 mRNA
CTD
PMID:16039771 PMID:16231126
NCBI chr12:14,369,950...14,398,803
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Ddit3
DNA-damage inducible transcript 3
increases expression multiple interactions
ISO EXP
Uranium results in increased expression of DDIT3 mRNA Uranium results in increased expression of DDIT3 protein EIF2AK3 protein promotes the reaction [Uranium results in increased expression of DDIT3 protein]; THBS1 protein inhibits the reaction [Uranium results in increased expression of DDIT3 protein]
CTD
PMID:14971665 PMID:37270086
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
G
Dgka
diacylglycerol kinase, alpha
affects expression
ISO
Uranium affects the expression of DGKA mRNA
CTD
PMID:15672453
NCBI chr 7:1,733,247...1,761,181
Ensembl chr 7:1,148,735...1,175,110
G
Dixdc1
DIX domain containing 1
affects expression
ISO
Uranium affects the expression of DIXDC1 mRNA
CTD
PMID:15672453
NCBI chr 8:51,007,835...51,081,191
Ensembl chr 8:51,007,838...51,081,090
G
Dmp1
dentin matrix acidic phosphoprotein 1
decreases expression
ISO
Uranium results in decreased expression of DMP1 mRNA
CTD
PMID:31120128
NCBI chr14:5,528,441...5,542,078
Ensembl chr14:5,528,431...5,539,323
G
Dnaja2
DnaJ heat shock protein family (Hsp40) member A2
affects expression
ISO
Uranium affects the expression of DNAJA2 mRNA
CTD
PMID:15672453
NCBI chr19:21,497,792...21,516,904
Ensembl chr19:21,497,729...21,516,901
G
Dnajc9
DnaJ heat shock protein family (Hsp40) member C9
affects expression
ISO
Uranium affects the expression of DNAJC9 mRNA
CTD
PMID:15672453
NCBI chr15:3,923,842...3,928,118
Ensembl chr15:3,923,268...3,928,118
G
Dnmt1
DNA methyltransferase 1
increases expression
EXP
Uranium results in increased expression of DNMT1 mRNA
CTD
PMID:29024790
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:19,440,611...19,486,659
G
Dnmt3a
DNA methyltransferase 3 alpha
increases expression
EXP
Uranium results in increased expression of DNMT3A mRNA
CTD
PMID:29024790
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
G
Dnmt3b
DNA methyltransferase 3 beta
increases expression
EXP
Uranium results in increased expression of DNMT3B mRNA
CTD
PMID:29024790
NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:142,130,592...142,169,124
G
Dnmt3l
DNA methyltransferase 3 like
affects expression
EXP
Uranium affects the expression of DNMT3L mRNA
CTD
PMID:29024790
NCBI chr20:10,614,933...10,629,337
Ensembl chr20:10,614,934...10,629,516
G
Dpysl5
dihydropyrimidinase-like 5
increases expression
ISO
Uranium results in increased expression of DPYSL5 mRNA
CTD
PMID:15672453
NCBI chr 6:25,575,104...25,659,422
Ensembl chr 6:25,575,104...25,659,422
G
Dstyk
dual serine/threonine and tyrosine protein kinase
affects expression
ISO
Uranium affects the expression of DSTYK mRNA
CTD
PMID:15672453
NCBI chr13:43,857,266...43,905,280
Ensembl chr13:43,857,266...43,905,269
G
Dtna
dystrobrevin, alpha
increases expression
ISO
Uranium results in increased expression of DTNA mRNA
CTD
PMID:15672453
NCBI chr18:14,687,193...14,944,232
Ensembl chr18:14,587,852...14,944,261
G
Dtymk
deoxythymidylate kinase
affects expression
ISO
Uranium affects the expression of DTYMK mRNA
CTD
PMID:15672453
NCBI chr 9:101,762,899...101,771,733
Ensembl chr 9:94,315,552...94,324,870
G
Dzank1
double zinc ribbon and ankyrin repeat domains 1
increases expression
ISO
Uranium results in increased expression of DZANK1 mRNA
CTD
PMID:15672453
NCBI chr 3:131,855,890...131,908,217
Ensembl chr 3:131,852,552...131,908,156
G
Eef1a1
eukaryotic translation elongation factor 1 alpha 1
affects expression
ISO
Uranium affects the expression of EEF1A1 mRNA
CTD
PMID:15672453
NCBI chr 8:88,221,839...88,225,688
Ensembl chr 8:79,341,557...79,344,839
G
Eef1g
eukaryotic translation elongation factor 1 gamma
affects expression
ISO
Uranium affects the expression of EEF1G mRNA
CTD
PMID:15672453
NCBI chr 1:205,860,713...205,871,319
Ensembl chr 1:205,860,698...205,872,382
G
Eif1
eukaryotic translation initiation factor 1
affects expression
ISO
Uranium affects the expression of EIF1 mRNA
CTD
PMID:15672453
NCBI chr10:85,246,751...85,248,842
Ensembl chr10:85,246,764...85,427,327 Ensembl chr 5:85,246,764...85,427,327
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
increases expression multiple interactions
EXP
Uranium results in increased expression of EIF2AK3 mRNA; Uranium results in increased expression of EIF2AK3 protein EIF2AK3 protein promotes the reaction [Uranium results in increased expression of CASP3 protein]; EIF2AK3 protein promotes the reaction [Uranium results in increased expression of DDIT3 protein]; THBS1 protein inhibits the reaction [Uranium results in increased expression of EIF2AK3 mRNA]; THBS1 protein inhibits the reaction [Uranium results in increased expression of EIF2AK3 protein]
CTD
PMID:37270086
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:102,805,510...102,866,911
G
Epor
erythropoietin receptor
decreases expression
EXP
Uranium results in decreased expression of EPOR mRNA
CTD
PMID:18375546
NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:20,489,678...20,494,257
G
Eps15
epidermal growth factor receptor pathway substrate 15
affects expression
ISO
Uranium affects the expression of EPS15 mRNA
CTD
PMID:15672453
NCBI chr 5:124,045,865...124,146,221
Ensembl chr 5:124,045,926...124,146,221
G
Erbb3
erb-b2 receptor tyrosine kinase 3
affects expression
ISO
Uranium affects the expression of ERBB3 mRNA
CTD
PMID:15672453
NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:996,225...1,015,525
G
Evi5
ecotropic viral integration site 5
affects expression
ISO
Uranium affects the expression of EVI5 mRNA
CTD
PMID:15672453
NCBI chr14:1,875,601...2,021,678
Ensembl chr14:1,875,647...2,021,678
G
Evl
Enah/Vasp-like
affects expression
ISO
Uranium affects the expression of EVL mRNA
CTD
PMID:15672453
NCBI chr 6:127,473,119...127,594,342
Ensembl chr 6:127,474,543...127,594,344
G
Fam3c
FAM3 metabolism regulating signaling molecule C
affects expression
ISO
Uranium affects the expression of FAM3C mRNA
CTD
PMID:15672453
NCBI chr 4:50,839,929...50,887,276
Ensembl chr 4:50,838,818...50,888,078
G
Faslg
Fas ligand
increases expression
EXP
Uranium results in increased expression of FASLG mRNA
CTD
PMID:16854789
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:74,154,954...74,162,215
G
Fmo3
flavin containing dimethylaniline monoxygenase 3
increases expression
EXP
Uranium results in increased expression of FMO3 mRNA
CTD
PMID:37270086
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Uranium results in increased expression of FOS mRNA
CTD
PMID:14971665
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Fshb
follicle stimulating hormone subunit beta
increases expression
EXP
Uranium analog results in increased expression of FSHB protein
CTD
PMID:27544493
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
G
Fut8
fucosyltransferase 8
affects expression
ISO
Uranium affects the expression of FUT8 mRNA
CTD
PMID:15672453
NCBI chr 6:95,949,246...96,176,677
Ensembl chr 6:95,949,991...96,176,677
G
G3bp1
G3BP stress granule assembly factor 1
affects expression
ISO
Uranium affects the expression of G3BP1 mRNA
CTD
PMID:15672453
NCBI chr10:39,586,864...39,620,268
Ensembl chr10:39,586,864...39,620,268
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
ISO
Uranium results in increased expression of GADD45A mRNA
CTD
PMID:14971665
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:96,154,789...96,157,115
G
Gata6
GATA binding protein 6
decreases expression
EXP
Uranium analog results in decreased expression of GATA6 mRNA
CTD
PMID:27544493
NCBI chr18:2,460,909...2,492,322
Ensembl chr18:2,188,121...2,219,532
G
Gfra1
GDNF family receptor alpha 1
decreases expression
EXP
Uranium results in decreased expression of GFRA1 mRNA
CTD
PMID:37270086
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
G
Ghrl
ghrelin and obestatin prepropeptide
multiple interactions decreases expression decreases response to substance
ISO EXP
Anisomycin inhibits the reaction [GHRL protein inhibits the reaction [Uranium results in decreased expression of and results in decreased secretion of TNFRSF11B protein]]; Anisomycin inhibits the reaction [GHRL protein inhibits the reaction [Uranium results in increased expression of and results in increased secretion of TNFSF11 protein]]; GHRL protein inhibits the reaction [Uranium results in decreased expression of and results in decreased secretion of TNFRSF11B protein]; GHRL protein inhibits the reaction [Uranium results in increased expression of and results in increased secretion of TNFSF11 protein] Uranium results in decreased expression of GHRL protein GHRL protein results in decreased susceptibility to Uranium GHRL protein inhibits the reaction [Uranium results in decreased expression of and results in decreased secretion of TNFRSF11B protein]; GHRL protein inhibits the reaction [Uranium results in decreased expression of GHSR protein]; GHRL protein inhibits the reaction [Uranium results in decreased secretion of ALPL protein]; GHRL protein inhibits the reaction [Uranium results in decreased secretion of BGLAP protein]; GHRL protein inhibits the reaction [Uranium results in increased activity of CASP3 protein]; GHRL protein inhibits the reaction [Uranium results in increased expression of and results in increased secretion of TNFSF11 protein]; GHRL protein inhibits the reaction [Uranium results in increased secretion of ACP5 protein]
CTD
PMID:29477364
NCBI chr 4:148,421,315...148,431,128
Ensembl chr 4:146,865,712...146,869,621
G
Ghsr
growth hormone secretagogue receptor
decreases expression multiple interactions
EXP
Uranium results in decreased expression of GHSR protein GHRL protein inhibits the reaction [Uranium results in decreased expression of GHSR protein]
CTD
PMID:29477364
NCBI chr 2:112,196,158...112,201,666
Ensembl chr 2:110,268,489...110,271,865
G
Glo1
glyoxalase 1
affects expression
ISO
Uranium affects the expression of GLO1 mRNA
CTD
PMID:15672453
NCBI chr20:8,665,061...8,683,095
Ensembl chr20:8,662,801...8,681,649
G
Glul
glutamate-ammonia ligase
affects expression
ISO
Uranium affects the expression of GLUL mRNA
CTD
PMID:15672453
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:66,025,630...66,035,108
G
Gpx1
glutathione peroxidase 1
affects expression decreases expression
ISO EXP
Uranium affects the expression of GPX1 mRNA Uranium analog results in decreased expression of GPX1 mRNA
CTD
PMID:15672453 PMID:27544493
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024
G
Grb2
growth factor receptor bound protein 2
affects expression
ISO
Uranium affects the expression of GRB2 mRNA
CTD
PMID:15672453
NCBI chr10:101,380,354...101,448,138
Ensembl chr10:100,869,718...100,949,309
G
Gspt1
G1 to S phase transition 1
increases expression
ISO
Uranium results in increased expression of GSPT1 mRNA
CTD
PMID:15672453
NCBI chr10:4,362,528...4,397,215
Ensembl chr10:4,362,510...4,397,198
G
Gsta2
glutathione S-transferase alpha 2
multiple interactions
EXP
[Acetaminophen co-treated with Uranium analog] results in decreased expression of GSTA2 mRNA; Uranium analog promotes the reaction [Acetaminophen results in increased expression of GSTA2 mRNA]
CTD
PMID:17126469
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
G
Gsta3l1
glutathione S-transferase alpha 3 like 1
decreases expression
EXP
Uranium results in decreased expression of GSTA3L1 mRNA
CTD
PMID:37270086
NCBI chr 9:23,619,691...23,628,517
Ensembl chr 9:23,620,010...23,632,333
G
Gstp1
glutathione S-transferase pi 1
decreases expression increases expression
EXP
Uranium analog results in decreased expression of GSTP1 mRNA Uranium results in increased expression of GSTP1 mRNA
CTD
PMID:27544493 PMID:37270086
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
H2bc1
H2B clustered histone 1
decreases expression
EXP
Uranium analog results in decreased expression of H2BC1 mRNA
CTD
PMID:27544493
NCBI chr17:41,599,912...41,600,381
Ensembl chr17:41,171,903...41,176,782 Ensembl chr17:41,171,903...41,176,782
G
Hadh
hydroxyacyl-CoA dehydrogenase
affects expression
ISO
Uranium affects the expression of HADH mRNA
CTD
PMID:15672453
NCBI chr 2:222,462,049...222,504,446
Ensembl chr 2:219,787,927...219,830,353
G
Hbp1
HMG-box transcription factor 1
affects expression
ISO
Uranium affects the expression of HBP1 mRNA
CTD
PMID:15672453
NCBI chr 6:54,257,118...54,283,373
Ensembl chr 6:48,529,372...48,555,787
G
Hmgb1
high mobility group box 1
affects expression
ISO
Uranium affects the expression of HMGB1 mRNA; Uranium affects the expression of HMGB1 protein
CTD
PMID:15672453
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmox2
heme oxygenase 2
increases expression
EXP
Uranium results in increased expression of HMOX2 mRNA
CTD
PMID:18375546
NCBI chr10:10,797,076...10,831,178
Ensembl chr10:10,797,055...10,831,148
G
Hnf4a
hepatocyte nuclear factor 4, alpha
increases expression
EXP
Uranium results in increased expression of HNF4A mRNA
CTD
PMID:17118558
NCBI chr 3:172,606,220...172,667,758
Ensembl chr 3:152,186,787...152,248,320
G
Hnrnpc
heterogeneous nuclear ribonucleoprotein C
affects expression
ISO
Uranium affects the expression of HNRNPC mRNA
CTD
PMID:15672453
NCBI chr15:27,253,098...27,282,779
Ensembl chr15:24,779,450...24,809,183
G
Hsd3b1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
decreases expression
EXP
Uranium analog results in decreased expression of HSD3B1 mRNA
CTD
PMID:27544493
NCBI chr 2:188,858,574...188,864,694
Ensembl chr 2:186,169,863...186,175,999
G
Hsp90ab1
heat shock protein 90 alpha family class B member 1
affects expression
ISO
Uranium affects the expression of HSP90AB1 mRNA; Uranium affects the expression of HSP90AB1 protein
CTD
PMID:15672453
NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:15,433,691...15,438,488
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression
ISO
Uranium results in increased expression of HSPA5 mRNA
CTD
PMID:14971665
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
G
Iars2
isoleucyl-tRNA synthetase 2, mitochondrial
affects expression
ISO
Uranium affects the expression of IARS2 mRNA
CTD
PMID:15672453
NCBI chr13:96,831,484...96,865,518
Ensembl chr13:96,831,484...96,865,501
G
Id2
inhibitor of DNA binding 2
affects expression
ISO
Uranium affects the expression of ID2 mRNA
CTD
PMID:15672453
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Ifng
interferon gamma
increases expression decreases secretion
EXP ISO
Uranium results in increased expression of IFNG mRNA Uranium results in decreased secretion of IFNG protein
CTD
PMID:16854789 PMID:23659960
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Ifrd2
interferon-related developmental regulator 2
affects expression
ISO
Uranium affects the expression of IFRD2 mRNA
CTD
PMID:15672453
NCBI chr 8:108,260,969...108,266,191
Ensembl chr 8:108,260,969...108,266,194
G
Ik
IK cytokine
affects expression
ISO
Uranium affects the expression of IK mRNA
CTD
PMID:15672453
NCBI chr18:28,358,004...28,372,809
Ensembl chr18:28,357,977...28,378,832
G
Il10
interleukin 10
increases expression increases secretion
EXP ISO
Uranium results in increased expression of IL10 mRNA Uranium results in increased secretion of IL10 protein
CTD
PMID:17566059 PMID:23659960
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il18
interleukin 18
decreases secretion
ISO
Uranium results in decreased secretion of IL18 protein
CTD
PMID:23659960
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
increases expression decreases secretion
EXP ISO
Uranium results in increased expression of IL1B mRNA Uranium results in decreased secretion of IL1B protein
CTD
PMID:17566059 PMID:23659960
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il4
interleukin 4
increases secretion
ISO
Uranium results in increased secretion of IL4 protein
CTD
PMID:23659960
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:37,771,203...37,776,750
G
Insig1
insulin induced gene 1
affects expression
ISO
Uranium affects the expression of INSIG1 mRNA
CTD
PMID:15672453
NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:7,315,495...7,323,952
G
Iqgap2
IQ motif containing GTPase activating protein 2
affects expression
ISO
Uranium affects the expression of IQGAP2 mRNA
CTD
PMID:15672453
NCBI chr 2:26,894,836...27,170,270
Ensembl chr 2:26,894,825...27,170,279
G
Kazn
kazrin, periplakin interacting protein
affects expression
ISO
Uranium affects the expression of KAZN mRNA
CTD
PMID:15672453
NCBI chr 5:154,392,793...155,381,567
Ensembl chr 5:154,392,793...154,779,074
G
Kdm2b
lysine demethylase 2B
affects expression
ISO
Uranium affects the expression of KDM2B mRNA
CTD
PMID:15672453
NCBI chr12:33,566,530...33,701,366
Ensembl chr12:33,574,657...33,701,355
G
Kdm4b
lysine demethylase 4B
increases expression
ISO
Uranium results in increased expression of KDM4B mRNA
CTD
PMID:15672453
NCBI chr 9:1,158,737...1,237,233
Ensembl chr 9:1,158,752...1,236,543
G
Kdm5b
lysine demethylase 5B
affects expression
ISO
Uranium affects the expression of KDM5B mRNA
CTD
PMID:15672453
NCBI chr13:46,001,589...46,073,868
Ensembl chr13:46,002,542...46,073,872
G
Kif1b
kinesin family member 1B
increases expression
ISO
Uranium results in increased expression of KIF1B mRNA
CTD
PMID:15672453
NCBI chr 5:164,890,778...165,025,848
Ensembl chr 5:159,561,271...159,742,778
G
Kif3b
kinesin family member 3B
affects expression
ISO
Uranium affects the expression of KIF3B mRNA
CTD
PMID:15672453
NCBI chr 3:162,218,621...162,258,191
Ensembl chr 3:141,758,466...141,797,963
G
Kif3c
kinesin family member 3C
affects expression
ISO
Uranium affects the expression of KIF3C mRNA
CTD
PMID:15672453
NCBI chr 6:32,086,879...32,125,812
Ensembl chr 6:26,366,531...26,406,130
G
Kit
KIT proto-oncogene receptor tyrosine kinase
decreases expression
EXP
Uranium analog results in decreased expression of KIT mRNA
CTD
PMID:27544493
NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,548,877...32,624,652
G
Kpna3
karyopherin subunit alpha 3
affects expression
ISO
Uranium affects the expression of KPNA3 mRNA
CTD
PMID:15672453
NCBI chr15:35,536,310...35,610,066
Ensembl chr15:35,536,316...35,610,419
G
Lad1
ladinin 1
affects expression
ISO
Uranium affects the expression of LAD1 mRNA
CTD
PMID:15672453
NCBI chr13:47,249,605...47,263,967
Ensembl chr13:47,249,605...47,263,967
G
Lamp2
lysosomal-associated membrane protein 2
affects expression
ISO
Uranium affects the expression of LAMP2 mRNA
CTD
PMID:15672453
NCBI chr X:122,038,734...122,087,745
Ensembl chr X:117,057,606...117,260,522
G
Ldha
lactate dehydrogenase A
affects expression
ISO
Uranium affects the expression of LDHA mRNA
CTD
PMID:15672453
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
G
Lhb
luteinizing hormone subunit beta
increases expression
EXP
Uranium analog results in increased expression of LHB protein
CTD
PMID:27544493
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Lhcgr
luteinizing hormone/choriogonadotropin receptor
decreases expression
EXP
Uranium analog results in decreased expression of LHCGR mRNA
CTD
PMID:27544493
NCBI chr 6:11,415,361...11,480,834
Ensembl chr 6:5,661,871...5,724,521
G
Lonp2
lon peptidase 2, peroxisomal
increases expression
ISO
Uranium results in increased expression of LONP2 mRNA
CTD
PMID:15672453
NCBI chr19:20,407,475...20,498,985
Ensembl chr19:20,407,477...20,499,014
G
Lpin1
lipin 1
affects expression
ISO
Uranium affects the expression of LPIN1 mRNA
CTD
PMID:15672453
NCBI chr 6:45,039,110...45,145,845
Ensembl chr 6:39,312,748...39,417,097
G
M6pr
mannose-6-phosphate receptor, cation dependent
affects expression
ISO
Uranium affects the expression of M6PR mRNA
CTD
PMID:15672453
NCBI chr 4:155,501,080...155,510,219
Ensembl chr 4:155,500,921...155,510,216
G
Maob
monoamine oxidase B
decreases expression
ISO
Uranium results in decreased expression of MAOB mRNA; Uranium results in decreased expression of MAOB protein
CTD
PMID:30076899
NCBI chr X:8,490,405...8,594,065
Ensembl chr X:5,907,266...6,011,003
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
multiple interactions increases expression
ISO
bafilomycin A1 promotes the reaction [Uranium results in increased expression of MAP1LC3A protein]
CTD
PMID:31120128
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:143,783,024...143,784,670
G
Marcks
myristoylated alanine rich protein kinase C substrate
affects expression
ISO
Uranium affects the expression of MARCKS mRNA
CTD
PMID:15672453
NCBI chr20:42,240,185...42,245,882
Ensembl chr20:40,685,315...40,691,012
G
Mat2b
methionine adenosyltransferase 2 non-catalytic beta subunit
affects expression
ISO
Uranium affects the expression of MAT2B mRNA
CTD
PMID:15672453
NCBI chr10:25,609,202...25,626,694
Ensembl chr10:25,106,930...25,122,777
G
Mcfd2
multiple coagulation factor deficiency 2, ER cargo receptor complex subunit
affects expression
ISO
Uranium affects the expression of MCFD2 mRNA
CTD
PMID:15672453
NCBI chr 6:7,274,469...7,285,841
Ensembl chr 6:7,274,469...7,285,841
G
Mdh2
malate dehydrogenase 2
affects expression
ISO
Uranium affects the expression of MDH2 mRNA
CTD
PMID:15672453
NCBI chr12:26,530,886...26,543,841
Ensembl chr12:20,894,262...20,907,271
G
Metap2
methionyl aminopeptidase 2
affects expression
ISO
Uranium affects the expression of METAP2 mRNA
CTD
PMID:15672453
NCBI chr 7:28,412,429...28,440,458
Ensembl chr 7:28,411,608...28,440,434
G
Mfsd4a
major facilitator superfamily domain containing 4A
affects expression
ISO
Uranium affects the expression of MFSD4A mRNA
CTD
PMID:15672453
NCBI chr13:43,469,488...43,510,467
Ensembl chr13:43,469,488...43,510,467
G
Micu1
mitochondrial calcium uptake 1
affects expression
ISO
Uranium affects the expression of MICU1 mRNA
CTD
PMID:15672453
NCBI chr20:27,668,681...27,816,322
Ensembl chr20:27,668,747...27,814,964
G
Mllt10
MLLT10, histone lysine methyltransferase DOT1L cofactor
affects expression
ISO
Uranium affects the expression of MLLT10 mRNA
CTD
PMID:15672453
NCBI chr17:80,821,870...80,949,349
Ensembl chr17:80,822,556...80,949,345
G
Msh2
mutS homolog 2
affects expression
ISO
Uranium affects the expression of MSH2 mRNA
CTD
PMID:15672453
NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:6,813,795...6,872,938
G
Msrb1
methionine sulfoxide reductase B1
affects expression
ISO
Uranium affects the expression of MSRB1 mRNA
CTD
PMID:15672453
NCBI chr10:13,764,883...13,770,609
Ensembl chr10:13,764,883...13,770,609
G
Mt2
metallothionein 2
increases expression
ISO
Uranium results in increased expression of MT2A mRNA
CTD
PMID:14971665
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,832,002...10,832,784
G
Nadk2
NAD kinase 2, mitochondrial
increases expression
ISO
Uranium results in increased expression of NADK2 mRNA
CTD
PMID:15672453
NCBI chr 2:58,117,674...58,159,815
Ensembl chr 2:58,117,674...58,159,808
G
Nae1
NEDD8 activating enzyme E1 subunit 1
affects expression
ISO
Uranium affects the expression of NAE1 mRNA
CTD
PMID:15672453
NCBI chr19:452,462...478,591
Ensembl chr19:446,000...472,371
G
Naip6
NLR family, apoptosis inhibitory protein 6
affects expression
ISO
Uranium affects the expression of NAIP mRNA
CTD
PMID:15672453
NCBI chr 2:31,507,423...31,559,098
Ensembl chr 2:31,507,424...31,570,542
G
Nampt
nicotinamide phosphoribosyltransferase
affects expression
ISO
Uranium affects the expression of NAMPT mRNA
CTD
PMID:15672453
NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:49,424,332...49,462,100
G
Nap1l1
nucleosome assembly protein 1-like 1
affects expression
ISO
Uranium affects the expression of NAP1L1 mRNA
CTD
PMID:15672453
NCBI chr 7:46,933,278...46,957,853
Ensembl chr 7:46,933,356...46,956,593
G
Nars1
asparaginyl-tRNA synthetase 1
affects expression
ISO
Uranium affects the expression of NARS1 mRNA
CTD
PMID:15672453
NCBI chr18:60,259,506...60,275,782
Ensembl chr18:57,989,308...58,005,622
G
Ncoa7
nuclear receptor coactivator 7
affects expression
ISO
Uranium affects the expression of NCOA7 mRNA
CTD
PMID:15672453
NCBI chr 1:26,856,228...27,016,950
Ensembl chr 1:26,856,530...27,015,871
G
Ndfip1
Nedd4 family interacting protein 1
affects expression
ISO
Uranium affects the expression of NDFIP1 mRNA
CTD
PMID:15672453
NCBI chr18:30,516,931...30,567,199
Ensembl chr18:30,250,613...30,322,311
G
Ndrg2
NDRG family member 2
affects expression
ISO
Uranium affects the expression of NDRG2 mRNA
CTD
PMID:15672453
NCBI chr15:24,600,981...24,609,621
Ensembl chr15:24,600,982...24,609,626
G
Ndrg4
NDRG family member 4
increases expression
ISO
Uranium results in increased expression of NDRG4 mRNA
CTD
PMID:15672453
NCBI chr19:9,351,408...9,387,398
Ensembl chr19:9,351,404...9,386,914
G
Nefl
neurofilament light chain
affects expression
ISO
Uranium affects the expression of NEFL mRNA
CTD
PMID:15672453
NCBI chr15:46,477,330...46,481,203
Ensembl chr15:42,301,916...42,305,793
G
Neil2
nei-like DNA glycosylase 2
affects expression
ISO
Uranium affects the expression of NEIL2 mRNA
CTD
PMID:15672453
NCBI chr15:37,444,676...37,454,863
Ensembl chr15:37,445,381...37,454,863
G
Nos2
nitric oxide synthase 2
decreases activity multiple interactions
EXP
Uranium results in decreased activity of NOS2 protein [[Uranium results in decreased activity of NOS2 protein] co-treated with [Uranium results in increased activity of NOS3 protein]] results in decreased abundance of Nitrates; [[Uranium results in decreased activity of NOS2 protein] co-treated with [Uranium results in increased activity of NOS3 protein]] results in decreased abundance of Nitrites
CTD
PMID:17566059
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
multiple interactions decreases expression increases activity
EXP
[[Uranium results in decreased activity of NOS2 protein] co-treated with [Uranium results in increased activity of NOS3 protein]] results in decreased abundance of Nitrates; [[Uranium results in decreased activity of NOS2 protein] co-treated with [Uranium results in increased activity of NOS3 protein]] results in decreased abundance of Nitrites Uranium results in decreased expression of NOS3 mRNA
CTD
PMID:17566059
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Notch1
notch receptor 1
decreases expression
EXP
Uranium results in decreased expression of NOTCH1 mRNA
CTD
PMID:27639536
NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:9,278,086...9,323,531
G
Notch2
notch receptor 2
affects expression
ISO
Uranium affects the expression of NOTCH2 mRNA
CTD
PMID:15672453
NCBI chr 2:188,299,336...188,432,823
Ensembl chr 2:185,610,589...185,744,088
G
Npepl1
aminopeptidase-like 1
affects expression
ISO
Uranium affects the expression of NPEPL1 mRNA
CTD
PMID:15672453
NCBI chr 3:162,893,932...162,906,491
Ensembl chr 3:162,893,943...162,906,492
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
Uranium results in increased expression of NQO1 mRNA
CTD
PMID:37270086
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nr1h2
nuclear receptor subfamily 1, group H, member 2
decreases expression
EXP
Uranium results in decreased expression of NR1H2 mRNA
CTD
PMID:17118558
NCBI chr 1:104,178,483...104,183,863
Ensembl chr 1:95,041,967...95,047,377
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
increases expression
EXP
Uranium results in increased expression of NR1H3 mRNA
CTD
PMID:16231126
NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:77,158,808...77,168,722
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
increases expression
EXP
Uranium results in increased expression of NR1H4 mRNA
CTD
PMID:16231126
NCBI chr 7:25,733,471...25,829,440
Ensembl chr 7:23,846,122...23,942,047
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases expression
EXP
Uranium results in increased expression of NR1I2 mRNA
CTD
PMID:16039771
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:62,460,213...62,496,658
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
increases expression
EXP
Uranium results in increased expression of NR1I3 mRNA
CTD
PMID:16039771 PMID:16231126
NCBI chr13:86,165,327...86,170,362
Ensembl chr13:83,632,899...83,637,906
G
Nrf1
nuclear respiratory factor 1
affects expression
ISO
Uranium affects the expression of NRF1 mRNA
CTD
PMID:15672453
NCBI chr 4:59,632,366...59,738,166
Ensembl chr 4:58,664,957...58,825,328
G
Ns5atp4
NS5A transactivated protein 4
affects expression
ISO
Uranium affects the expression of C1ORF43 mRNA
CTD
PMID:15672453
NCBI chr 2:175,494,406...175,507,281
Ensembl chr 2:175,494,304...175,510,663
G
Nsg2
neuronal vesicle trafficking associated 2
affects expression
ISO
Uranium affects the expression of NSG2 mRNA
CTD
PMID:15672453
NCBI chr10:15,601,594...15,661,441
Ensembl chr10:15,601,596...15,661,441
G
Nt5e
5' nucleotidase, ecto
affects expression
ISO
Uranium affects the expression of NT5E mRNA
CTD
PMID:15672453
NCBI chr 8:98,150,925...98,195,646
Ensembl chr 8:89,270,696...89,314,881
G
Oat
ornithine aminotransferase
affects expression
ISO
Uranium affects the expression of OAT mRNA
CTD
PMID:15672453
NCBI chr 1:196,777,973...196,797,754
Ensembl chr 1:187,347,865...187,367,682
G
Ocln
occludin
increases expression
EXP
Uranium analog results in increased expression of OCLN mRNA
CTD
PMID:27544493
NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:31,657,220...31,764,150
G
Paip2b
poly(A) binding protein interacting protein 2B
affects expression
ISO
Uranium affects the expression of PAIP2B mRNA
CTD
PMID:15672453
NCBI chr 4:116,292,001...116,323,387
Ensembl chr 4:116,292,020...116,323,379
G
Parp4
poly (ADP-ribose) polymerase family, member 4
increases expression
ISO
Uranium results in increased expression of PARP4 mRNA
CTD
PMID:15672453
NCBI chr15:30,690,503...30,792,868
Ensembl chr15:30,686,613...30,828,810
G
Pbx3
PBX homeobox 3
affects expression
ISO
Uranium affects the expression of PBX3 mRNA
CTD
PMID:15672453
NCBI chr 3:17,488,691...17,682,412
Ensembl chr 3:17,488,693...17,682,791
G
Pdcd6ip
programmed cell death 6 interacting protein
affects expression
ISO
Uranium affects the expression of PDCD6IP mRNA
CTD
PMID:15672453
NCBI chr 8:122,469,223...122,524,993
Ensembl chr 8:113,590,998...113,646,773
G
Pdcd7
programmed cell death 7
affects expression
ISO
Uranium affects the expression of PDCD7 mRNA
CTD
PMID:15672453
NCBI chr 8:65,862,606...65,877,333
Ensembl chr 8:65,862,387...65,877,333
G
Pde1a
phosphodiesterase 1A
affects expression
ISO
Uranium affects the expression of PDE1A mRNA
CTD
PMID:15672453
NCBI chr 3:64,745,140...65,025,178
Ensembl chr 3:64,747,269...65,024,874
G
Pdpn
podoplanin
increases expression
ISO
Uranium results in increased expression of PDPN protein
CTD
PMID:31120128
NCBI chr 5:160,884,995...160,919,112
Ensembl chr 5:155,601,691...155,635,656
G
Pfkfb4
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4
affects expression
ISO
Uranium affects the expression of PFKFB4 mRNA
CTD
PMID:15672453
NCBI chr 8:109,643,558...109,687,006
Ensembl chr 8:109,643,937...109,685,634
G
Pgd
phosphogluconate dehydrogenase
affects expression
ISO
Uranium affects the expression of PGD mRNA
CTD
PMID:15672453
NCBI chr 5:164,865,830...164,882,029
Ensembl chr 5:159,561,271...159,742,778
G
Phf10
PHD finger protein 10
affects expression
ISO
Uranium affects the expression of PHF10 mRNA
CTD
PMID:15672453
NCBI chr 1:55,952,249...55,968,994
Ensembl chr 1:55,952,253...55,969,038
G
Pi4k2a
phosphatidylinositol 4-kinase type 2 alpha
affects expression
ISO
Uranium affects the expression of PI4K2A mRNA
CTD
PMID:15672453
NCBI chr 1:240,902,804...240,929,234
Ensembl chr 1:240,902,855...240,929,337
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
affects expression
ISO
Uranium affects the expression of PIK3R1 mRNA
CTD
PMID:15672453
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:32,882,032...32,963,631
G
Pip4k2b
phosphatidylinositol-5-phosphate 4-kinase type 2 beta
affects expression
ISO
Uranium affects the expression of PIP4K2B mRNA
CTD
PMID:15672453
NCBI chr10:83,202,379...83,231,292
Ensembl chr10:82,701,098...82,734,938
G
Plekhb2
pleckstrin homology domain containing B2
affects expression
ISO
Uranium affects the expression of PLEKHB2 mRNA
CTD
PMID:15672453
NCBI chr 9:37,049,580...37,082,231
Ensembl chr 9:37,038,751...37,082,231
G
Ppia
peptidylprolyl isomerase A
affects expression
ISO
Uranium affects the expression of PPIA mRNA
CTD
PMID:15672453
NCBI chr14:81,279,292...81,282,960
Ensembl chr14:81,275,091...81,299,601
G
Ppp2ca
protein phosphatase 2 catalytic subunit alpha
affects expression
ISO
Uranium affects the expression of PPP2CA mRNA
CTD
PMID:15672453
NCBI chr10:36,856,534...36,878,789
Ensembl chr10:36,358,101...36,377,862
G
Prdx2
peroxiredoxin 2
affects expression
ISO
Uranium affects the expression of PRDX2 mRNA
CTD
PMID:15672453
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
G
Prpf4b
pre-mRNA processing factor 4B
affects expression
ISO
Uranium affects the expression of PRP4K mRNA
CTD
PMID:15672453
NCBI chr17:29,985,343...30,020,285
Ensembl chr17:29,985,343...30,019,625
G
Psma4
proteasome 20S subunit alpha 4
affects expression
ISO
Uranium affects the expression of PSMA4 mRNA
CTD
PMID:15672453
NCBI chr 8:55,340,431...55,347,893
Ensembl chr 8:55,340,386...55,347,890
G
Psmg1
proteasome assembly chaperone 1
affects expression
ISO
Uranium affects the expression of PSMG1 mRNA
CTD
PMID:15672453
NCBI chr11:35,276,080...35,285,541
Ensembl chr11:35,276,011...35,285,622
G
Ptges3
prostaglandin E synthase 3
affects expression
ISO
Uranium affects the expression of PTGES3 mRNA
CTD
PMID:15672453
NCBI chr 7:490,698...507,759
Ensembl chr 7:490,656...508,084
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
EXP
Uranium results in increased expression of PTGS2
CTD
PMID:17566059
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Pth
parathyroid hormone
decreases expression increases expression
EXP
Uranium results in decreased expression of PTH protein Uranium results in increased expression of PTH protein
CTD
PMID:16436523 PMID:16502312
NCBI chr 1:176,942,901...176,946,034
Ensembl chr 1:167,508,598...167,511,530
G
Ptk2
protein tyrosine kinase 2
affects expression
ISO
Uranium affects the expression of PTK2 mRNA
CTD
PMID:15672453
NCBI chr 7:107,015,730...107,220,865
Ensembl chr 7:105,126,728...105,331,783
G
Ptma
prothymosin alpha
affects expression
ISO
Uranium affects the expression of PTMA mRNA
CTD
PMID:15672453
NCBI chr 9:94,624,194...94,628,276
Ensembl chr 9:87,176,230...87,180,333
G
Pum1
pumilio RNA-binding family member 1
affects expression
ISO
Uranium affects the expression of PUM1 mRNA
CTD
PMID:15672453
NCBI chr 5:148,120,712...148,238,468
Ensembl chr 5:142,837,127...142,954,039
G
Rab11fip4
RAB11 family interacting protein 4
affects expression
ISO
Uranium affects the expression of RAB11FIP4 mRNA
CTD
PMID:15672453
NCBI chr10:64,550,109...64,658,123
Ensembl chr10:64,550,177...64,654,759
G
Rab2a
RAB2A, member RAS oncogene family
affects expression
ISO
Uranium affects the expression of RAB2 mRNA
CTD
PMID:15672453
NCBI chr 5:26,473,424...26,537,441
Ensembl chr 5:21,676,129...21,739,899
G
Rab7a
RAB7A, member RAS oncogene family
affects expression
ISO
Uranium affects the expression of RAB7 mRNA
CTD
PMID:15672453
NCBI chr 4:122,019,281...122,068,067
Ensembl chr 4:120,461,963...120,506,889
G
Rabggtb
Rab geranylgeranyltransferase subunit beta
affects expression
ISO
Uranium affects the expression of RABGGTB mRNA
CTD
PMID:15672453
NCBI chr 2:242,844,758...242,850,951
Ensembl chr 2:242,844,762...242,851,050
G
Rac1
Rac family small GTPase 1
affects expression
ISO
Uranium affects the expression of RAC1 mRNA
CTD
PMID:15672453
NCBI chr12:16,150,411...16,170,864
Ensembl chr12:11,036,698...11,057,251
G
Ralgdsl1
ral guanine nucleotide dissociation stimulator like 1
affects expression
ISO
Uranium affects the expression of RGL mRNA
CTD
PMID:15672453
NCBI chr13:64,634,489...64,904,170
Ensembl chr13:64,635,246...64,904,191
G
Ran
RAN, member RAS oncogene family
affects expression
ISO
Uranium affects the expression of RAN mRNA
CTD
PMID:15672453
NCBI chr12:33,311,155...33,314,339
Ensembl chr12:27,674,050...27,678,276
G
Rbbp7
RB binding protein 7, chromatin remodeling factor
affects expression
ISO
Uranium affects the expression of RBBP7 mRNA
CTD
PMID:15672453
NCBI chr X:31,913,080...31,931,245
Ensembl chr X:31,913,081...31,931,226
G
Rbm3
RNA binding motif protein 3
increases expression
ISO
Uranium results in increased expression of RBM3 mRNA
CTD
PMID:15672453
NCBI chr X:17,020,863...17,024,341
Ensembl chr X:14,348,910...14,353,580
G
Rbm8a
RNA binding motif protein 8A
affects expression
ISO
Uranium affects the expression of RBM8A mRNA
CTD
PMID:15672453
NCBI chr 2:184,165,189...184,167,959
Ensembl chr 2:184,165,193...184,167,959
G
Rdx
radixin
affects expression
ISO
Uranium affects the expression of RDX mRNA
CTD
PMID:15672453
NCBI chr 8:52,379,494...52,437,673
Ensembl chr 8:52,379,494...52,437,678
G
Reep1
receptor accessory protein 1
affects expression
ISO
Uranium affects the expression of REEP1 mRNA
CTD
PMID:15672453
NCBI chr 4:103,746,004...103,862,347
Ensembl chr 4:103,745,633...103,862,338
G
RGD1311745
similar to RIKEN cDNA 1110059G10
increases expression
ISO
Uranium results in increased expression of KIAA1143 mRNA
CTD
PMID:15672453
NCBI chr 8:122,598,363...122,609,127
Ensembl chr 8:122,598,401...122,609,168
G
Rhoa
ras homolog family member A
affects expression
ISO
Uranium affects the expression of RHOA mRNA
CTD
PMID:15672453
NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:108,991,954...109,025,746
G
Rhot1
ras homolog family member T1
affects expression
ISO
Uranium affects the expression of RHOT1 mRNA
CTD
PMID:15672453
NCBI chr10:65,198,700...65,262,807
Ensembl chr10:65,170,560...65,262,804
G
Rmi1
RecQ mediated genome instability 1
affects expression
ISO
Uranium affects the expression of RMI1 mRNA
CTD
PMID:15672453
NCBI chr17:6,256,533...6,264,523
Ensembl chr17:6,256,450...6,264,695
G
Rnf10
ring finger protein 10
affects expression
ISO
Uranium affects the expression of RNF10 mRNA
CTD
PMID:15672453
NCBI chr12:41,341,708...41,375,505
Ensembl chr12:41,341,717...41,375,504
G
Rnf123
ring finger protein 123
affects expression
ISO
Uranium affects the expression of RNF123 mRNA
CTD
PMID:15672453
NCBI chr 8:108,740,176...108,768,177
Ensembl chr 8:108,739,620...108,767,675
G
Rnf144a
ring finger protein 144A
affects expression
ISO
Uranium affects the expression of RNF144A mRNA
CTD
PMID:15672453
NCBI chr 6:42,899,767...43,019,769
Ensembl chr 6:42,903,174...43,020,012
G
Rngtt
RNA guanylyltransferase and 5'-phosphatase
affects expression
ISO
Uranium affects the expression of RNGTT mRNA
CTD
PMID:15672453
NCBI chr 5:47,706,929...47,913,297
Ensembl chr 5:47,706,799...47,913,295
G
Rpa1
replication protein A1
affects expression
ISO
Uranium affects the expression of RPA1 mRNA
CTD
PMID:15672453
NCBI chr10:60,148,869...60,199,970
Ensembl chr10:60,148,793...60,199,949
G
Rpl15
ribosomal protein L15
affects expression
ISO
Uranium affects the expression of RPL15 mRNA
CTD
PMID:15672453
NCBI chr15:7,503,883...7,507,166
Ensembl chr15:7,503,883...7,507,165 Ensembl chr12:7,503,883...7,507,165
G
Rpl22
ribosomal protein L22
affects expression
ISO
Uranium affects the expression of RPL22 mRNA
CTD
PMID:15672453
NCBI chr 5:162,835,241...162,843,394
Ensembl chr 5:162,833,740...162,843,368 Ensembl chr 7:162,833,740...162,843,368 Ensembl chr 4:162,833,740...162,843,368
G
Rpl24
ribosomal protein L24
affects expression
ISO
Uranium affects the expression of RPL24 mRNA
CTD
PMID:15672453
NCBI chr11:44,653,937...44,659,346
Ensembl chr11:44,653,937...44,659,370
G
Rsl24d1
ribosomal L24 domain containing 1
affects expression
ISO
Uranium affects the expression of RSL24D1 mRNA
CTD
PMID:15672453
NCBI chr 8:73,852,991...73,861,996
Ensembl chr 8:73,852,996...73,862,001
G
RT1-A2
RT1 class Ia, locus A2
affects expression
ISO
Uranium affects the expression of HLA-E mRNA
CTD
PMID:15672453
NCBI chr20:4,872,720...4,876,425
G
Rxra
retinoid X receptor alpha
decreases expression
EXP
Uranium results in decreased expression of RXRA mRNA
CTD
PMID:17118558
NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:10,989,832...11,073,712
G
S100g
S100 calcium binding protein G
decreases expression increases expression
EXP
Uranium results in decreased expression of S100G mRNA Uranium results in increased expression of S100G mRNA
CTD
PMID:16502312
NCBI chr X:35,337,636...35,340,205
Ensembl chr X:31,705,866...31,708,433
G
Scamp1
secretory carrier membrane protein 1
affects expression
ISO
Uranium affects the expression of SCAMP1 mRNA
CTD
PMID:15672453
NCBI chr 2:25,433,958...25,516,734
Ensembl chr 2:25,433,959...25,516,673
G
Scn2b
sodium voltage-gated channel beta subunit 2
affects expression
ISO
Uranium affects the expression of SCN2B mRNA
CTD
PMID:15672453
NCBI chr 8:45,425,629...45,437,765
Ensembl chr 8:45,425,629...45,437,765
G
Scp2
sterol carrier protein 2
affects expression
ISO
Uranium affects the expression of SCP2 mRNA
CTD
PMID:15672453
NCBI chr 5:128,035,714...128,110,015
Ensembl chr 5:122,776,549...122,881,287
G
Sdc3
syndecan 3
affects expression
ISO
Uranium affects the expression of SDC3 mRNA
CTD
PMID:15672453
NCBI chr 5:148,249,792...148,282,524
Ensembl chr 5:142,965,591...142,996,480
G
Sdcbp
syndecan binding protein
affects expression
ISO
Uranium affects the expression of SDCBP mRNA
CTD
PMID:15672453
NCBI chr 5:24,245,279...24,314,712
Ensembl chr 5:19,489,961...19,527,572
G
Sec24b
SEC24 homolog B, COPII coat complex component
affects expression
ISO
Uranium affects the expression of SEC24B mRNA
CTD
PMID:15672453
NCBI chr 2:218,562,670...218,632,753
Ensembl chr 2:218,562,676...218,632,699
G
Sec62
SEC62 homolog, preprotein translocation factor
affects expression
ISO
Uranium affects the expression of SEC62 mRNA
CTD
PMID:15672453
NCBI chr 2:112,570,810...112,598,198
Ensembl chr 2:112,570,819...112,601,814
G
Selenoi
selenoprotein I
affects expression
ISO
Uranium affects the expression of SELENOI mRNA
CTD
PMID:15672453
NCBI chr 6:26,073,127...26,111,326
Ensembl chr 6:26,072,648...26,111,314
G
Serbp1
Serpine1 mRNA binding protein 1
affects expression
ISO
Uranium affects the expression of SERBP1 mRNA
CTD
PMID:15672453
NCBI chr 4:96,401,587...96,421,816
Ensembl chr 4:96,401,477...96,421,813
G
Sfxn3
sideroflexin 3
affects expression
ISO
Uranium affects the expression of SFXN3 mRNA
CTD
PMID:15672453
NCBI chr 1:253,856,935...253,866,219
Ensembl chr 1:243,907,751...243,917,073
G
Slc11a2
solute carrier family 11 member 2
decreases expression increases expression
EXP
Uranium results in decreased expression of SLC11A2 protein Uranium results in increased expression of SLC11A2 mRNA
CTD
PMID:18375546
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
G
Slc17a2
solute carrier family 17, member 2
affects expression
ISO
Uranium affects the expression of SLC17A2 mRNA
CTD
PMID:15672453
NCBI chr17:41,318,312...41,339,012
Ensembl chr17:41,319,701...41,336,325
G
Slc25a5-ps11
solute carrier family 25 member 5, pseudogene 11
affects expression
ISO
Uranium affects the expression of SLC25A6 mRNA
CTD
PMID:15672453
NCBI chr18:70,846,358...70,847,597
Ensembl chr18:68,571,300...68,572,199
G
Slc2a3
solute carrier family 2 member 3
affects expression
ISO
Uranium affects the expression of SLC2A3 mRNA
CTD
PMID:15672453
NCBI chr 4:157,632,887...157,698,034
Ensembl chr 4:155,960,946...156,025,472
G
Slc34a1
solute carrier family 34 member 1
multiple interactions
EXP
SLC34A1 protein results in increased uptake of [Uranium binds to Phosphates]
CTD
PMID:16476458
NCBI chr17:9,218,876...9,233,852
Ensembl chr17:9,218,876...9,233,852
G
Slc44a5
solute carrier family 44, member 5
affects expression
ISO
Uranium affects the expression of SLC44A5 mRNA
CTD
PMID:15672453
NCBI chr 2:242,911,050...243,208,018
Ensembl chr 2:242,911,325...243,206,404
G
Slc8a1
solute carrier family 8 member A1
decreases expression
EXP
Uranium results in decreased expression of SLC8A1 mRNA
CTD
PMID:17118558
NCBI chr 6:18,975,498...19,299,704
Ensembl chr 6:13,194,662...13,535,628
G
Smap1
small ArfGAP 1
affects expression
ISO
Uranium affects the expression of SMAP1 mRNA
CTD
PMID:15672453
NCBI chr 9:26,250,178...26,342,151
Ensembl chr 9:26,249,978...26,342,170
G
Smarcc1
SWI/SNF related BAF chromatin remodeling complex subunit C1
affects expression
ISO
Uranium affects the expression of SMARCC1 mRNA
CTD
PMID:15672453
NCBI chr 8:110,111,097...110,214,734
Ensembl chr 8:110,111,122...110,214,720
G
Smc5
structural maintenance of chromosomes 5
affects expression
ISO
Uranium affects the expression of SMC5 mRNA
CTD
PMID:15672453
NCBI chr 1:220,769,366...220,839,138
Ensembl chr 1:220,769,366...220,839,096
G
Snap91
synaptosome associated protein 91
affects expression
ISO
Uranium affects the expression of SNAP91 mRNA
CTD
PMID:15672453
NCBI chr 8:87,738,056...87,852,690
Ensembl chr 8:87,738,824...87,852,367
G
Snx6
sorting nexin 6
affects expression
ISO
Uranium affects the expression of SNX6 mRNA
CTD
PMID:15672453
NCBI chr 6:72,230,950...72,274,157
Ensembl chr 6:72,229,870...72,315,911
G
Spatc1l
spermatogenesis and centriole associated 1-like
affects expression
ISO
Uranium affects the expression of SPATC1L mRNA
CTD
PMID:15672453
NCBI chr20:12,074,040...12,083,873
Ensembl chr20:12,074,047...12,083,301
G
Spp1
secreted phosphoprotein 1
decreases secretion decreases expression
ISO
Uranium results in decreased secretion of SPP1 protein Uranium results in decreased expression of SPP1 mRNA
CTD
PMID:21324525 PMID:31120128
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
G
Spp2
secreted phosphoprotein 2
affects expression
ISO
Uranium affects the expression of SPP2 mRNA
CTD
PMID:15672453
NCBI chr 9:96,454,636...96,474,453
Ensembl chr 9:89,007,175...89,026,688
G
Srrm1
serine and arginine repetitive matrix 1
affects expression
ISO
Uranium affects the expression of SRRM1 mRNA
CTD
PMID:15672453
NCBI chr 5:152,843,167...152,875,554
Ensembl chr 5:147,559,514...147,591,849
G
Ssx2ip
SSX family member 2 interacting protein
affects expression
ISO
Uranium affects the expression of SSX2IP mRNA
CTD
PMID:15672453
NCBI chr 2:235,298,012...235,330,750
Ensembl chr 2:235,298,088...235,330,745
G
Star
steroidogenic acute regulatory protein
decreases expression
EXP
Uranium analog results in decreased expression of STAR mRNA
CTD
PMID:27544493
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:66,264,807...66,271,672
G
Stk36
serine/threonine kinase 36
affects expression
ISO
Uranium affects the expression of STK36 mRNA
CTD
PMID:15672453
NCBI chr 9:83,625,905...83,652,785
Ensembl chr 9:76,176,920...76,204,422
G
Stmn1
stathmin 1
affects expression
ISO
Uranium affects the expression of STMN1 mRNA
CTD
PMID:15672453
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
G
Stmn2
stathmin 2
affects expression
ISO
Uranium affects the expression of STMN2 mRNA
CTD
PMID:15672453
NCBI chr 2:93,204,690...93,252,011
Ensembl chr 2:93,204,692...93,252,011
G
Sult1b1
sulfotransferase family 1B member 1
multiple interactions
EXP
[Acetaminophen co-treated with Uranium analog] results in decreased expression of SULT1B1 mRNA
CTD
PMID:17126469
NCBI chr14:20,492,763...20,505,491
Ensembl chr14:20,492,708...20,505,483
G
Taldo1
transaldolase 1
affects expression
ISO
Uranium affects the expression of TALDO1 mRNA
CTD
PMID:15672453
NCBI chr 1:205,923,196...205,933,526
Ensembl chr 1:196,493,589...196,503,974
G
Tdg
thymine-DNA glycosylase
affects expression decreases expression
ISO EXP
Uranium affects the expression of TDG mRNA Uranium results in decreased expression of TDG mRNA
CTD
PMID:15672453 PMID:29024790
NCBI chr 7:22,965,388...22,990,311
Ensembl chr 7:21,077,853...21,097,567
G
Tet2
tet methylcytosine dioxygenase 2
decreases expression
EXP
Uranium results in decreased expression of TET2 mRNA
CTD
PMID:29024790
NCBI chr 2:221,988,645...222,072,813
Ensembl chr 2:221,988,645...222,072,534
G
Tet3
tet methylcytosine dioxygenase 3
decreases expression
EXP
Uranium results in decreased expression of TET3 mRNA
CTD
PMID:29024790
NCBI chr 4:115,867,412...115,964,433
Ensembl chr 4:115,871,265...115,964,193
G
Tf
transferrin
multiple interactions
ISO
Uranium binds to and results in decreased stability of TF protein
CTD
PMID:17266333
NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:103,767,995...103,816,511
G
Tfam
transcription factor A, mitochondrial
affects expression
ISO
Uranium affects the expression of TFAM mRNA
CTD
PMID:15672453
NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,356,197...17,368,292
G
Tgfb1
transforming growth factor, beta 1
decreases expression
EXP
Uranium analog results in decreased expression of TGFB1 mRNA
CTD
PMID:27544493
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Tgif2
TGFB-induced factor homeobox 2
affects expression
ISO
Uranium affects the expression of TGIF2 mRNA
CTD
PMID:15672453
NCBI chr 3:145,333,152...145,348,599
Ensembl chr 3:145,333,418...145,348,596 Ensembl chr17:145,333,418...145,348,596
G
Tgoln2
trans-golgi network protein 2
affects expression
ISO
Uranium affects the expression of TGOLN2 mRNA
CTD
PMID:15672453
NCBI chr 4:104,663,356...104,671,208
Ensembl chr 4:104,663,353...104,671,164
G
Thbs1
thrombospondin 1
decreases expression multiple interactions
EXP
Uranium results in decreased expression of THBS1 mRNA THBS1 protein inhibits the reaction [Uranium results in increased expression of CASP3 protein]; THBS1 protein inhibits the reaction [Uranium results in increased expression of DDIT3 protein]; THBS1 protein inhibits the reaction [Uranium results in increased expression of EIF2AK3 mRNA]; THBS1 protein inhibits the reaction [Uranium results in increased expression of EIF2AK3 protein]; Uranium results in decreased expression of and results in decreased secretion of THBS1 protein
CTD
PMID:37270086
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:105,056,292...105,071,440
G
Them5
thioesterase superfamily member 5
decreases expression
EXP
Uranium results in decreased expression of THEM5 mRNA
CTD
PMID:37270086
NCBI chr 2:181,980,783...181,986,002
Ensembl chr 2:181,980,783...181,986,002
G
Tlk1
tousled-like kinase 1
affects expression
ISO
Uranium affects the expression of TLK1 mRNA
CTD
PMID:15672453
NCBI chr 3:55,520,559...55,627,580
Ensembl chr 3:55,503,358...55,691,968
G
Tmem230
transmembrane protein 230
affects expression
ISO
Uranium affects the expression of TMEM230 mRNA
CTD
PMID:15672453
NCBI chr 3:119,473,109...119,497,617
Ensembl chr 3:119,480,735...119,497,614
G
Tnf
tumor necrosis factor
decreases expression decreases secretion
EXP ISO
Uranium results in decreased expression of TNF mRNA Uranium results in decreased secretion of TNF protein
CTD
PMID:17566059 PMID:23659960
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf11b
TNF receptor superfamily member 11B
multiple interactions
EXP ISO
GHRL protein inhibits the reaction [Uranium results in decreased expression of and results in decreased secretion of TNFRSF11B protein]; Uranium results in decreased expression of and results in decreased secretion of TNFRSF11B protein Anisomycin inhibits the reaction [GHRL protein inhibits the reaction [Uranium results in decreased expression of and results in decreased secretion of TNFRSF11B protein]]; GHRL protein inhibits the reaction [Uranium results in decreased expression of and results in decreased secretion of TNFRSF11B protein]; Uranium results in decreased expression of and results in decreased secretion of TNFRSF11B protein
CTD
PMID:29477364
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:85,566,520...85,594,538
G
Tnfrsf1b
TNF receptor superfamily member 1B
affects expression
ISO
Uranium affects the expression of TNFRSF1B mRNA
CTD
PMID:15672453
NCBI chr 5:162,356,250...162,387,411
Ensembl chr 5:157,070,642...157,104,206
G
Tnfrsf9
TNF receptor superfamily member 9
affects expression
ISO
Uranium affects the expression of TNFRSF9 mRNA
CTD
PMID:15672453
NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:161,381,662...161,408,000
G
Tnfsf11
TNF superfamily member 11
multiple interactions
EXP ISO
GHRL protein inhibits the reaction [Uranium results in increased expression of and results in increased secretion of TNFSF11 protein]; Uranium results in increased expression of and results in increased secretion of TNFSF11 protein Anisomycin inhibits the reaction [GHRL protein inhibits the reaction [Uranium results in increased expression of and results in increased secretion of TNFSF11 protein]]; GHRL protein inhibits the reaction [Uranium results in increased expression of and results in increased secretion of TNFSF11 protein]; Uranium results in increased expression of and results in increased secretion of TNFSF11 protein
CTD
PMID:29477364
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:53,673,877...53,705,445
G
Tnp1
transition protein 1
affects expression
ISO
Uranium affects the expression of TNP1 mRNA
CTD
PMID:15672453
NCBI chr 9:74,594,463...74,595,072
Ensembl chr 9:74,594,466...74,595,274
G
Tnp2
transition protein 2
decreases expression
EXP
Uranium analog results in decreased expression of TNP2 mRNA
CTD
PMID:27544493
NCBI chr10:4,879,812...4,880,540
Ensembl chr10:4,879,812...4,880,538
G
Tnpo1
transportin 1
affects expression
ISO
Uranium affects the expression of TNPO1 mRNA
CTD
PMID:15672453
NCBI chr 2:30,207,529...30,300,162
Ensembl chr 2:30,211,510...30,300,375
G
Tomm20
translocase of outer mitochondrial membrane 20
affects expression
ISO
Uranium affects the expression of TOMM20 mRNA
CTD
PMID:15672453
NCBI chr19:54,925,197...54,935,188
Ensembl chr19:54,923,402...54,935,198
G
Trak2
trafficking kinesin protein 2
affects expression
ISO
Uranium affects the expression of TRAK2 mRNA
CTD
PMID:15672453
NCBI chr 9:67,842,680...67,909,786
Ensembl chr 9:60,350,012...60,413,996
G
Trim28
tripartite motif-containing 28
affects expression
ISO
Uranium affects the expression of TRIM28 mRNA
CTD
PMID:15672453
NCBI chr 1:73,652,441...73,659,388
Ensembl chr 1:73,652,709...73,659,380
G
Trpv5
transient receptor potential cation channel, subfamily V, member 5
increases expression decreases expression
EXP
Uranium results in increased expression of TRPV5 mRNA Uranium results in decreased expression of TRPV5 mRNA
CTD
PMID:16502312 PMID:17118558
NCBI chr 4:71,503,085...71,531,134
Ensembl chr 4:70,536,440...70,562,745
G
Tuba1a
tubulin, alpha 1A
affects expression
ISO
Uranium affects the expression of TUBA1A mRNA
CTD
PMID:15672453
NCBI chr 7:131,992,151...131,996,850
Ensembl chr 7:130,081,032...130,196,186
G
Ube2d2
ubiquitin-conjugating enzyme E2D 2
affects expression
ISO
Uranium affects the expression of UBE2D2 mRNA
CTD
PMID:15672453
NCBI chr18:27,364,325...27,406,322
Ensembl chr18:27,364,303...27,406,181
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
multiple interactions
EXP
[Acetaminophen co-treated with Uranium analog] results in decreased expression of UGT2B1 mRNA
CTD
PMID:17126469
NCBI chr14:21,378,882...21,390,631
Ensembl chr14:21,024,006...21,035,986
G
Ulk2
unc-51 like autophagy activating kinase 2
affects expression
ISO
Uranium affects the expression of ULK2 mRNA
CTD
PMID:15672453
NCBI chr10:46,951,038...47,029,844
Ensembl chr10:46,454,030...46,530,407
G
Ung
uracil-DNA glycosylase
affects expression
ISO
Uranium affects the expression of UNG mRNA
CTD
PMID:15672453
NCBI chr12:48,145,838...48,154,789
Ensembl chr12:42,485,276...42,494,206
G
Vdac2
voltage-dependent anion channel 2
affects expression
ISO
Uranium affects the expression of VDAC2 mRNA
CTD
PMID:15672453
NCBI chr15:2,512,214...2,526,105
Ensembl chr15:2,463,056...2,476,553
G
Vdr
vitamin D receptor
decreases expression
EXP
Uranium results in decreased expression of VDR mRNA
CTD
PMID:17118558
NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:128,987,981...129,037,677
G
Vps13b
vacuolar protein sorting 13 homolog B
affects expression
ISO
Uranium affects the expression of VPS13B mRNA
CTD
PMID:15672453
NCBI chr 7:66,557,862...67,128,429
Ensembl chr 7:66,558,471...67,128,429
G
Vps13d
vacuolar protein sorting 13 homolog D
affects expression
ISO
Uranium affects the expression of VPS13D mRNA
CTD
PMID:15672453
NCBI chr 5:162,113,732...162,339,121
Ensembl chr 5:156,830,512...157,055,891
G
Vps26b
VPS26 retromer complex component B
affects expression
ISO
Uranium affects the expression of VPS26B mRNA
CTD
PMID:15672453
NCBI chr 8:25,415,877...25,436,985
Ensembl chr 8:25,415,261...25,436,985
G
Vsnl1
visinin-like 1
affects expression
ISO
Uranium affects the expression of VSNL1 mRNA
CTD
PMID:15672453
NCBI chr 6:34,038,641...34,159,479
Ensembl chr 6:34,038,642...34,159,479
G
Vta1
vesicle trafficking 1
affects expression
ISO
Uranium affects the expression of VTA1 mRNA
CTD
PMID:15672453
NCBI chr 1:9,032,861...9,080,635
Ensembl chr 1:9,032,335...9,080,635
G
Wasl
WASP like actin nucleation promoting factor
affects expression
ISO
Uranium affects the expression of WASL mRNA
CTD
PMID:15672453
NCBI chr 4:53,083,536...53,132,061
Ensembl chr 4:53,083,536...53,132,022
G
Wdr59
WD repeat domain 59
affects expression
ISO
Uranium affects the expression of WDR59 mRNA
CTD
PMID:15672453
NCBI chr19:39,416,432...39,483,773
Ensembl chr19:39,416,429...39,483,698
G
Wfdc2
WAP four-disulfide core domain 2
affects expression
ISO
Uranium affects the expression of WFDC2 mRNA
CTD
PMID:15672453
NCBI chr 3:153,286,946...153,314,832
Ensembl chr 3:153,286,131...153,292,807
G
Wnt3a
Wnt family member 3A
decreases expression
EXP
Uranium results in decreased expression of WNT3A mRNA
CTD
PMID:27639536
NCBI chr10:44,533,734...44,577,919
Ensembl chr10:44,034,194...44,078,324
G
Wnt7b
Wnt family member 7B
affects expression
ISO
Uranium affects the expression of WNT7B mRNA
CTD
PMID:15672453
NCBI chr 7:118,514,684...118,559,316
Ensembl chr 7:116,634,814...116,679,581
G
Wsb2
WD repeat and SOCS box-containing 2
affects expression
ISO
Uranium affects the expression of WSB2 mRNA
CTD
PMID:15672453
NCBI chr12:39,217,645...39,238,634
Ensembl chr12:39,217,648...39,238,640
G
Ythdf3
YTH N6-methyladenosine RNA binding protein F3
affects expression
ISO
Uranium affects the expression of YTHDF3 mRNA
CTD
PMID:15672453
NCBI chr 2:98,350,304...98,384,608
Ensembl chr 2:98,350,588...98,384,606
G
Ywhab
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
affects expression
ISO
Uranium affects the expression of YWHAB protein
CTD
PMID:15672453
NCBI chr 3:152,659,663...152,682,105
Ensembl chr 3:152,659,651...152,682,105
G
Ywhaq
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
affects expression
ISO
Uranium affects the expression of YWHAQ mRNA
CTD
PMID:15672453
NCBI chr 6:46,664,358...46,694,875
Ensembl chr 6:40,935,949...40,966,273
G
Zbtb16
zinc finger and BTB domain containing 16
increases expression
EXP
Uranium results in increased expression of ZBTB16 mRNA
CTD
PMID:37270086
NCBI chr 8:57,885,886...58,073,507
Ensembl chr 8:48,994,566...49,177,011
G
Zfp82
zinc finger protein 82
affects expression
ISO
Uranium affects the expression of ZFP82 mRNA
CTD
PMID:15672453
NCBI chr 1:85,291,462...85,311,265
Ensembl chr 1:85,293,220...85,311,318
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
Ytterbium analog results in increased expression of BAX protein
CTD
PMID:19632212
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
Ytterbium analog results in decreased expression of BCL2 protein
CTD
PMID:19632212
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Cacna1g
calcium voltage-gated channel subunit alpha1 G
multiple interactions
ISO
Ytterbium inhibits the reaction [CACNA1G protein results in increased transport of Barium]
CTD
PMID:12163980
NCBI chr10:79,851,886...79,919,926
Ensembl chr10:79,355,008...79,422,752
G
Casp9
caspase 9
increases activity
ISO
Ytterbium analog results in increased activity of CASP9 protein
CTD
PMID:19632212
Ensembl chr 5:154,109,046...154,126,626
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
Ytterbium analog results in increased cleavage of PARP1 protein
CTD
PMID:19632212
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all